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ABSTRACT 
 
 In the current post-genomic world, the exponential amassing of protein sequences is 
overwhelming the scientific community’s ability to experimentally assign each protein’s 
function. The use of automated, homology-based annotations has allowed a reprieve from this 
efflux of data, but has led to widespread misannotation and nonannotation in protein sequence 
databases. This dissertation details the functional and physiological characterization of the 
mannonate dehydratase subgroup (ManD) of the enolase superfamily (ENS). The outcome 
affirms the dangers of homology-based annotations while discovering novel metabolic pathways. 
Furthermore, the experimental verification of these pathways (in vitro and in vivo) has provided 
a platform to test the general strategies for improved functional and metabolic characterization 
being developed by the Enzyme Function Initiative (EFI). 
 Prior to this study, one member of the ManD subgroup had been characterized and was 
shown to dehydrate D-mannonate to 2-keto-3-deoxy-D-gluconate.  Forty-two additional 
members of the ManD, selected from across the sequence space of the subgroup, were screened 
for activity and kinetic constants were determined. The members of the once isofunctional 
subgroup were found to differ in both catalytic efficiency and substrate specificity: 1) high 
efficiency (kcat/KM = 103 to 104 M-1s-1) dehydration of D-mannonate, 2) low efficiency (kcat/KM = 
101 to 102 M-1s-1) dehydration of D-mannonate and/or D-gluconate, and 3) no-activity with either 
D-mannonate or D-gluconate (or any other acid sugar tested). The novel D-gluconate activity in 
this subgroup was investigated, and the mechanism of its enzymatic action was discovered. 
 Physiologically, D-mannonate dehydration is essential to D-glucuronate metabolism. The 
D-mannonate dehydratase, UxuA, is not a member of the ENS.  No  uxuA genes are found in the 
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genome of organisms with high efficiency ManDs. Through in vitro characterization and in vivo 
verification, a high efficiency ManD was discovered in Caulobacter crescentus CB15 that 
fulfills the same physiological role as UxuA and is an example of convergent evolution. 
 The genomes of organisms with low efficiency members of the ManD subgroup 
generally have the uxuA gene. Therefore, they likely fulfill a different physiological role than the 
high efficiency ManDs.  Their in vitro characterization and in vivo functional verification lead to 
the discovery of a novel L-gulonate metabolic pathway in Chromohalobacter salexigens 
DMS3043 where L-gulonate is converted to D-mannonate by a dehydrogenase and a reductase. 
While the low efficiency ManD found in C. salexigens is not metabolically essential to this 
pathway, its presence lead to the discovery of the pathway. Similar methods in Salmonella 
enterica subsp. enterica serovar Enteritidis str. P125109 lead to the discovery a novel L-idonate 
pathway where L-idonate is converted to D-gluconate by two dehydrogenases and then 
dehydrated (the traditional pathway phosphorylates D-gluconate). This pathway directly involves 
a low efficiency GlcD that is a member of the ManD subgroup and raises interesting questions 
about the physiological role of low efficiency enzymes and redundant pathways. As a whole, this 
dissertation displays how function diverges as sequence diverges while laying bare the dangers 
of annotation via homology; concurrently, it demonstrates how the continually advancing 
assignment strategies of the EFI can be used to discover new enzymatic functions and metabolic 
pathways. 
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CHAPTER 1: INTRODUCTION  
 
1.1. Focus of Study 
This dissertation outlines the development and execution of an experimental strategy 
whose purpose is to combat the problem of mis- and nonannotation in protein databases. 
Specifically, this strategy was employed to facilitate functional annotations of enolase 
superfamily members in the D-mannonate (ManD) subgroup and the L-fuconate dehydratase 
family in the mandelate racemase (MR) subgroup. In doing so, a novel activity was found in the 
ManD subgroup, a previously undiscovered example of convergent evolution was discovered, a 
novel metabolic pathway was established, and many physiological functions were correctly 
annotated. This work was completed as part of the Enzyme Function Initiative (EFI), and, as 
such, is of general interest to a broad host of disciplines including, but not limited to, 
bioinformatics, enzymology, systems biology, metabolic engineering, and microbiology. 
 
1.2. Dilemma of the Post-Genomic Era 
The genomic era began in 1973, when Fiers determined the sequence of the first gene, 
bacteriophage MS2 coat protein [1]. Technology advanced such that in ~20 years the sequence of 
the first bacterial genome was published [2]. In 2003, exactly 30 years after the sequence of the 
first gene was deciphered, the International Human Genome Sequencing Consortium (IHGSC) 
concluded the genomics era with the complete sequencing of the human genome [3, 4]. Thus 
began the dawn of the post-genomic era, and realization of the informational overload which 
would follow. 
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In the post-genomic era, sequencing technology has advanced to such a degree that it is 
routine to sequence an organism’s genome. This has led to an exponential rise in the number of 
proteins in the Translated European Molecular Biology Laboratory Nucleotide Sequence 
Database (TrEMBL). The TrEMBL database automatically annotates its proteins via homology, 
since it is impossible to experimentally verify every protein discovered in sequencing projects. 
This fact is evident in the Swiss-Prot protein database, which manually curates its annotations 
via literature citations, taxonomy, and cross-referenced databases (www.uniprot.org). At the time 
of composition of this thesis, the TrEMBL database comprised of ~53M proteins whereas the 
Swiss-Prot database only comprised of ~550k entries (~1% overlap). Strikingly, TrEMBL 
database entries are growing exponentially and Swiss-Prot entries are leveling off (Figure 1.1). 
The realization that the vast majority of proteins are annotated by automated, homology-based  
Figure 1.1.  The number of TrEMBL and Swis-Prot database entries at the time of composition.   
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methods has raised concerns among the biological community of the accuracy of protein 
databases such as TrEMBL. 
 
1.2.1. Mis- and Non-annotation in Protein Sequence Databases 
As early as 1996, it was recognized that automated methods would be needed to sift 
through all of the genetic data that would be generated as more organisms had their genome’s 
sequenced [5]. By 1998, apprehension of using homology-based annotations was already 
building. Karp called into question the accuracy of the process, and warned of the catastrophe rgr 
propagation of error could cause [6]. This warning was validated in 2002 when Gilks and co-
workers studied the percolation of error in protein databases; their conclusion was that complete 
loss of information would ultimately arise if the quality of homology-based annotations was not 
improved [7]. In fact, by this time, error was already rampant in the databases: a 2001 study by 
Devos and Valencia claimed that erroneous annotations may account for as high as 30% of all 
annotations [8]. Presumably, this error percentage would be higher when only looking at 
homology-based annotations. As such, a 2007 study of the Gene Ontology database estimated 
that up to 49% of homology-based annotations may be misannotated [9]. As the number of 
proteins in the TrEMBL database (i.e. proteins annotated by homology) continue to grow, and 
dwarf the number of manually curated proteins; the warnings of Karp and Gilks become more 
corporeal. New methods are needed not only to keep misannotation in check, but to quickly and 
accurately aide in the annotation of newly discovered proteins from genome sequencing projects. 
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1.3 The Enzyme Function Initiative 
The widespread non- and misannoation present in protein databases is an extensive 
problem. Any method which hopes to combat this must be capable of predicting functions in a 
high-throughput manner, but also enable the focused enzymatic characterization of a practical 
number of proteins. These newly discovered functions would be intelligently transferable to 
similar proteins and greatly improve the current number of protein annotations with experimental 
evidence (even if indirect). The Enzyme Function Initiative (EFI) was founded in May 2010 with 
this aim in mind [10]. The specific goal being “to develop and disseminate integrated 
sequence/structure-based strategies that incorporate a spectrum of essential expertise, including 
high-throughput bioinformatics, computation, and structural biology that will enable focused 
experimental enzymology, genetics, and metabolomics.” 
(http://enzymefunction.org/about/overview).  
 
1.3.1 Strategy of the EFI  
The EFI follows a general strategy beginning with bioinformatics and culminating with 
the determination of a protein’s physiological function through in vivo experimentation. An 
enzyme’s “protein family”  as classified by Pfam [11], InterPro [12], or ad hoc BLASTing can 
be used to generate a sequence similarity network (SSN, [13]) of all homologous proteins within 
that family where nodes represent protein sequences and connections are drawn between nodes 
that satisfy a user-defined sequence identity cutoff. Clusters formed within the SSN are evaluated 
for known/unknown functions. This network topology is instrumental in target determination and 
assignment of function to a protein of unknown function. 
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 When a target is chosen, it is cloned from its source organism and expressed in 
Escherichia coli. If soluble, the protein is purified and crystallized, and subjected to screening 
for binding partners via ThermoFluor [14], and its in vitro enzymatic activity is characterized 
(high-throughput screening, testing of proposed substrates from docking/ThermoFluor, etc.). If 
the target is crystallized, or a structure for a closely-related homologue is available, metabolite 
docking [15-17] can be performed on the crystal structure (or homology model) to aid in 
substrate determination. ThermoFluor is a fluorescence-based method which monitors if a 
metabolite stabilizes a protein by determining the melting temperature of a target protein in the 
presence and absence of ligand. If a metabolite stabilizes the target protein, it is thought to bind 
the protein and is a potential ligand/substrate. Thus, substrate determination for in vitro 
enzymatic characterization can be aided by metabolite docking hits, ThermoFluor hits, genome 
context, or high-throughput screening of compound libraries.  
Once the substrate is determined, in vivo data must be obtained to verify that the reaction 
is physiologically relevant. Within the EFI, three main techniques exist to achieve this goal: 
transcriptomics, phenotypic knockout studies, and metabolomics. Reverse-transcriptase PCR 
[18] is the primary form of transcriptomics used in the EFI, but in some cases RNA-seq [19] is 
implemented. Phenotypic knockout studies aim to find growth/no growth phenotypes for 
mutants, but this can vary depending on the target of interest. While metabolomics has a large 
variety of uses [20-22], the EFI primarily utilizes it to find intermediates in specific metabolic 
pathways. It is particularly useful when combined with knockout studies, as specific 
intermediates will accumulate in the cellular cytoplasm as a result of impaired metabolism.  
This is the idea of ‘new’ versus ‘old’ enzymology that has been introduced by the EFI. 
Old enzymology defines a protein’s function solely based on a chemical reaction observed in 
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vitro. New enzymology demands that in vivo evidence validate the in vitro reaction before a 
function is assigned. This ensures accurate annotation of the gene. The work in this thesis 
describes the implementation of the EFI strategy to functionally and physiologically characterize 
enolase superfamily members belonging to the D-mannonate dehydratase (ManD) subgroup in 
addition to L-fuconate dehydratases (FucD) in the MR subgroup.  
 
1.4 The Enolase Superfamily 
 The enolase superfamily (ENS) was discovered when Babbitt and co-workers realized the 
structural and mechanistic similarities between enolase, muconate-lactonizing enzyme (MLE), 
and mandelate racemase (MR) [23, 24] (Figure 1.2). In the ENS, evolution modified the 
common active site architectures to allow various enolic intermediates to differ in their overall 
reactions. Specifically, ENS members share an (α + β) capping domain for substrate specificity 
and a modified (β/α)8-barrel domain ((β/α)7β-barrel) for acid/base chemistry [25, 26]. 
Mechanistic similarities stem from a common partial reaction: abstraction of a proton alpha to a 
carboxylate group to form an enedioate intermediate that is stabilized by a divalent metal cation 
(usually Mg2+) [23] (Figure 1.3). Subgroups are differentiated based on the conserved metal-
binding residues at the ends of the 3rd, 4th, and 5th β-strands, as well as conserved catalytic 
acid/base residues at the ends of the 2nd, 3rd, 6th, and 7th β-strands of the modified (β/α)8-barrel 
domain. The ENS is particularly interesting because the members share the same structural 
motifs and utilize common chemistry, but are functionally diverse (e.g. β-elimination and 1,1-
proton transfer reactions) [10, 27] (Figure 1.4). This makes the superfamily an ideal model 
obtaining a better definition of the structure-function relationship. The following work has 
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implications not only in more refined functional annotation algorithms, but also enzyme 
evolution and protein engineering. 
 
Figure 1.2. Crystal structures of an enolase (PDB 1PDY), MLE (PDB 1BKH), and MR (PDB 
2MNR). The common structural motifs are labeled on 1PDY. The capping domain has green-
labeled β-sheets and magenta-labeled α-helices. The modified TIM-barrel has blue-labeled β-
sheets and red-labeled α-helices. In the MR and MLE subgroups, the “20s” loop (star) from 
capping domain extends over the active site. 
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Figure 1.3. The common partial reaction shared by all ENS members: base-catalyzed abstraction 
of a proton alpha to a carboxylate group to form an enediolate intermediate. This intermediate is 
stabilized by the divalent metal cation, Mg2+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.4. All known reactions within the 
Adapted from a power point slide provided by Dr. John Gerlt.
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ENS. Distinct subgroups are separated by blue boxes. 
 
 
10 
 
 
1.4.1 The Mannonate Dehydratase Subgroup 
The D-mannonate dehydratase subgroup (ManD) of the ENS was discovered by Rakus 
and co-workers in 2007 [28]. A ManD from Novosphingobium aromaticivorans (NaManD) was 
screened for dehydration activity using a library of acid sugars and found to be specific to the 
dehydration of D-mannonate to 2-keto-3-deoxy-D-mannonate: kcat of 1.3 ± 0.1 s-1 and kcat/KM of 
6.9 x 103 M-1 s-1 (Figure 1.5).  The residues responsible for Mg2+ binding are Asp, Glu, and Glu 
at the end of the 3rd, 4th, and 5th β-strands  [28].  
 
      
Figure 1.5. The dehydration of D-mannonate to 2-keto-3-deoxy-D-mannonate. NaManD 
performs this reaction with a kcat of 1.3 ± 0.1 s-1 and kcat/KM of 6.9 x 103 M-1 s-1. 
 
The catalytic base is a Tyr located at the start of the “150-180s” loop (between the 2nd and 3rd β-
strands); the catalytic acid, His, is located at the end of the 3rd β-strand [28]. The “150-180s” 
loop is unique to the ManD subgroup. Other acid sugar dehydratases are found in the enolase 
superfamily, but they occlude the active site from solvent using a “20s” loop from the capping 
domain (seen in Figure 1.2). This sets ManDs apart in that their capping domain does not 
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interact with the active site directly like most other ENS members (Figure 1.6). Physiologically, 
D-mannonate dehydration is known to be involved in D-glucuronate metabolism [29], although, 
the enzyme characterized to dehydrate D-mannonate in this pathway, UxuA (utilization of 
hexuronate A), is not an ENS member. Therefore, it remains to be verified that ManDs are also 
involved in D-glucuronate metabolism. In this dissertation, it is determined how function 
diverges as sequence diverges in the ManD subgroup, and the physiological role of high and low 
efficiency ManDs is investigated. 
 
Figure 1.6. Crystal structure of NaManD (PDB 2QJJ). The capping domain has green-labeled β-
sheets and magenta-labeled α-helices. The modified TIM-barrel has blue-labeled β-sheets and 
red-labeled α-helices. The “150-180s” loop is colored orange. Mg2+ and the metal binding 
residues are shown to visualize the active site. 
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1.4.2 Fuconate Dehydratases in the Mandelate Racemase Subgroup 
 L-Fuconate dehydration activity was discovered in the MR subgroup of the ENS by Yew 
and co-workers [30]. The L-fuconate dehydratase (FucD) from Xanthomonas campestris 
(XcFucD) was found to dehydrate L-fuconate with a kcat of 15 ± 0.2 s-1 and kcat/KM of 4.5 x 104 
M-1 s-1 [30] (Figure 1.7). Being of the MR subgroup, the Mg2+ binding residues are the Asp, Glu, 
and Glu at the end of the 3rd, 4th, and 5th β-strands respectively [24]. Additionally, all MR 
subgroup members have a conserved general base, KxK motif at the end of the 2nd β-strand, and 
general acid, His-Asp dyad located at the ends of the 6th and 7th β-strands, respectively [24]. 
Physiologically, L-fuconate dehydration is proposed to be involved in the metabolism of L-
fucose though no in vivo experimentation has been performed [30]. Interestingly, other than the 
namesake enzyme, enolase, L-fuconate dehydratases are the only ENS members found in 
eukaryotes. In this dissertation, a human FucD, rTSγ, is characterized as an L-fuconate 
dehydratase and the role of an isoform, rTSβ, in chemotherapeutic resistance is investigated.  
 
Figure 1.7. The dehydration of L-fuconate to 2-keto-3-deoxy-L-fuconate. XcFucD performs this 
reaction with a kcat of 15 ± 0.2 s-1 and kcat/KM of 4.5 x 104 M-1 s-1. 
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CHAPTER 2: DISCOVERY OF FUNCTION IN THE ENOLASE SUPERFAMILY;  
D-MANNONATE AND D-GLUCONATE DEHYDRATASES IN THE D-MANNONATE 
DEHYDRATASE SUBGROUP 
 
ABSTRACT:  The continued increase in the size of the protein sequence databases as a result of 
advances in genome sequencing technology is overwhelming the ability to perform experimental 
characterization of function.  Consequently, functions are assigned to the vast majority of 
proteins via automated, homology-based methods, with the result that as many as 50% are 
incorrectly annotated or unannotated (Schnoes et al., 2009).  This manuscript describes a study 
of the D-mannonate dehydratase (ManD) subgroup of the enolase superfamily (ENS) to 
investigate how function diverges as sequence diverges.  Previously, one member of the 
subgroup had been experimentally characterized as ManD [dehydration of D-mannonate to 2-
keto-3-deoxy-D-mannonate (equivalently, 2-keto-3-deoxy-D-gluconate)].  In this study, 42 
additional members were characterized to sample sequence-function space in the ManD 
subgroup.  These were found to differ in both catalytic efficiency and substrate specificity: 1) 
high efficiency (kcat/KM = 103 to 104 M-1s-1) for dehydration of D-mannonate, 2) low efficiency 
(kcat/KM = 101 to 102 M-1s-1) for dehydration of D-mannonate and/or D-gluconate, and 3) no-
activity with either D-mannonate or D-gluconate (or any other acid sugar tested).  Thus, the 
ManD subgroup is not isofunctional and includes D-gluconate dehydratases (GlcDs) that are 
divergent from the GlcDs that have been characterized in the mandelate racemase subgroup of 
the ENS (Lamble et al., 2004) (Ahmed et al., 2005).  These observations signal caution for 
functional assignment based on sequence homology and lay the foundation for the studies of the 
physiological functions of the GlcDs and the promiscuous ManDs/GlcDs. 
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Reprinted (adapted) with permission from Wichelecki, D. J., Balthazor, B. M., Chau, A. A., 
Vetting, M. W., Fedorov, A. A., Fedorov, E. V., Lukk, T., Patskovsky, Y. V., Stead, M. B., 
Hillerich, B. S., Seidel, R. D., Almo, S. C., and Gerlt, J. A. Biochemistry. 2014 Apr 
29;53(16):2722-31. 
 
2.1. Introduction 
The massive influx of sequence data since the first bacterial genome sequence was 
published in 1995 has necessitated a reliance on homology-based annotations of protein function 
[2, 5].  However, because this method assigns the function of the “closest” homologue, an 
estimated 30-50% of the functional annotations in the databases are incorrect [8, 9, 31], with the 
magnitude of the problem increasing as the incorrect annotations are propagated in assigning 
functions to proteins discovered in newly sequenced genomes.  In a study of several functionally 
diverse superfamilies, Schnoes, Babbitt, and coworkers concluded that 85% of misannotations 
resulted from annotations which were more detailed than justified3.  Automated methods often 
are able to achieve high degrees of accuracy in the transfer of the first three Enzyme Commission 
(EC) code numbers, but accurate transfer of the fourth EC code number (substrate specificity) is 
much more difficult [32].  This study examines the D-mannonate dehydratase (ManD) subgroup 
of the enolase superfamily (ENS) to determine experimentally, on a large scale, how function 
diverges as sequence diverges in highly homologous enzymes.  Our results illustrate the 
difficulty of accurately assigning function via homology-based methods and, also, provide 
insights into how different functions can arise in highly homologous enzymes. 
Two conserved features are shared by members of the ENS:  mechanism and structure.  
The mechanism is general base-catalyzed abstraction of a proton alpha to a carboxylate group of 
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the substrate to form an enediolate intermediate [23].  The enediolate intermediate is stabilized 
by coordination to an active site divalent metal cation (usually Mg2+).  Furthermore, members of 
the ENS share a common structural motif: an (α+β) capping domain that contains the residues 
that determine substrate specificity and a modified TIM-barrel domain ((β/α)7β-barrel) that 
contains the residues that mediate acid/base chemistry [25, 26]. Subgroups are differentiated by 
the conserved metal-binding residues at the ends of the 3rd, 4th, and 5th β-strands as well as 
conserved catalytic acid/base residues at the ends of the 2nd, 3rd, 6th, and/or 7th β-strands of the 
modified TIM-barrel domain. The ENS is particularly interesting because its members share a 
common mechanism and the same structural motif but are functionally diverse (e.g., β-
elimination and 1,1-proton transfer reactions) [10, 27].  Thus, the ENS is a good model to 
investigate how function diverges as sequence diverges.  
In 2007, Rakus and coworkers discovered the ManD subgroup of the ENS [28]. In that 
study, a protein from Novosphingobium aromaticivorans (NaManD) was structurally 
characterized and discovered to catalyze the syn-dehydration of D-mannonate to 2-keto-3-deoxy-
D-mannonate (equivalently, 2-keto-3-deoxy-D-gluconate) (EC 4.2.1.8 and Unitprot ID 
A4XF23). The Mg2+-binding residues located at the ends of the 3rd, 4th, and 5th β-strands are 
Asp 210, Glu 236, and Glu 262, respectively.  The general base that abstracts the 2-proton is the 
Tyr 159-Arg 147 dyad in the “150-180s” loop between the 2nd and 3rd β-strands; the general acid 
that facilitates departure of the 3-hydroxyl group is His 212 located at the end of the 3rd β-strand 
[28] (Figure 2.1).  His 315 located at the end of the 7th β-strand that is hydrogen-bonded to the 
5-hydroxyl group of the D-mannonate substrate is also conserved.  Since this study, no other 
members of the ManD subgroup have been experimentally characterized.  Given the 
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conservation of metal-binding residues, catalytic residues, and active site architecture, the 
assumption was that the entire subgroup is isofunctional.  
Figure 2.1. Denotes the structural features of the ManDs (PDB 2QJJ). On the left, the “150-
180s” loop (blue), TIM barrel (red), and capping domain (green) are displayed. The right inset 
shows the active site residues: metal binding Asp210, Glu236, Glu262 (green); Tyr157-Arg149 
catalytic dyad (magenta); acidic His212 (blue); and conserved His315 at the end of the 7th β-
strand (red). The ligand, D-mannonate, is shown in light blue from the 2QJM structure. 
 
In this study, we sought to investigate how function diverges as sequence diverges within 
this subgroup and to determine if the ManD subgroup is, in fact, isofunctional.  When the target 
proteins for this study were selected in April 2011, the ManD subgroup included NaManD [28] 
and 299 uncharacterized proteins that share ≥35% sequence identity [Structure-Function Linkage 
Database (http://sfld.rbvi.ucsf.edu/)].  [At the time of submission of this manuscript, the 
UniProtKB database contained the sequences for 2919 members of the ManD subgroup.]  Forty 
three members representing the breadth of sequence-function space were produced as soluble 
proteins and screened for activity using a library of acid sugars.  Surprisingly, we found that the 
ManD subgroup is not isofunctional; instead, in addition to ManDs it also contains D-gluconate 
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dehydratases (GlcDs) that catalyze the anti-dehydration of D-gluconate to 2-keto-3-deoxy-D-
gluconate as well promiscuous proteins that catalyze both the ManD and GlcD reactions 
(Scheme 2.1). In addition, a wide range of catalytic efficiencies (values of kcat/KM) was  
 
 
Scheme 2.1. The dehydration of D-mannonate/D-gluconate to 2-keto-3-deoxy-D-gluconate. 
 
discovered. Using sequence similarity networks (SSNs) [13], the members with these divergent 
functions could be separated into isofunctional clusters.  Furthermore, sixteen unique crystal 
structures (for a total of 36 unliganded and liganded structures) were solved to survey sequence 
and structure space; these revealed conserved active site structures but divergent conformations 
for the “150-180s” loops that contain the general basic Tyr-Arg dyads and close over the active 
site to sequester the substrate from solvent.  Taken together, the functional and structural data 
provide a comprehensive description of how in vitro function diverges as sequence diverges. 
 
2.2 Materials and methods 
Cloning, Expression, and Purification of Targets (AECOM). pNIC28-BSA4-based 
expression vectors were transformed into BL21(DE3) E. coli containing the pRIL plasmid 
(Stratagene) and used to inoculate a 10mL 2xYT culture containing 25ug/mL Kanamycin and 
18 
 
34ug/mL Chloramphenicol.  The cultures were allowed to grow overnight at 37°C in a shaking 
incubator.  The overnight culture was used to inoculate 2L of PASM-5052 auto-induction media 
[33].  The culture was placed in a LEX48 airlift fermenter and incubated at 37°C for 4 hours and 
then at 22°C overnight.  The culture was harvested and pelleted by centrifugation. 
Cells were resuspended in lysis buffer (20 mM HEPES, pH 7.5, 500 mM NaCl, 20 mM 
imidazole, and 10% glycerol) and lysed by sonication.  The lysate was clarified by centrifugation 
at 35,000g for 30 min.  The protein was purified using an AKTAxpress FPLC (GE Healthcare).  
The lysate was loaded onto a 1 mL His60 column (Clontech), washed with 10 column volumes 
of lysis buffer, and eluted with buffer containing 20 mM HEPES, pH 7.5, 500 mM NaCl, 500 
mM Imidazole, and 10% glycerol.  This partially purified protein was loaded onto a HiLoad 
S200 16/60 PR gel filtration column equilibrated with SECB buffer (20 mM HEPES, pH7.5, 150 
mM NaCl, 10% glycerol, and 5 mM DTT).  The protein was analyzed by SDS-PAGE, flash 
frozen in liquid nitrogen, and stored at -80°C. 
Expression and Purification of N-terminal His-tagged Proteins (UIUC).  Genes in 
pET15b (Novagen) were expressed in Escherichia coli strain BL21.  Small-scale cultures were 
grown at 37˚ C for 18 hrs in 5 mL of LB containing 100 µg/mL ampicillin and used to inoculate 
1 L LB containing 100 µg/mL ampicillin.  IPTG (500 µM) was added at OD600 nm = 0.6-0.8 to 
induce expression.  The induced cultures then were grown for an additional 18 hrs at 37˚ C.  The 
cells were harvested by centrifugation at 5000 rpm for 10 minutes and resuspended in 70 mL of  
binding buffer (6 mM imidazole, 20 mM Tris-HCl, pH 7.9, 5 mM MgCl2, and 500 mM NaCl).  
The resuspended cells were lysed by sonication and centrifuged at 17,000 rpm for 30 minutes.  
The supernatant was loaded onto a column of 50 mL chelating Sepharose Fast Flow (Amersham 
Biosciences) charged with Ni2+ and eluted with a linear gradient of imidazole (0 – 1 M over 600 
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mL).  Fractions were analyzed using SDS-PAGE.  Fractions containing protein at high purity 
(>90%) were combined and dialyzed against 4 L of buffer containing 100 mM imidazole, 20 mM 
Tris-HCl, pH 7.9, 10 mM MgCl2, 150 mM NaCl, and 10% glycerol for 2 hrs at 4 ˚C. The protein 
was dialyzed in this manner a total of three times. Finally, the protein was concentrated to a 
maximum of ~10 mg/mL (depending on solubility) and flash-frozen using liquid nitrogen and 
stored at -80˚ C. 
Expression and Purification of Tagless ManD Constructs (UIUC). The genes in pET17b 
(Novagen) were expressed in Escherichia coli strain BL21.  Small-scale cultures were grown at 
37 ˚C for 18 hrs in 5 mL of LB containing 100 µg/mL ampicillin and used to inoculate 1 L LB 
containing 100 µg/mL ampicillin.  The 1L cultures were grown for an additional 18 hrs at 37 ˚C 
without induction.  The cells were harvested by centrifugation at 5000 rpm for 10 minutes and 
resuspended in 70 mL of binding buffer.  The resuspended cells were lysed by sonication and 
centrifuged at 17,000 rpm for 30 minutes.  The supernatant was loaded onto a 300 mL DEAE 
Sepharose column (Amersham Biosciences) and eluted with a linear gradient of NaCl (0 - 1 M 
over 1.6 L) in 10 mM Tris-HCl, pH 7.9, containing 5 mM MgCl2. Fractions containing the 
protein of interest at high purity were combined and dialyzed against 4 L buffer containing 10 
mM Tris-HCl, pH 7.9, and 5 mM MgCl2 for 2 hours at 4 ˚C. The dialyzed protein was then 
loaded onto a 30 mL Q-Sepharose column (Amersham Biosciences) and eluted with a linear 
gradient of NaCl (0 - 1 M over 500 mL) in 10 mM Tris-HCl,pH 7.9, containing 5 mM MgCl2. 
Fractions containing the protein of interest at high purity were combined and dialyzed in 4 L 
buffer containing 10 mM Tris-HCl, pH 7.9, containing 5 mM MgCl2 for 2 hrs at 4 ˚C. 
Ammonium sulfate was added to a final concentration of 1 M, and the sample was loaded onto a 
30 mL phenylsepharose column (Amersham Biosciences). The protein was eluted with a 
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gradient of ammonium sulfate (1 - 0 M over 500 mL) in 10 mM Tris-HCl, pH 7.9, containing 5 
mM MgCl2. Fractions with pure protein (SDS-PAGE) were combined and dialyzed against 4 L 
buffer containing 10 mM Tris-HCl, pH 7.9, 5 mM MgCl2, 150 mM NaCl, and 10% glycerol for 2 
hrs at 4 ˚C.  Finally, the protein was concentrated to a maximum of ~10 mg/ml (depending on 
solubility) and flash frozen in liquid nitrogen and stored at -80˚ C. 
Screen for Dehydration.  Reactions to test for enzymatic activity were performed in 
acrylic, UV transparent 96-well plates (Corning Incorporated) using a library of 72 acid sugars 
(Figure A.1).  Reactions (60 µL) contained 50 mM HEPES, pH 7.9, 10 mM MgCl2, 1 µM 
enzyme, and 1 mM of acid sugar substrate (blanks without enzyme).  The plates were incubated 
at 30 ˚C for 16 hrs.  A 1% semicarbazide reagent solution (240 µL) was added to each well and 
incubated for 1 hr at room temperature. The absorbancies were measured at 250 nm (ε = 10,200 
M-1cm-1) using a Tecan Infinite M200PRO plate reader.  
Kinetic Assays.  Dehydration of D-mannonate and D-gluconate was quantitated using 
either a discontinuous assay with the semicarbazide reagent [34, 35] or a continuous, 
coupled-enzyme spectrophotometric assay.  In the latter assay, the product was phosphorylated 
using 2-keto-3-deoxy-D-gluconate kinase (KdgK) and ATP; formation of ADP was measured 
using pyruvate kinase (PK) and L-lactate dehydrogenase (LDH).  The assay (200 µL) at 25 °C 
contained 50 mM potassium HEPES, pH 7.5, 5 mM MgCl2, 1.5 mM ATP, 1.5 mM PEP, 0.16 
mM NADH, 9 units of PK, 9 units of LDH, 18 units of KdgK, and ManD/GlcD.  Dehydration 
was quantitated by measuring the decrease in absorbance at 340 nm (ε = 6220 M-1 cm-1).  
Low-activity enzymes were characterized using the discontinuous assay; high-activity ManDs 
were characterized using the coupled assay. 
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Site-Directed Mutagenesis (SDM).  Mutants were constructed using primers designed 
with the Agilent Technologies online webserver (https://www.genomics.agilent.com/) and 
purchased from Bio-Synthesis, Inc.  Forward and reverse primers containing the mutations of 
interest are listed in Table A.1. PCR reactions (30 µL) contained 1 mM MgCl2, 1X Pfx Amp 
Buffer, 0.33 mM dNTP, 0.33 µM of FOR/REV primer, and 1.25 units Pfx polymerase 
(Invitrogen Platinum Pfx DNA Polymerase kit). The templates were 50 ng ManD-containing 
pET15b (NaManD) or pET17b (CsManD). Amplifications were performed according to the 
manufacturer’s guidelines.  After addition of DpnI (10 units), the reactions were incubated for 4 
hrs at 37 ˚C. The DpnI-digested products were purified by gel electrophoresis, extracted and 
transformed (electroporation, Bio-Rad Micropulsar Electroporator) into XL1 Blue competent 
cells.  Finally, plasmids isolated from the transformants were sequenced to confirm the 
mutations.  
Circular Dichroism of NaManD and CsManD Loop Mutants.  The circular dichroism 
spectrum of a 10 µM solution of mutant enzyme in an optically clear borate buffer (50 mM boric 
acid, 100 mM KCl, 0.7 mM DTT, pH 8.0) was measured from 190-260 nm using a Jasco J-715 
spectropolarimeter.  Five replicate measurements were made. 
Protein crystallization and X-ray diffraction data collection. Proteins were crystallized 
by the sitting-drop vapor diffusion method. The concentrated (usually 5-40 mg/ml) protein 
solutions (from 0.3 to 1 µL) were mixed with an equal volume of a precipitant solution and 
equilibrated at room temperature (~294 °K) against the same precipitant solution in clear tape-
sealed 96-well INTELLI-plates (Art Robbins Instruments, Sunnyvale, CA). Crystallization was 
performed using either a TECAN crystallization robot (TECAN US, Research Triangle Park, 
NC) or a PHOENIX crystallization robot (Art Robbins Instruments) and four types of 
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commercial crystallization screens: the WIZARD I&II screen (Emerald BioSystems, Bainbridge 
Island, WA); the INDEX HT and the CRYSTAL SCREEN HT (both from Hampton Research, 
Aliso Viejo, CA); and the MCSG screen (Microlytic, Woburn, MA).  The appearance of protein 
crystals has been monitored either by visual inspection or using a Rock Imager 1000 
(Formulatrix, Waltham, MA) starting within 24 hours of incubation and again at weeks 1, 2, 3, 5, 
8, and 12. Where necessary, the crystallization conditions were optimized manually using 
24-well Cryschem sitting drop plates (Hampton Research). The crystallization conditions for all 
crystal structures are listed in the PDB methods tab and the Supplementary Information. The 
crystals were either directly frozen in liquid nitrogen or treated with a cryoprotectant (glycerol or 
ethylene glycol, 20-30%, vol/vol) before freezing.  
The X-ray diffraction data for the frozen crystals were collected at 100 °K on the 
beamline X29A (National Synchrotron Light Source, Brookhaven National Laboratory, Upton, 
NY) using a wavelength of 1.075 Å or on the beamline 31I-D (LRL-CAT, Advanced Photon 
Source, Argonne National Laboratory, IL, USA) using a wavelength of 0.9793 Å. The diffraction 
data were processed and scaled with SCALA [36] (APS data) or HKL [37] (NSLS data). The 
crystal structures reported here were determine by molecular replacement using coordinates for 
similar structures from the PDB (listed in each PDB deposition as REMARK 200: STARTING 
MODEL) and PHASER MR software (the CCP4 program package suite [38]. Each structure was 
refined using the programs REFMAC [39] or PHENIX [40] and the resulting models were 
rebuilt manually using COOT visualization and refinement software [41]. The data collection 
and refinement statistics for all crystal structures are listed in the Table A.2. 
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2.3 Results and Discussion 
Selection of Targets.  In April 2011, the Structure-Function Linkage Database (SFLD; 
sfld.rbvi.ucsf.edu/) contained 300 sequences for the ManD subgroup of the ENS (NaManD and 
299 uncharacterized homologues).  These sequences were used to generate a sequence similarity 
network (SSN) with a BLASTP e-value threshold of 10-80 (~35% sequence identity) (Figure 
2.2a) [13, 42, 43].  As the BLASTP e-value threshold is decreased to 10-190, the sequences 
segregate into several clusters sharing >70% sequence identity (Figure 2.2c). 
 
Figure 2.2. Sequence similarity networks (SSNs) of the ManD subgroup of the ENS at several 
e-value thresholds to illustrate the effect of increasing stringency on clustering.  Panel A, 10-80, 
~35% identity.  Panel B, 10-120, ~45% identity.  Panel C, 10-190, ~75% identity. Pink coloring 
indicates proteins predicted to be ManDs by the Structure Function Linkage Database. Green 
coloring indicates proteins that were purified and subjected to activity screening. 
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The genome neighborhoods of the genes encoding members of the ManD subgroup (± 10 
genes) were analyzed to aid in target selection for protein production and structure 
determination.  The genome neighborhoods of some members encode 2-keto-3-deoxy-D-
gluconate kinase (KdgK) and 2-keto-3-deoxy-D-gluconate-6-P aldolase (KdgA).  KdgK and 
KdgA metabolize the 2-keto-3-deoxy-D-gluconate product of the ManD reaction to pyruvate and 
D-glyceraldehyde 3-phosphate, indicating a catabolic role for the proximal member of the ManD 
subgroup.  Alternatively, for some members the genome neighborhoods lack these enzymes but 
contain, for example, dehydrogenases, suggesting divergent catalytic and metabolic functions.  
Targets for protein production by the Protein Core of the Enzyme Function Initiative (EFI; 
enzymefunction.org), functional characterization by the University of Illinois, and structure 
determination by the Structure Core of the EFI were chosen from both types of genome 
neighborhoods.  A large number of targets (115) were chosen with the anticipation that not all 
targets would produce soluble, purified proteins. 
Substrate Screening.  Of the 115 targets, 42 were produced as soluble, purified proteins 
(sharing less than 95% sequence identity).  The ManD SSN in Figure 2.2 highlights the diversity 
of purified proteins assayed.  The proteins were screened for dehydration activity with a library 
of 72 acid sugars using a semicarbazide-based assay (Figure A.1) [30, 44, 45].  The catalytically 
active proteins (24 of the 42 screened) utilize D-mannonate, D-gluconate, or both as substrates; 
no other hits were observed with the acid sugar library.  Positive hits were verified with 1H NMR 
spectra of the products (2-keto-3-deoxy-D-mannonate/2-keto-3-deoxy-D-gluconate) before the 
proteins were subject to more in-depth analyses to determine kinetic constants.  The ability of 
some members to catalyze the dehydration of D-gluconate was not expected (vide infra).   
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The kinetic characterizations revealed further unexpected divergence in function (Table 
2.1). Among the newly characterized ManDs, seven dehydrate D-mannonate with catalytic 
efficiencies similar to that of NaManD (kcat/KM = 103 to 104 M-1s-1).  However, 16 targets 
showed low catalytic efficiencies (kcat/KM = 101 to 102 M-1s-1); 19 showed no detectable activity 
with any member of the acid sugar library.  Three of the 12 proteins that dehydrate D-mannonate 
with low catalytic efficiency also dehydrate D-gluconate with low catalytic efficiency.  
Furthermore, four of the 23 targets with no activity on D-mannonate dehydrate D-gluconate.  
Thus, the functionally characterized members were assigned into three categories according to 
catalytic efficiency and substrate specificity: 1) high-activity (kcat/KM = 103 to 104 M-1s-1) and 
specific for D-mannonate; 2) low-activity (kcat/KM = 101 to 102 M-1s-1) and specific for either 
D-mannonate or D-gluconate or promiscuous for both; and 3) no-activity with either 
D-mannonate or D-gluconate (or any acid sugar in the library).  The SSN constructed with a 
threshold of 10-190 (~75% sequence identity) segregates groups with different catalytic 
efficiencies and substrate specificities (Figure 2.3).   
Divergence in Activity.  Members with different in vitro activities are assumed to have 
different in vivo functions.  Physiologically, the dehydration of D-mannonate to 2-keto-3-deoxy-
D-mannonate is found in the D-glucuronate degradation pathway in which D-glucuronate is 
isomerized to 5-keto-D-mannonate and then reduced to D-mannonate.  The D-mannonate is 
dehydrated, phosphorylated, and cleaved by an aldolase to form pyruvate and glyceraldehyde 
3-phosphate.  When this pathway was discovered in E. coli and Erwinia carotovora, dehydration 
of D-mannonate was found to be catalyzed by a dehydratase, UxuA, that is not a member of the 
ENS [29, 46].  Therefore, the discovery that members of the ManD subgroup dehydrate 
D-mannonate with high catalytic efficiency implies convergent evolution of function in different  
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Table 2.1. Kinetic Parameters of Assayed ENS Mannonate Dehydratases  
Cluster   Uniprot ID 
D-Mannonate 
kcat (s-1) 
D-Mannonate 
kcat/KM (M-1s-1) 
D-Gluconate 
kcat (s-1) 
D-Gluconate 
kcat/KM (M-1s-1) 
End of 7th 
β-strand UxuA? 
1 A5KUH4 --- --- --- --- Pro Yes 
1 C9NUM5 --- --- --- --- Pro No 
1 C9Y5D5 --- --- --- --- Pro Yes 
1 D0KC90 --- --- --- --- Pro Yes 
1 A4W7D6 --- --- --- --- Pro Yes 
1 D0X4R4 --- --- --- --- Pro Yes 
1 A6AMN2 --- --- --- --- Pro Yes 
1 Q6DAR4 --- --- --- --- Pro Yes 
1 C6DI84 --- --- --- --- Pro Yes 
6 B8HCK2 --- --- --- --- Pro No 
9 C9CN91 --- --- --- --- Pro Yes 
9 C8ZZN2 --- --- --- --- Pro Yes 
10 C7PW26 --- --- --- --- Pro No 
Singleton A6M2W4 --- --- --- --- Pro Yes 
Singleton Q2CIN0 --- --- --- --- Pro Yes 
Singleton A8RQK7 --- --- --- --- Pro Yes 
Singleton C6CVY9 --- --- --- --- Gly Yes 
Singleton C9A1P5 --- --- --- --- Pro Yes 
Singleton B5GCP6 --- --- --- --- Pro No 
3 A6VRA1 0.02 ± 0.001 160 --- --- Ala Yes 
3 E1V4Y0 0.03 ± 0.006 20 0.05 ± 0.004 20 Pro Yes 
3 B3PDB1 0.03 ± 0.002 100 --- --- Ala Yes 
3 CsManD/Q1QT89 0.02 ± 0.0005 5 0.04 ± 0.006 40 Pro Yes 
4 Q8FHC7 0.02 ± 0.001  10 --- --- Pro Yes 
4 A4WA78 0.02 ± 0.002 30 --- --- Pro Yes 
4 B1ELW6 0.02 ± 0.001  20 --- --- Pro Yes 
4 D8ADB5 0.01 ± 0.002 30 --- --- Pro Yes 
4 J7KNU2 0.01 ± 0.001 20 --- --- Pro Yes 
4 B5RAG0 0.01 ± 0.001 50 --- --- Pro Yes 
5 D4GJ14 --- --- 0.04 ± 0.003 120 Pro Yes 
5 B5R541 --- --- 0.05 ± 0.003 80 Pro Yes 
5 B5QBD4 --- --- 0.02 ± 0.0005 150 Pro Yes 
5 C6CBG9 0.04 ± 0.002 50 0.03 ± 0.002 60 Pro Yes 
Singleton D9UNB2 0.004 ± 0.001 60 --- --- Pro Yes 
8 D7BPX0 --- --- 0.01 ± 0.002 40 Pro No 
2 Q1NAJ2 2 ± 0.07 4200 --- --- Ala No 
2 Q9AAR4 1 ± 0.006 12300 --- --- Ala No 
2 Q9A4L8 0.65 ± 0.02 1200 --- --- Ala No 
2 B0T4L2 0.3 ± 0.01 1200 --- --- Ala No 
2 B0T0B1 2 ± 0.2 12100 0.003 ± 0.001 5 Ala No 
2 A5V6Z0 4 ± 0.2 2900 0.01 ± 0.001 10 Ala No 
2 NaManD/A4XF23 1.3 ± 0.1 3200 --- --- Ala No 
7 G7TAD9 0.8 ± 0.03 4400 --- --- Ala No 
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Figure 2.3.  SSN showing the distribution of high- (green), low- (blue), and no-activity (red) 
proteins along with substrate specificities (M, D-mannonate; G, D-gluconate; M/G, D-
mannonate and D-gluconate).  Proteins for which structures were determined by marked with 
asterisks. This SSN also shows that the identities of Pro and Ala residues associated with 
different substrate specificities for D-mannonate and D-gluconate are separated at an e-value 
threshold of at 10-190: Clusters 1, 4, 5, 6, 8, 9, and 10 contain Pro; Clusters 2 and 7 contain Ala; 
and Cluster 3 contains both.  Pro-containing clusters exhibit low or no dehydration activity; 
Purely Ala-containing clusters exhibit high dehydration activity with D-mannonate. 
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superfamilies within the D-glucuronate catabolic pathway. Interestingly, the genomes of all of 
the organisms encoding high-activity ManDs lack the gene encoding UxuA; however, the 
genomes of the majority of organisms with low- or no-activity ManDs have a gene encoding 
UxuA (Table 2.1).  This suggests that the high-activity ManDs perform the same role as UxuA 
in the encoding organisms; however, the low-activity members have a different metabolic 
function.  In those organisms that encode low- or no-activity members of the ManD subgroup but 
no UxuA, growth on D-glucuronate likely is enabled by an alternate catabolic pathway, such as 
the uronate dehydrogenase/KduI pathway [47, 48].  Therefore, members with low in vitro 
catalytic efficiencies likely have different in vivo metabolic functions, even if they can dehydrate 
D-mannonate.  In work that will be described elsewhere, we are characterizing some of these 
divergent physiological functions. 
D-Gluconate Dehydration. Although, in retrospect, the discovery of D-gluconate as a 
substrate for some members is not surprising because D-gluconate and D-mannonate are epimers 
at carbon-2 so they yield the same dehydration product, this stereochemical difference requires 
that a base other than the Tyr-Arg dyad in the “150-180s” loop abstract the 2-proton from 
D-gluconate. To investigate which residue could function as the D-gluconate specific base, 
D-mannonate and D-gluconate were modeled into the active site of the member from 
Chromohalobacter salexigens (CsManD) (Uniprot ID Q1QT89) that dehydrates both D-
mannonate and D-gluconate (PDB code 3BSM).  This was accomplished by superposing the 
structures of NaManD with D-mannonate in its active site (2QJM), Uniprot ID B5R541 with 
D-gluconate in its active site (3TWB), and unliganded CsManD (3BSM) (Figure 2.4).  Based on 
this comparison, we hypothesized that the conserved His after the 7th β-strand is the base in D-
gluconate dehydration (His 315 in CsManD).  
  
Figure 2.4.  A superposition of a structu
NaManD) with one with D-gluconate bound in the active site (3TWB; 
161 is the general base that abstracts the 2
the departure of the 3-OH group from D
general base that abstracts the 2
hydroxyl of D-mannonate. The 
mannonate and 3.1Å from C2 of D
abstraction or hydrogen bonding.
 
Site-directed mutagenesis was performed to convert His
Gln.  His 315 is conserved in all members of the ManD subgrou
hydrogen bonds to 5-hydroxyl group of D
dehydration activity with D-gluconate. However, the H315Q mutant maintained wild
catalytic efficiency with D-mannonate (
29 
 
re with D-mannonate bound in the active site (2QJM, 
CsManD).  In 2QJM, Tyr 
-proton and His 215 is the general acid that catalyzes 
-mannonate.  In 3TWB, His 315 is proposed to be the 
-proton from D-gluconate or hydrogen bonds with the C5 
ε-nitrogen of His315 is 3.0Å from the C5 hydroxyl of D
-gluconate. Both distances are appropriate for proton 
 
 315 in CsManD to either Asn or 
p, including NaManD, because it 
-mannonate (Figure A.2) [28]. Both mutants abolished 
Table 2.2). In contrast, the H315N mutant was inactive 
-
-type 
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with D-mannonate, presumably because it is not able to hydrogen bond to the 5-hydroxyl group.  
These studies support the suggested role of His 315 as the base for dehydration of D-gluconate. 
 
 
 
 
 
Structure analysis. “New” crystal structures were solved for 12 sequence diverse 
members of the subgroup; structures previously were available for 4 other members.  Taken 
together, a total of 36 unliganded and liganded structures are now available for members of the 
ManD subgroup (Table A.3).  These structures were used to identify the general base that 
initiates dehydration of D-gluconate and also yielded insights into how structure diverges as 
sequence diverges. An overlay of one structure from each structure-containing cluster is shown 
in Figure 2.5 (the overlay includes only structures with ordered “150-180s” loops). The 
structures of the modified TIM-barrel and capping domains are highly conserved, although the 
conformations of the “150-180s” loop are divergent. The sequences of this loop are also highly 
variable (Figure A.3).  
 
 
 
 
 
Table 2.2. Kinetic Parameters of CsManD H315 Mutant 
 D-Mannonate D-Gluconate 
Protein WT H315Q H315N WT H315Q H315N 
kcat/KM (M-1s-1) 10 10 NA 40 NA NA 
NA = no activity 
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Figure 2.5.  An overlay of NaManD (blue), CsManD (tan), Uniprot ID Q8FHC7 (green), 
Uniprot ID B5R541 (magenta), Uniprot ID A5KUH4 (red), and Uniprot ID A6M2W4 (grey) 
showing the overall structural homology.  The “150-180s” loops are conformationally distinct.  
 
Initially, the “150-180s” loops were proposed to contain the substrate specificity 
determinants in analogy with the “20s” loops in other ENS members[49]. Of the 36 structures 
available (Table A.3), 9 have an ordered “150-180s” loop covering the active site, 3 with a 
substrate bound.  Seven of the 11 structures with disordered “150-180s” loops also have a 
substrate bound.  The disorder of the loop, even in the presence of substrate, suggests that the 
Top 
Side 
Loop 
Cap 
Barrel 
 
90° 
 substrate and the “150-180s” loop are not 
substrate and an ordered loop, the only hydrogen bonds to the substrate involve ordered water 
molecules and backbone amide groups.  This suggests a role other than determining substrate 
specificity for the “150-180s” loops. 
To determine the importance of the sequence of the “150
loops in CsManD (A164 to E172) and 
substrate were mutated to AGAGGAGAG (
hydrogen-bonding interactions with the substrate. Both mutants were expressed and purified as 
Figure 2.6. An overlay of CsManD (4F4R, blue ribbon, orange loop) and 
ribbon, green loop) showing the regions of their “150
sequences of the loops are given with the area of mutagenesis highlighted with yellow.
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interacting strongly.  In the structures with a bound 
 
-180s” loops, segments of the 
NaManD (V161 to E169) that are proximal to the 
Figure 2.6) to eliminate any 
NaManD (2QJJ, tan 
-180s” loops that were mutated. The 
ionic or 
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soluble proteins; correct folding was verified via circular dichroism and x-ray crystallography 
(Figure A.4 and A2.5). Screening of both mutants with the acid sugar library showed a complete 
loss of activity.  We conclude that this loop is important for catalysis, although its exact 
contribution is unknown. 
Structural differences between D-mannonate/D-gluconate specific ManDs.  The 
structures of proteins with divergent functions are very similar.  A superposition of the structures 
of a high-activity ManD (NaManD), a low activity ManD (Uniprot ID Q8FHC7), a low-activity 
GlcD (Uniprot ID B5R541), and a member with no activity (Unitprot ID A5KUH4) reveals that 
the identities and positions of the active site residues are conserved (Figure 2.7).  In addition, the  
Figure 2.7.  An overlay of the active sites of NaManD (2QJJ, high-activity, D-mannonate 
specific - red), CsManD (4F4R, low-activity, promiscuous for D-mannonate/D-gluconate - blue), 
Uniprot ID D4GJ14 (3T6C, low-activity, D-gluconate specific - green), and Uniprot ID 
A4W7D6 (3TJI, no-activity - magenta).  The metal binding and acid/base residues are 
superimposable. The Pro/Ala dimorphism is also shown. The ligands are D-mannonate from 
2QJM (red) and D-gluconate from 3T6C (green). 
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residues within 6 Å of the substrate are conserved.  The primary site of divergence in the active 
site is a Pro/Ala substitution two residues after the conserved His at the end of the 7th β-strand 
that hydrogen bonds to the 5-hydroxyl group of the substrate in the ManD reaction or is the 
general base in the GlcD reaction (Figure 2.4).  When this substitution is mapped onto the SSN, 
low- and no activity proteins possess Pro at this position but high-activity ManDs possess an Ala 
(Figure 2.3).  The single exception is cluster 3, which is recently separated from cluster 2 (i.e. 
connected at an e-value of 10-184). Cluster 2 includes high-activity ManDs that contain Ala; 
cluster 3 contains low-activity proteins that contain either Ala or Pro.  Members that contain Pro 
dehydrate both D-mannonate and D-gluconate, but members with Ala dehydrate only D-
mannonate. Two of the 8 high-activity ManDs also dehydrate D-gluconate, but with very low 
catalytic efficiency. We hypothesize that the proteins in cluster 3 may be intermediates in the 
evolution of the GlcD function. 
This hypothesis was investigated by constructing the NaManD A314P and CsManD 
P317A mutants.  The A314P mutant of NaManD maintained its specificity for D-mannonate, but 
with a reduced catalytic efficiency (3200 M-1s-1 to 60 M-1s-1).  The P317A mutant of CsManD 
maintained low-activity on D-mannonate and D-gluconate; the catalytic efficiency for 
D-mannonate is increased (from 5 M-1s-1 to 100 M-1s-1), but that for D-gluconate is somewhat 
decreased (from 40 M-1s-1 to 5 M-1s-1). Thus, we conclude that 1) Ala favors D-mannonate 
dehydration and disfavors D-gluconate dehydration; and 2) Pro disfavors D-mannonate 
dehydration.  A restriction of backbone flexibility may explain the observed change in substrate 
specificity and catalytic efficiency, with the flexibility associated with Ala allowing 
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hydrogen-bonding to the substrate and the rigidity associated with Pro promoting general-base 
catalysis. 
Proteins with no activity.  The genes encoding many inactive members of the ManD 
subgroup are neighbors of genes encoding 2-keto-3-deoxy-D-gluconate kinase and 2-keto-3-
deoxy-D-gluconate-6-phosphate aldolase that are downstream of ManD in the D-glucuronate 
catabolic pathway (Figure A.6). However, they have no activity with D-mannonate or the three 
carbon-2 or -3 epimers that would be dehydrated to 2-keto-3-deoxy-D-mannonate (D-altronate, 
D-allonate, or D-gluconate).  Variations in pH, temperature, salt concentration, osmolarity, 
osmolytes, and metal cations as well as the presence of dithiothreitol and nucleotide mono-, di-, 
and triphosphates were tested to determine whether these enzymes may be subject to 
unanticipated regulation; however, no changes in activity were observed.  D-Mannonate 
6-phosphate and D-gluconate 6-phosphate also were tested, but no activity was observed.  
Perhaps these proteins function in multienzyme complexes (channeling) or utilize an acid sugar 
that is not present in our library.  
 
2.4 Conclusions 
The ManD subgroup of the ENS is an excellent example of highly homologous proteins 
that have divergent catalytic efficiencies and substrate specificities.  Unexpectedly, we 
discovered that the ManD subgroup is not isofunctional:  in addition to the ManDs, some 
members catalyze the dehydration of D-gluconate and others are promiscuous for dehydration of 
both D-mannonate and D-gluconate.  Clearly, automated methods would provide 
misleading/incorrect annotations that would be of limited/no value in deducing their metabolic 
functions.  We have also determined that the structural determinations of substrate specificity are 
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both indirect and subtle:  a Pro/Ala substitution appears to be the major determination of 
specificity.    
In addition, the role of the sequence divergent and conformationally flexible “150-180s” 
loop is uncertain.  The side chains of the loop makes no direct contacts with the substrate, so the 
loop does not appear to be a determinant of substrate specificity as has been well-established for 
members of the muconate lactonizing enzyme (MLE) and mandelate racemase (MR) subgroups 
in the ENS.  Although we attempted to determine whether the loop is involved in protein-protein 
interactions/substrate channeling, we could not obtain any conclusive results.   
We also discovered that the catalytic efficiencies of members of the subgroup are highly 
variable, despite conservation of active site residues and structures.  This data may provide 
important insights for the metabolic engineering community. The data illustrates how closely 
related sequences can perform different reactions, and therefore, may help guide studies which 
aim to redesign proteins for use in new pathways.  
Enzymological dogma has been that enzymes have evolved to achieve catalytic 
perfection, i.e., the reactions are diffusion-controlled.  In vitro experiments alone can and will 
not provide biological insights into why the values of kcat/KM for some of the members of the 
subgroup are “low”. We have selected several of these for future biological/metabolic 
characterization so that we might be able to better understand the relationship between catalytic 
efficiencies and metabolic requirements. 
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CHAPTER 3: Identification of the In vivo Function of the High Efficiency D-Mannonate 
Dehydratase in Caulobacter crescentus NA1000 from the Enolase Superfamily  
 
ABSTRACT: The D-mannonate dehydratase (ManD) subgroup of the enolase superfamily 
contains members of varying catalytic activities (high efficiency, low efficiency, or no activity) 
which dehydrate D-mannonate and/or D-gluconate to 2-keto-3-deoxy-D-gluconate (Wichelecki 
et al. Biochemistry 2014, 53, 2722-2731). Despite extensive in vitro characterization, the in vivo 
physiological role of a ManD has yet to be established. In this study, we report the in vivo 
functional characterization of a high efficiency ManD from Caulobacter crescentus NA1000 
(UniProt ID B8GZZ7) by in vivo discovery of its essential role in D-glucuronate metabolism.  
This in vivo functional annotation may be extended to ~50 additional proteins. 
 
Reprinted (adapted) with permission from Wichelecki, D. J., Graff, D. C., Al-Obaidi, N., Almo, 
S. C., and Gerlt, J. A. Biochemistry. 2014 Jul 1;53(25):4087-9. 
 
3.1. Introduction 
The enolase superfamily (ENS) has been the subject of function discovery-based research 
since it was demonstrated that its homologous members catalyze different chemical 
reactions[50]. Although all members of the ENS catalyze a common partial reaction (general 
base-catalyzed abstraction of a proton alpha to a carboxylate group to form a Mg2+-stabilized 
enediolate intermediate), their overall reactions and chemistries can be quite diverse (e.g., 
β-elimination and 1,1-proton transfer reactions)[27],[10]. Nevertheless, the members of ENS 
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share significant structural homology:  they share a (β/α)7(β)-barrel domain for acid/base 
catalysis and an (α+β) capping domain for substrate specificity[26, 30, 34, 44, 45, 51]. 
When the D-mannonate dehydratase (ManD) subgroup of the ENS was discovered in 
2007, all of its members were assumed to catalyze the dehydration of D-mannonate to 2-keto-3-
deoxy-D-gluconate[28]. The Asp, Glu, and Glu ligands for the essential Mg2+ are located at the 
ends of the 3rd, 4th, and 5th β-strands, respectively, of the barrel domain. The general base catalyst 
is a Tyr-Arg dyad located at the start of the “150-180s” loop (between the 2nd and 3rd β-strands); 
the general acid catalyst is a His located at the end of the 3rd β-strand[28].  
A large-scale in vitro survey of sequence-function space in the ManD subgroup was 
supported by the Enzyme Function Initiative (EFI; U54GM093342), a large-scale, collaborative, 
project focused on devising tools and strategies to address and correct the widespread non- and 
misannotation present in today’s automatically curated protein databases[10],[31]. For confident 
functional/physiological assignment, the EFI seeks not only in vitro enzymatic activity (values of 
kcat and kcat/KM) but also in vivo metabolic function.   
The ManD subgroup of the ENS (in Pfam families PF02746 and PF13378) initially was 
thought to be isofunctional, but the survey of the sequence space revealed dehydration activity 
with D-mannonate and/or D-gluconate[52].  The members of the ManD subgroup have a range 
of catalytic activities and efficiencies: high efficiency (specific to D-mannonate with a kcat/KM of 
103 to 104 M-1s-1), low efficiency (D-mannonate and/or D-gluconate with a kcat/KM of 101 to 102 
M-1s-1), and no activity[52]. However, the in vivo physiological function had not been assigned to 
any member of the ManD subgroup.  The only metabolic pathway in which dehydration of 
D-mannonate is known to occur is the catabolism of D-glucuronate (Figure 1), in which the 
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ManD reaction is performed by the well-characterized UxuA (utilization of hexuronate 
A)[29],[53] that is included in Pfam family PF03786. 
One high efficiency ManD (Uniprot ID B8GZZ7; PDB 3VCN and 4GME) was shown to 
be specific for D-mannonate with a catalytic efficiency of 1.2 x 104 M-1s-1 [52]. The UxuAs in 
D-glucuronate catabolism have catalytic efficiencies of ~103 M-1s-1. Interestingly, low 
efficiency/no activity ManDs are encoded by genomes that encode a member of the UxuA 
family; however, genomes that encode a high efficiency ManD do not encode a UxuA[52]. This 
suggested that high efficiency ManDs are analogs for UxuAs, with low efficiency/no activity 
ManDs likely having different physiological functions.  
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Figure 3.1. Degradation pathway of D-glucuronate in E. coli. The dehydration of D-mannonate 
to 2-keto-3-deoxy-D-gluconate is performed by UxuA. 
 
Of the high efficiency ManDs that were characterized in vitro, we selected B8GZZ7 for 
in vivo study because its encoding organism, Caulobacter crescentus NA1000, is amenable to 
genetic manipulation[54]. Caulobacter crescentus is an important organism in the study of 
asymmetric cell division and prokaryotic development because it can differentiate into mobile 
swarmer cells and immobile stalk cells[54]. Species of Caulobacter utilize aquatic vegetation as 
carbon source in freshwater environments[54]; D-glucuronate makes up a large part of plant cell-
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wall biomass[55]. Therefore, we hypothesized that Caulobacter crescentus NA1000 could utilize 
D-glucuronate as a carbon source via B8GZZ7, a high efficiency ManD, despite the absence of 
UxuA. 
 
3.2 Materials and methods 
qRT-PCR of B8GZZ7/Mannosidase Genes. Caulobacter crescentus NA1000 (culture 
from Smit lab, University of British Columbia) was grown to an OD of 0.4 - 0.5 in M2 minimal 
salts media (6.1 mM Na2HPO4, 3.9 mM KH2PO4, 9.3 mM NH4Cl, 0.5 mM MgSO4, 10 µM 
FeSO4, 0.5 mM CaCl2) and 10 mM D-glucuronate (Sigma-Aldrich) or 10 mM D-glucose 
(Sigma-Aldrich). 500 µl of cells were incubated in 1 ml of RNA Protect (Qiagen) for 5 min at 
room temperature. Cells were pelleted at 15,000 rpm and the supernatant was removed. mRNA 
was then purified from the cells using an RNeasy Mini Kit (Qiagen). The RNA was cleaned up 
using RNase-free DNase (Qiagen) following the manufacturer’s protocol. Purity was verified 
using 30 µL PCR reactions consisting of 50 ng mRNA, 1 mM MgCl2, 1X Pfx amplification 
buffer, 2X PCR enhancer, 0.33 mM dNTP,  0.33 µM of FOR/REV primers 
(B8GZZ7_RTPCR_FOR and B8GZZ7_RTPCR_REV), and 1.25 units Pfx polymerase 
(Invitrogen Platinum Pfx DNA Polymerase kit). The PCR reaction was run on a gel to check for 
amplification. The concentration was determined spectrophotometrically at 280 nm. cDNA was 
made using Protoscript First Strand (New England Biolabs) and 1 µg mRNA. Manufacturer’s 
protocol was followed. The qRT-PCR reaction was performed using the Light Cycler 480 SYBR 
Green I Master Kit (Roche) and a Light Cycler 480 II (Roche) per the manufacturer’s protocol. 
Table 1 contains sequences of the qRT-PCR primers (labeled as RTPCR). The RpoD (RNA 
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polymerase sigma factor) primers were included to normalize the results based on the amount of 
cDNA added. 
Construction of the Knockout of the Gene Encoding Q9AAR. The knockout of the gene 
encoding B8GZZ7 in C. crescentus NA1000 was constructued using overlap extension and a 
suicide vector (pK19mobsacB, from ATCC# 87097)[56]. 600 p upstream and downstream of the 
gene encoding B8GZZ7 (Locus tag  CC_0532) start and stop codons was amplified via 30 µL 
PCR reactions consisting of 50 ng C. crescentus NA1000 genomic DNA, 1 mM MgCl2, 1X Pfx 
Amp Buffer, 2X PCR enhancer 0.33 mM dNTP, 0.33 µM of FOR/REV primers [Table 1: 
B8GZZ7_BAMHI_FOR (upstream), B8GZZ7_BAMHI_Extend_REV (upstream), 
 
Table 3.1. qRT-PCR primers used in this study 
Primer name Sequence 
B8GZZ7_RTPCR_FOR 5’- CGACCGCCAAGTATCTCAAC -3’ 
B8GZZ7_RTPCR_REV 5’- AGCCAGAACAGGCGATAGG -3’ 
Mannosidase_RTPCR_FOR 5’- GCCAATCTGGACGAGGAAG -3’ 
Mannosidase_RTPCR_FOR 5’- ATGGTGTGGGAGCGATAGAG -3’ 
RpoD_RTPCR_FOR 5’- CTGATGCCGTAGCTGTCGG -3’ 
RpoD_RTPCR_REV 5’- GGCCTATGAAGGCCTGTCG -3’ 
UxaC_RTPCR_FOR 5'- ACGTGTTCAGCCAGGTGTTC -3' 
UxaC_RTPCR_REV 5'- GTGATGCTGAAGGCTCTCGT -3' 
UxuB_RTPCR_FOR 5'- GAAACCGCGCACATCATC -3' 
UxuB_RTPCR_REV 5'- CATGGTCGACAGCATCACAC -3' 
KdgK_RTPCR_FOR 5'- CCGGTGAAGTGAACTGGGAAA -3' 
KdgK_RTPCR_REV 5'- GCGGTAGTTCAGGTCGTAG -3' 
KdgpA_RTPCR_FOR 5'- CGAGATCGTCAAGGTGTTCC -3' 
KdgpA_RTPCR_REV 5'- CTTGGCGTCCAGCATCTCT -3' 
B8GZZ7_BamHI_FOR 5'- CAAATGGCTCGACCACCGGATCCACGGTCACTATTCGCAG -3' 
B8GZZ7_BamHI_Extend_REV 5’- GGCCGCGCCCCGGCCGACAGGGGGGGACCTGGCGTTGCTGAGTGCGGCC-3’ 
B8GZZ7_EcoRI_REV 5'- CGACGCATACGGATTCTCATGACGGGCGC -3' 
B8GZZ7_EcoRI_Extend_FOR 5’- GGCCGCACTCAGCAACGCCAGGTCCCCCCCTGTCGGCCGGGGCGCGGCC-3’ 
B8GZZ7_NdeI_FOR 5'-CTCAGCAACGCCAGGCATATGCTCAAGATCATCG-3' 
B8GZZ7_BamHI_REV 5'-CCCCGGATCCCAGGGGGTTACCAGTTGAAC-3' 
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B8GZZ7_EcoRI_REV (downstream), B8GZZ7_EcoRI_Extend_FOR (downstream)], and 1.25 
units Pfx polymerase (Invitrogen Platinum Pfx DNA Polymerase kit). These amplifications 
contained homologous extension regions. These upstream and downstream fragments were then 
PCR amplified again with the same reaction mixture except the 50ng of each fragment was used 
as template and B8GZZ7_BAMHI_FOR and B8GZZ7_EcoRI_REV primers were used. The 
product was digested by BamHI and EcoRI (New England Biolabs) and ligated into BamHI- and 
EcoRI-digested pK19mobsacB to form pK19mobsacB:B8GZZ7. Successful ligations were 
transformed into E. coli XL1-Blue for storage. The knockout of the gene encoding B8GZZ7 was 
constructued via homologous recombination by transforming in pK19mobsacB: B8GZZ7 into C. 
crescentus NA1000 via electroporation[57]. PYE plates (0.2% peptone, 0.1% yeast extract, 
0.01% CaCl2, 0.02% MgSO4, and 1.2% agar) containing kanamycin (50 µg/ml) were used to 
identify single-crossover events. Four rounds of subculturing were used to encourage 
double-crossover events. Double-crossover events were identified by growing the subcultured C. 
crescentus on PYE plates with 10% sucrose. The colonies were then PCR amplified using the 
previous PCR mixture, but using cells as template. B8GZZ7_BAMHI_FOR and 
B8GZZ7_EcoRI_REV primers were used. The resulting amplification was sequenced for 
verification of the knockout. 
Complementation of the Knockout of the Gene Encoding B8GZZ7. B8GZZ7 was 
amplified from 50 ng C. crescentus NA1000 genomic DNA using the same reaction mixture as 
in the qRT-PCR methods section and the primers B8GZZ7_NdeI_FOR and 
B8GZZ7_BamHI_REV. The amplification product was digested with NdeI and BamHI (New 
England Biolabs) and ligated into NdeI/BamHI-digested pSRK-Kan[58] (Farrand laboratory, 
UIUC). Successful ligations were transformed into E. coli XL1-Blue for storage. For 
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complementation, successful ligations were transformed into wild type C. crescentus and the 
∆B8GZZ7 strain as previously described. 
C. crescentus NA1000 Wildtype, ∆B8GZZ7, and Complementation Growth Curves. 
Wildtype C. crescentus NA1000, the ∆B8GZZ7 strain, the B8GZZ7-complemented ∆B8GZZ7 
strain, and the ∆B8GZZ7-complemented wild type strain were grown to an optical density of 0.4 
to 0.5 in PYE media. The cells were pelleted and resuspended in M2 minimal salts media then 
used to inoculate cultures of M2 minimal salts media containing 10 mM D-glucuronate and 500 
µM IPTG (Sigma-Aldrich) with a normalized amount of cells. Growth curves were made using a 
Bioscreen C instrument (Growth Curves USA). Cells were grown at 30°C for 120 hours with 
continuous shaking. 
Fluorescence–based thermal shift assay (ThermoFluor). The library consists of 188 
ligands in duplicate wells, plus 8 control wells (protein without compound) (Table B.2). 
Compound stocks are dissolved in ThermoFluor running buffer (100 mM HEPES pH 7.5, 150 
mM NaCl) to a concentration of 1 mM.  The protein of interest is diluted to 10 µM in 5x SYPRO 
orange (Sigma-Aldrich). 1 µl of the 5x SYPRO orange protein mix is added to 9 µl of compound 
dissolved in ThermoFluor running buffer in a 384 clear well plate. Using “Applied Biosystems 
7900HT Fast Real-Time PCR System” (Life Technologies) the temperature was increased from 
22 to 99°C at a rate of 3°C/min. As the protein is melting under the effect of increasing 
temperature, the machine will scan the fluorescence signal from each well at multiple time points 
creating a point curve for each reaction. Using the start point and peak point of melting 
temperature, we calculate the middle of the curve point using a Boltzmann fit for each reaction 
(TM value). We subtract that value from the average of the 8 control well’s TM to get the delta TM 
45 
 
for each well. A hit is considered significant if the ∆TM is greater than or equal to 4°C or 3 times 
the range value of the control wells TM. 
 
3.3 Results and Discussion 
The gene encoding B8GZZ7 is located in a genome neighborhood that is not indicative of 
D-glucuronate metabolism. Nearby genes encode catabolic enzymes for N-acetyl-glucosamine-
6-phosphate, a mannosidase, and a GntR transcriptional regulator (Figure 2). Nevertheless, the  
 
Figure 3.2. The genome neighborhoods of B8GZZ7, a high efficiency ManD, (top) and 
canonical D-glucuronate catabolism genes (bottom). The genes directly involved in 
D-glucuronate metabolism are highlighted in green. 
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ability of D-glucuronate to up-regulate the gene encoding B8GZZ7 was investigated via qRT-
PCR.  Expression of the gene encoding B8GZZ7 was induced > 1000-fold when C. crescentus 
NA1000 was grown on D-glucuronate as carbon source (relative to growth on D-xylose) (Figure 
3). Importantly, the gene encoding the mannosidase immediately upstream of the gene encoding 
 
Figure 3.3. Up-regulation of the genes encoding B8GZZ7 and the D-glucuronate catabolism 
genes shown in Figure 2. 
 
 B8GZZ7 was not upregulated (Figure 3); therefore, the gene encoding B8GZZ7 is transcribed 
separately from its genome neighbors and is likely not involved in N-acetyl-glucosamine 
catabolism. Absence of co-transcription of the genome neighborhood was further verified by the 
lack of a PCR product when cDNA was amplified using primers inside of the genes encoding 
both B8GZZ7 and the mannosidase (such that the potential product would span the gap between 
the two genes).   Thus, we conclude that genomic context can be misleading for functional 
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assignment in the absence of definitive information on regulation and the identities of 
transcriptional units. 
ThermoFluor[14] ligand binding studies were performed on the GntR transcriptional 
regulator in the genome neighborhood of B8GZZ7 using a library of acid sugars, including 
D-glucuroante and D-mannonate, as well as other metabolites (Table B.2). This assay yielded no 
stabilizing ligands, providing further evidence that the gene encoding B8GZZ7 is regulated 
separately. 
The genes encoding the remaining enzymes in the canonical D-glucuronate pathway are 
located elsewhere in the genome, closely clustered with other sugar metabolizing genes (Figure 
2). The genes encoding D-glucuronate isomerase (UxaC), fructuronate reductase (UxaB), 2-keto-
3-deoxy-D-gluconate kinase (KdgK), and 2-keto-3-deoxy-D-gluconate-6-phosphate aldolase 
(KdgpA) were upregulated when grown on D-glucuronate (relative to growth on D-xylose) 
(Figure 3). These qRT-PCR data provide compelling evidence that B8GZZ7 is performing the 
ManD reaction in the canonical D-glucuronate catabolic pathway. 
The knockout of the gene encoding B8GZZ7 showed no growth on D-glucuronate 
(Figure B.1). Complementation of the knockout with an IPTG-inducible gene encoding B8GZZ7 
(pSRK-Kan)[58] restored growth on D-glucuronate. Although the growth rate of the 
complemented knockout strain was slower than that of wild-type C. crescentus NA1000 on 
D-glucuronate, the wild-type strain transformed with the same complementation vector showed a 
similar growth defect (Figure B.1), likely due to toxicity of plasmid-based expression of 
B8GZZ7. The requirement of B8GZZ7 for growth on D-glucuronate and complementation of the 
growth defect by supplying B8GZZ7 in trans verifies that B8GZZ7 is the ManD for D-
glucuronate metabolism in C. crescentus NA1000. 
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We visualize functional diversity in the ManD subgroup using sequence similarity 
networks[52]. Using an E-value threshold of 10-190, corresponding to ~75% identity, the clusters 
are isofunctional as judged by a sequence alignment[52]. B8GZZ7 is a member of an 
isofunctional cluster that includes 55 additional proteins (Figure B.2 and Table A3.3). None of 
the organisms that encode these proteins encode the UxuA in D-glucuronate catabolism, 
although the genes encoding all of the other enzymes needed for catabolism of D-glucuronate via 
the pathway shown in Figure 1 are present in the genomes.  
The genomes of a few of these organisms, including C. crescentus NA1000, encode two 
high efficiency ManDs.  In C. crescentus NA1000, the second ManD (UniProt ID B8H1R9) is 
not involved in D-glucuronate catabolism:  the knockout of the gene encoding the B8H1R9 
retains the ability to utilize D-glucuronate as carbon source (Figure B.1); also, the gene encoding 
B8H1R9 is not upregulated by D-glucuronate.  Apparently, the ManD activity of B8H1R9 is 
essential for another metabolic function that is currently unknown.   
We are confident that we can transfer the now verified physiological function of B8GZZ7 
to the high efficiency ManDs that are encoded by organisms with a single orthologue—all of 
these organisms encode the other enzymes in D-glucuronate catabolism.  For those organisms 
that encode two high efficiency ManDs, genome context is sufficient to assign function in some 
cases, e.g., Sphinogomonas wittichii and Sphingomonas sp. MM-1; in other cases, such as C. 
crescentus NA1000 described in this manuscript, transcriptomic and genetic experiments are 
needed to assign the physiological function. 
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3.4. Conclusions 
Previously, no physiological function for a ManD in the ENS had been determined.  We 
now have used in vivo approaches to establish that B8GZZ7, a high efficiency ManD in 
Caulobacter cresecentus NA1000, participates in D-glucuronate catabolism.  Thus, we conclude 
that the high efficiency ManDs in the ENS are examples of convergent evolution of function 
with the ManDs in the UxuA family.   
This study demonstrates that 1) the in vitro enzymatic activity alone cannot be used to 
infer in vivo physiological function for an “unknown” enzyme discovered in a genome project, 
and 2) genome context also is not sufficient to infer the in vivo physiological function.  In due 
course, we will report the in vivo physiological functions for members of the ManD subgroup 
that have low catalytic efficiencies for dehydration of D-mannonate and D-gluconate. 
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CHAPTER 4: INVESTIGATING THE PHYSIOLOGICAL ROLES OF 
LOW-EFFICIENCY D-MANNONATE AND D-GLUCONATE DEHYDRATASES IN 
THE ENOLASE SUPERFAMILY:  PATHWAYS FOR THE CATABOLISM OF 
L-GULONATE AND L-IDONATE  
 
ABSTRACT: The sequence/function space in the D-mannonate dehydratase subgroup (ManD) 
of the enolase superfamily was investigated to determine how enzymatic function diverges as 
sequence identity decreases (Wichelecki et al. Biochemistry 2014, 53, 2722-2731).  That study 
revealed that members of the ManD subgroup vary in substrate specificity and catalytic 
efficiency: high-efficiency (kcat/KM = 103 to 104 M-1s-1) for dehydration of D-mannonate, 
low-efficiency (kcat/KM = 101 to 102 M-1s-1) for dehydration of D-mannonate and/or D-gluconate, 
and no-activity.  Characterization of high-efficiency members revealed that these are ManDs in 
the D-glucuronate catabolic pathway (analogs of UxuA; Wichelecki et al. Biochemistry 2014, 53, 
4087-4089).  However, the genomes of organisms that encode low-efficiency members of the 
ManDs subgroup encode UxuAs; therefore, these must have divergent physiological functions.  
In this study, we investigated the physiological functions of three low-efficiency members of the 
ManD subgroup and identified a novel physiologically relevant pathway for L-gulonate 
catabolism in Chromohalobacter salexigens DSM3043 as well as cryptic pathways for 
L-gulonate catabolism in Escherichia coli CFT073 and L-idonate catabolism in Salmonella 
enterica subsp. enterica serovar Enteritidis str. P125109.  However, we could not identify 
physiological roles for the low-efficiency members of the ManD subgroup, allowing the 
suggestion that these pathways may be either evolutionary relics or the starting points for new 
metabolic potential. 
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Reprinted (adapted) with permission from Wichelecki, D. J., Vendiola, J. A. F., Al-Obaidi, N., 
Almo, S. C., and Gerlt, J. A. Accepteded to Biochemistry August 2014.  
 
4.1. Introduction 
As the protein databases continue to expand (release 2014_07 of UniProt contains 
80,370,243 nonredundant sequences) and, in parallel, the homologous families identified by 
Pfam increase in size and functional diversity (Pfam release 27.0 describes 14,831 families and 
515 clans), the problem of assigning function based on sequence identity/similarity is becoming 
increasingly more challenging.  For the past 25 years, we have developed the enolase 
superfamily (ENS) as a paradigm to characterize and understand the structural bases for 
divergence of function in functionally diverse superfamilies[28],[30],[34],[23].  The members of 
the ENS share not only a conserved structure, an (α+β) capping domain that determines substrate 
specificity and a modified TIM-barrel domain [(β/α)7β-barrel] that contains the acid/base 
residues that determine the reaction mechanism, but also a conserved mechanism that is initiated 
by abstraction of a proton from the carbon adjacent to a carboxylate group to generate a 
Mg2+-stabilized enolate anion intermediate[25],[26].  Our recent studies have focused on 
studying how function diverges as sequence diverges in homologous subgroups[59]. 
The D-mannonate dehydratase subgroup (ManD) of the ENS recently was found to 
include members that dehydrate D-mannonate and/or D-gluconate to 2-keto-3-deoxy-
D-gluconate (equivalently, 2-keto-3-deoxy-D-mannonate)[28],[59]. [The subgroup was named 
by the function of the first member that was functionally and structurally characterized, when 
(2007), the protein sequence databases were considerably smaller than they are today[28].]  Also, 
the members of the ManD subgroup display varying catalytic efficiencies: high-efficiency 
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(specific for D-mannonate with a kcat/KM of 103 to 104 M-1s-1), low-efficiency (D-mannonate 
and/or D-gluconate with a kcat/KM of 101 to 102 M-1s-1), and no activity[59]. Although we recently 
reported the physiological role of the high-efficiency ManDs[60], dehydration of D-mannonate 
in the D-glucuronate catabolic pathway in organisms that lack UxuA, the roles of the low-
efficiency members of the ManD subgroup have not been known.   
In this article, we describe in vitro characterization of two metabolic pathways that are 
encoded by the genes that are proximal to those that encode low-efficiency members of the 
ManD subgroup.  The pathways utilize two successive dehydrogenase reactions (oxidation 
followed by reduction) to catalyze epimerization of carbon-5 of a six-carbon acid sugar, one for 
conversion of L-gulonate to D-mannonate (Escherichia coli CFT073 and Chromohalobacter 
salexigens DSM3043) and the second for conversion of L-idonate to D-gluconate (Salmonella 
enterica subsp. enterica serovar Enteritidis str. P125109).   In vivo studies using genetic 
deletions (knockouts) and transcriptomics established that the L-gulonate pathway in C. 
salexigens DSM3043 allows growth on L-gulonate as carbon source.  However, we were unable 
to demonstrate a physiological requirement for the ManD (Uniprot ID Q1QT89; CsManD[61]) 
that catalyzes the dehydration of D-mannonate (kcat/KM, 5 M-1 s-1) and D-gluconate (kcat/KM of 40 
M-1 s-1)[59].  We also describe cryptic pathways for the catabolism of L-gulonate and L-idonate 
in E. coli CFT073 and S. enterica subsp. enterica serovar Enteritidis str. P125109, respectively, 
that are encoded by the same genome neighborhoods that encode the low-efficiency ManD and 
GlcD, respectively, that could participate in the pathways. 
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4.2 Materials and methods 
Cloning, expression, and purification. The genes encoding the L-gulonate 
5-dehydrogenase from Halomonas elongata DSM 2581 (HeGulDH, Uniprot ID E1V4Y1, an 
orthologue of the L-gulonate 5-dehydrogenase from C. salexigens DSM3043, CsGulDH), the 
L-idonate dehydrogenase from S. enteriditis (SeIdoDH, Uniprot ID B5R538), and the D-
gluconate dehydrogenase from S. enteriditis (SeGlucDH, Uniprot ID B5R540) were synthesized 
(Genscript) and codon-optimized for expression in Escherichia coli; the genes were synthesized 
with 5’-NdeI and 3’-BamHI restriction sites and were received in the vector pUC57.  The pUC57 
constructs were transformed into E. coli XLI Blue for subcloning and storage.  Purified vector 
was NdeI/BamHI (New England Biolabs) digested and ligated into NdeI/BamHI digested 
pET15b (Novagen). The pET15b constructs were transformed into E. coli BL21 (DE3) for 
expression.  The proteins were purified from 1 L cultures using a chelating Sepharose Fast Flow 
(Amersham Biosciences) column charged with Ni2+ as previously described[59], concentrated 
(HeGulDH to 15 mg/mL, SeIdoDH to 8.1 mg/mL, and SeGlcDH to 4.7 mg/mL), flash-frozen 
using liquid nitrogen, and stored at -80 ˚C prior to use. 
The gene encoding RspB, the L-idonate 5-dehydrogenase from E. coli CFT073 (Uniprot 
ID Q8FHC8), was amplified from E. coli CFT073 genomic DNA (ATCC 700928) using 
RspB_FOR and RspB_REV primers (Table C.1).  The PCR (30 µL) contained 50 ng template, 1 
mM MgCl2, 1X Pfx Amp Buffer, 0.33 mM dNTP, 0.33 µM of each primer, and 1.25 units Pfx 
polymerase (Invitrogen Platinum Pfx DNA Polymerase kit). Amplifications were performed 
according to the manufacturer’s guidelines. The amplified product was digested with 
NdeI/BamHI (New England Biolabs) and ligated into NdeI/BamHI digested pET15b (Novagen). 
The pET15b RspB construct was transformed into E. coli BL21 (DE3) for expression. RspB was 
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purified from a 1 L culture using a chelating Sepharose Fast Flow (Amersham Biosciences) 
column charged with Ni2+ as previously described[59]. The protein was concentrated to 4.2 
mg/mL, flash-frozen using liquid nitrogen, and stored at -80 ˚C prior to use. 
The gene encoding RspD, the D-mannonate 5-dehydrogenase from E. coli CFT073 
(Uniprot ID Q8FHD0), was amplified from E. coli CFT073 genomic DNA (ATCC 700928) 
using RspD_FOR and RspD_REV primers (Table C.1).  The PCR (30 µL) contained 50 ng 
template, 1 mM MgCl2, 1X Pfx Amp Buffer, 0.33 mM dNTP, 0.33 µM of each primer, and 1.25 
units Pfx polymerase (Invitrogen Platinum Pfx DNA Polymerase kit). Amplifications were 
performed according to the manufacturer’s guidelines. The amplified product was digested with 
SacI/BamHI (New England Biolabs) and ligated into SacI/BamHI digested pET17b (Novagen). 
The pET17b RspD construct was transformed into E. coli BL21 (DE3) for expression. RspD was 
purified from a 1 L culture using DEAE Sepharose, Q-Sepharose column, and phenyl sepharose 
columns (all Amersham Biosciences) as previously described[59]. The protein was concentrated 
to 13 mg/mL, flash-frozen using liquid nitrogen, and stored at -80 ˚C prior to use. 
The gene encoding CsGntR, the GntR transcriptional factor in the genome neighborhood 
of CsManD (Uniprot ID Q1QT90), was amplified from C. salexigens DSM3043 genomic DNA 
(ATCC BAA-138) using CsGntR_FOR and CsGntR_REV primers (Table C.1). The PCR was 
the same as for RspD described above but with the CsGntR primers. The amplified product was 
digested with NdeI and BamHI (New England Biolabs) and ligated into similarly digested 
pET15b. The pET15b CsGntR construct was transformed into E. coli BL21 (DE3) for 
expression.  CsGntR was purified from a 1 L culture using a chelating Sepharose Fast Flow 
(Amersham Biosciences) column charged with Ni2+ as previously described[59].   The protein 
55 
 
was concentrated to 12 mg/mL, flash-frozen using liquid nitrogen, and stored at -80 ˚C prior to 
use. 
 CsUxuA was obtained from Albert Einstein College of Medicine as previously 
described[59]. 
 Screen for Oxidation Activity of HeGulDH, SeGlcDH, SeIdoDH, RspB, and RspD.  
Reactions to test for oxidation activity were performed in acrylic, UV transparent 96-well plates 
(Corning Incorporated) using a library of 72 acid sugars (Figure C.1).  Reactions (60 µL) 
contained 50 mM HEPES, pH 7.9, 10 mM MgCl2, 1 mM NAD+, 1 µM enzyme, and 1 mM acid 
sugar substrate (blanks without enzyme).  The plates were incubated at 30 ˚C for 16 hrs. The 
absorbancies were measured at 340 nm (ε = 6220 M-1 cm-1) using a Tecan Infinite M200PRO 
plate reader. Products were verified via 1H NMR. 
Screen for Dehydration Activity of CsUxuA .  Reactions to test for dehydration activity 
were performed in acrylic, UV transparent 96-well plates (Corning Incorporated) using a library 
of 72 acid sugars (Figure C.1) as previously described[59]. 
Kinetic Assays for HeGulDH, SeIdoDH, RspB, and RspD. Oxidation of L-gulonate, 
L-idonate, or D-mannonate was monitored using a continuous spectrophotometric assay.  For 
HeGulDH, the assays (200 µL), at 25 °C, contained 50 mM potassium HEPES, pH 7.9, 5 mM 
MnSO4, 3 mM NAD+, and 200 nM HeGulDH.  For the remaining enzymes, the assays (200 µL), 
at 25 °C, contained 50 mM potassium HEPES, pH 7.9, 5 mM MgCl2, 3 mM NAD+, and either 
200 nM RspB, 200 nM SeIdoDH, or 20 nM RspD (lower concentration because of greater 
catalytic efficiency).  Substrates varied from 12.5 µM to 30 mM depending on the enzymes KM. 
Oxidation was quantitated by measuring the decrease in absorbance at 340 nm (ε = 6220 M-1 
cm-1). 
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Kinetic Assays for SeGlcDH. Reduction of 5-keto-D-gluconate (fructuronate) was 
monitored using a continuous spectrophotometric assay.  The assay (200 µL), at 25 °C, contained 
50 mM potassium HEPES, pH 7.9, 5 mM MgCl2, 200 µM NADH, and 200 nM SeGlcDH. 
Substrate varied from 50 µM to 30 mM.  Oxidation was quantitated by measuring the decrease in 
absorbance at 340 nm (ε = 6220 M-1 cm-1). 
Kinetic Assay of CsUxuA. Dehydration of D-mannonate was monitiored using a 
continuous, coupled-enzyme spectrophotometric assay as previously described[59]. 
Quantitative RT-PCR of CsManD, RspABCD, and SeGlcD Genome Neighborhoods.  C. 
salexigens DSM3043 was grown to an optical density (absorbance at 600 nm) of 0.4 - 0.5 in M9 
minimal salts medium plus additional NaCl (1.7 M NaCl, 6.1 mM Na2HPO4, 3.9 mM KH2PO4, 
9.3 mM NH4Cl, 0.5 mM MgSO4, 0.5 mM CaCl2) and 10 mM D-mannonate, 10 mM L-gulonate, 
10 mM D-glucuronate, or 10 mM D-glucose.  Cells were pelleted at 15,000 rpm, and the 
supernatant was removed.  mRNA was purified from the cells using an RNeasy Mini Kit 
(Qiagen). The RNA was further purified using RNase-free DNase (Qiagen) following the 
manufacturer’s protocol. Purity was verified using 30 µL PCR reactions consisting of 50 ng 
mRNA, 1 mM MgCl2, 1X Pfx Amp Buffer, 2X PCR enhancer 0.33 mM dNTP, 0.33 µM of 
primers (CsRpoD_RTPCR_FOR and CsRpoD_RTPCR_REV, Table C.1), and 1.25 units Pfx 
polymerase (Invitrogen Platinum Pfx DNA Polymerase kit).  The PCR reactions were 
electrophoresed on an agarose gel to check for amplification.  cDNA was prepared using 
Protoscript First Strand (New England Biolabs) and 1 µg mRNA; the manufacturer’s protocol 
was followed. The qRT-PCR reaction was performed using the Light Cycler 480 SYBR Green I 
Master Kit (Roche) and a Light Cycler 480 II (Roche) according to the manufacturer’s protocol. 
57 
 
The qRT-PCR primers are listed in Table C.1.  Cp values were analyzed using the Light Cycler 
480 application, and fold changes calculated in Microsoft Excel. 
Salmonella enterica serovar Enteritidis str. P125109 was grown was grown to an optical 
density (absorbance at 600 nm) of 0.4 - 0.5 in M2 minimal salts medium (6.1 mM Na2HPO4, 3.9 
mM KH2PO4, 9.3 mM NH4Cl, 0.5 mM MgSO4, 0.5 mM CaCl2, and 10 µM FeSO4) and either 10 
mM L-gulonate/D-glucose or 1 – 100 mM L-idonate/D-gluconate/D-glucose. The following 
steps are identical to those taken with C. salexigens. The primers for SeRspABCD and SeGlcD 
qRT-PCR are listed in Table C.1. 
Knockout Construction in C. salexigens DSM3043. The knockouts of genes in C. 
salexigens DSM3043 were constructed using overlap extension and a suicide vector 
(pK19mobsacB, ATCC# 87097)[56]. The DNA ~600 bp upstream and downstream of the gene 
of interest (GOI) was cloned using overlap extension to create a single linear product that 
perfectly excises the GOI as previously described (primers in Table C.1)[60].  This PCR product 
was digested with either EcoRI/HindIII or BamHI/HindIII (New England Biolabs) and ligated 
into similarly digested pK19mobsacB. The ligation products with confirmed sequences were 
transformed into E. coli WM6029 (obtained from Professor William Metcalf at the University of 
Illinois) for conjugation.  E. coli WM6029 plus pK19mobsacB containing the GOI and C. 
salexigens DSM3043 were grown to an optical density (absorbance at 600 nm) of 0.4 - 0.5 in 3 
mL PYE media[54] containing 500 mM NaCl and 50 µg/mL diaminopimelic acid (conjugation 
media). The cells were pelleted at 4500 rpm for 5 min, the supernatant was removed, and the 
cells were resuspended in 3 mL of conjugation media. Aliquots (250 µL) of both E. coli 
WM6029 plus pK19mobsacB containing the GOI and C. salexigens DSM3043 were mixed in a 
1.5 mL eppendorf tube and pelleted at 4500 rpm for 5 min.  The supernatant was removed, and 
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the cells were resuspended in 100 µL of conjugation media. The resuspended cells were 
inoculated onto a nitrocellulose filter, placed on a plate of conjugation medium plus 1.2% agar, 
and incubated overnight at 30 °C.  The overnight conjugation was resuspended in 1 mL of PYE 
medium containing 500 mM NaCl.  An aliquot (40 µL) of was plated onto PYE medium 
containing 500 mM NaCl, 4x Kn (200 µg/mL), and 1.2% agar for selection of single cross-over 
events.  Single cross-over events were verified by colony PCR.  Colonies with successful single-
crossover events were subcultured onto a plate of PYE medium containing 500 mM NaCl and 
1.2% agar.  Single colonies were plated onto PYE medium containing 500 mM NaCl, 20% 
sucrose, and 1.2% agar. Colonies were probed for double-crossover events via colony PCR. 
Successful double cross-over events were verified by isolating the genomic DNA (Qiagen 
DNeasy® Blood and Tissue Kit) and sequencing the knockout region. 
Knockout construction in Salmonella enterica serovar Enteritidis str. P125109. All 
knockouts were performed via the method described by Datsenko and Wanner for E. coli[62]. 
Primers are listed in Table C.1. 
Growth Curves of WT and Knockout Strains in Chromohalobacter salexigens DSM3043.  
All strains were grown to an optical density (absorbance at 600 nm) of 0.4 - 0.5 in 3 mL PYE 
medium containing 1.7 M NaCl (50 µg/mL streptomycin for conjugations). The cells were 
pelleted at 5000 rpm for 5 min and resuspended in 3 mL of M9 minimal salts medium containing 
1.7 M NaCl.  The cells were inoculated into triplicate 300 µL cultures of M9 minimal salts 
medium containing 1.7 M NaCl and 10 mM of either D-mannonate or L-gulonate.  Growth 
curves were recording using a Bioscreen C instrument (Growth Curves USA).  Cells were grown 
at 37 °C for 120 hours with continuous shaking. 
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Fluorescence–based Thermal Shift Assay for CsGntR (ThermoFluor). The library for 
screening the specificity of CsGntR contained 188 ligands in duplicate wells plus 8 control wells 
(protein without compound) (Figure C.2).  The assays were performed as previously 
described[60].  A hit is considered significant if the ∆TM is greater ≥ 4°C or 3 times the standard 
deviation of the TMs for the control wells. 
 
4.3 Results and Discussion 
In vitro pathway for CsManD. The genome neighborhood for CsManD suggests a 
pathway for D-glucuronate metabolism that involves dehydration of D-mannonate (Figure 
4.1)[29]. Specifically, the genome proximal fructuronate reductase that reduces fructuronate to 
D-mannonate and UxuA[53] that dehydrates D-mannonate to 2-keto-3-deoxy-D-mannonate (not 
a member of the ENS) are involved in D-glucuronate metabolism in many eubacteria[60].  
However, C. salexigens DSM3043 uses an alternate pathway for D-glucuronate metabolism 
initiated by oxidation of D-glucuronate to D-glucaro-1,5-lactone[63],[64],[65] (Figure 4.2).  
 
 
Figure 4.1. Genome neighborhood for CsManD in Chromohalobacter salexigens DSM3043. 
Carbohydrate metabolism genes are highlighted in green, TRAP transporters in red, and the 
GntR transcriptional regulator in orange.  
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The genome neighborhood encoding the predicted uronate dehydrogenase (Udh; Uniprot 
ID Q1QUN7) also encodes D-glucarolactone cycloisomerase (Gci; Uniprot ID Q1QUN5), a 
member of the amidohydrolase superfamily (presumably D-galactarolactone isomerase; Uniprot 
ID Q1QUN6), D-glucarate dehydratase (GlucD, Uniprot ID Q1QUM5), and 5-dehydro-4-deoxy-
D-glucarate dehydratase/decarboxylase (Uniprot ID Q1QUM4) (Figure C.3).  These enzymes 
are involved in an alternate pathway for D-glucuronate degradation[66],[67].   
The physiological relevance of these enzymes/genes was probed using RT-PCR, 
comparing growth on D-glucuronate to that on D-glucose. The genes encoding all of these 
enzymes are upregulated; however, the genome neighborhood encoding CsManD is not 
upregulated (Figure C.4).  Further studies are needed to determine whether C. salexigens 
DSM3043 utilizes the newly discovered Gci-based catabolic pathway[66],[67] to metabolize 
D-glucuronate or the previously described pathway in which D-glucarolactone is hydrolyzed to 
D-glucarate that is dehydrated by GlucD[63],[64],[65]; the Gci and “amidohydrolase” in C. 
salexigens DSM3043 are members of the same Pfam families as those characterized by Bouvier 
and coworkers[66], PF02746 and PF01979, respectively.  Irrespective of the precise pathway, we 
conclude that C. salexigens DSM 3043 metabolizes D-glucuronate via conversion to 
D-glucarolactone/D-glucarate and not D-mannonate. 
In addition to fructuronate reductase, a second alcohol dehydrogenase is encoded by the 
CsManD genome neighborhood. Its presence suggested that the genome neighborhood enables 
another acid sugar to be utilized as carbon source, with the oxidation product an intermediate in 
the ManD-utilizing D-glucuronate catabolic pathway, e.g., oxidation at carbon-5 of L-gulonate 
produces fructuronate (Figure 4.2).  Therefore, we hypothesized that the genome neighborhood 
of CsManD is responsible for L-gulonate metabolism. A pathway for L-gulonate catabolism in 
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E. coli K-12 was suggested by Cooper in 1980, but the gene/enzyme responsible for oxidation of 
L-gulonate was not identified[68]. Furthermore, Cooper was only able to see growth of E. coli 
K-12 after spontaneous mutations had occurred[68]. 
 
 
Figure 4.2.  Catabolic pathways for D-glucuronate in eubacteria. The pathway hypothesized for 
degradation of L-gulonate in C. salexigens is highlighted in red: CsGulDH (alcohol 
dehydrogenase), CsFR (fructuronate reductase), CsManD (D-mannonate dehydratase), and 
UxuA (D-mannonate dehydratase). Starting compounds are labeled in blue (D-glucuronate and 
L-gulonate). 
 
Functional Assignment in the CsManD Genome Neighborhood: CsUxuA.  The functions 
of the proteins encoded by the genome neighborhood must be determined to assign a 
physiological role to CsManD.  CsUxuA (Uniprot ID Q1QT83) was screened for dehydration 
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activity using a library of 72 acid sugars (Figure C.1).  The only hit was D-mannonate that was 
dehydrated to 2-keto-3-deoxy-D-mannonate with a catalytic efficiency of 1.5 x 103 M-1 s-1 
(Table 4.1). Therefore, it was unclear whether UxuA, CsManD, or both were responsible for 
D-mannonate dehydration in this pathway.   
 
 
 
 
 
Functional Assignment within the CsManD Genome Neighborhood: CsGulDH.  The 
alcohol dehydrogenase (CsGulDH; Uniprot ID Q1QT88) in the CsManD genome neighborhood 
was not amenable to purification, despite several cloning strategies. A presumably orthologous 
alcohol dehydrogenase from the closely related Halomonas elongata DSM 2581 (HeGulDH; 
Uniprot ID E1V4Y1) is 76% identical and 86% similar to CsGulDH.  Additionally, the genome 
neighborhood of HeGulDH is identical to the CsGulDH neighborhood.  The purified HeGulDH 
was screened for oxidation activity using the library of acid sugars (Figure C.1).  Multiple hits 
were observed, with L-gulonate exhibiting the most efficient oxidation (kcat/KM = 6 x 102 M-1s-1; 
Table 4.1). All three L-gulonate dehydrogenases discussed in this manuscript (CsGulDH, 
HeGulDH, and RspB) are in Pfam family PF08240. 
Functional Assignment within the CsManD Genome Neighborhood:  CsFR.  The 
fructuronate reductase (CsFR; Uniprot ID Q1QT84) in the CsManD genome neighborhood also 
was not amenable to purification.  CsFR is 43% identical and 59% similar to a D-mannonate 
oxidoreductase in Escherichia coli CFT073 (RspD, Uniprot ID Q8FHD0); both proteins belong 
Table 4.1. Kinetics for Enzymes Encoded by the CsManD Operon 
Protein Substrate kcat (s-1) kcat/KM (M-1s-1) 
CsManD[59] D-mannonate 0.02 ± 0.0005 5.0 x 100 
CsUxuA D-mannonate 1.6 ± 0.1 1.5 x 103 
HeGulDH (CsGulDH) L-gulonate 1.8 ± 0.13 6.0 x 102 
RspD (CsFR) D-mannonate 30 ± 1.8 2.8 x 105 
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to Pfam PF01232.  RspD was purified and screened for oxidation activity with the acid sugar 
library described previously (Figure C.1).  RspD exhibited specific oxidation of D-mannonate to 
fructuronate with a catalytic efficiency of 3 x 105 M-1 s-1 (Tables 4.1 and 4.2). Although the 
sequence similarity is not large, the similar genome contexts (vide infra) and enzymatic activities 
of CsGulDH/CsFR, and HeGulDH/RspD allow confident transfer of function between the two 
proteins, respectively.  Considering their in vitro activities, these proteins provide support for the 
L-gulonate catabolic pathway proposed by Cooper[68].  Therefore, we pursued in vivo validation 
to corroborate the in vitro data and confirm the pathway. 
 
 
 
 
 
Transcript Analysis of the CsManD Genome Neighborhood.  Transcript analysis via 
qRT-PCR of mRNA revealed that all of genes in the neighborhood of CsManD (Figure 4.1) 
were upregulated ~20-300 fold during growth on both D-mannonate and L-gulonate relative to 
that on D-glucose (Figure 4.3). Mutual upregulation in combination with close proximity and 
identical orientation implies these genes are in an operon, but northern blots were not performed 
for confirmation. These findings support the claim that the CsManD gene cluster is responsible 
for L-gulonate metabolism via D-mannonate. 
ThermoFluor for CsGntR. The GntR transcriptional regulator for the L-gulonate 
utilization operon (CsGntR; Uniprot ID Q1QT90) was expressed, purified, and analyzed by 
ThermoFluor using a library of 188 ligands (sugars, amino acids, and various metabolites) 
Table 4.2. Kinetics for Enzymes Encoded by the RspABD Operon 
Protein Substrate kcat (s-1) kcat/KM (M-1s-1) 
RspA[59] D-mannonate 0.02 ± 0.001 1.0 x 101 
RspB L-gulonate 3.9 ± 0.5 1.4 x 103 
RspD 5-keto-D-mannonate 30 ± 1.8 2.8 x 105 
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(Figure C.2). Both D-mannonate (∆Tm of 7 °C) and L-gulonate (∆Tm of 2 °C) were among the 
top 10 hits (Table C.2).  The ligand specificity of the GntR provides further support of the 
involvement of the operon in growth on L-gulonate and D-mannonate.  
 
 
Figure 4.3.  RT-PCR data for genes in the CsManD operon for cells grown on L-gulonate (top) 
or D-mannonate (bottom) versus growth on D-glucose.  Upregulation is observred for all genes 
on both L-gulonate and D-mannonate. 
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Knockout Studies in the CsManD Genome Neighborhood.  Gene deletion/knockouts 
(KOs) were constructed to further probe the proposed L-gulonate pathway. The following KO 
strains were constructed: ∆CsGulDH, ∆CsFR, ∆Cs, ∆CsManD, ∆(CsManD,CsUxuA), and 
∆(CsFR, CsUxuA); all of the genes were removed from the genome via homologous 
recombination.  Their growth phenotypes using either D-mannonate or L-gulonate as sole carbon 
source were recorded (Figure 4.4).  
 
Figure 4.4. Growth curves for wild type C. salexigens DSM3043 and various knockout strains. 
Growth was recorded in M9 minimal medium with 1.7 M NaCl and either L-gulonate (Panel A) 
or D-mannonate (Panel B) as the sole carbon source. 
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For both D-mannonate and L-gulonate, the wild type strain and the ∆CsManD KO had 
identical growth curves, indicating CsManD is not required for the catabolism of either carbon 
source.  In contrast, the ∆CsUxuA KO resulted in slower growth with both carbon sources, 
suggesting CsUxuA is the predominant ManD for both L-gulonate and D-mannonate catabolism. 
That the ∆(CsManD, CsUxuA) double KO was able to grow on D-mannonate and L-gulonate 
implicates a slower, as-of-yet unidentified pathway for D-mannonate catabolism.  Interestingly, 
the ∆(CsManD,CsUxuA) double KO exhibited growth retardation (relative to either single KO) 
when grown on L-gulonate, suggesting that CsManD plays a role in the alternate D-mannonate 
metabolic pathway when L-gulonate is the carbon source.  
Most importantly, the ∆CsGulDH, ∆CsFR, and ∆(CsFR,CsUxuA) knockout strains did 
not grow on L-gulonate. This provides convincing evidence that CsGulDH, CsFR, and CsUxuA 
are responsible for the catabolism of L-gulonate.  For D-mannonate, the growth rates for ∆CsFR 
and are very similar to that for ∆CsUxuA, which likely indicates a polar effect on CsUxuA when 
CsFR is knocked out (the genes encoding CsFR and CsUxuA are separated by 9 base pairs).  
Furthermore, the growth of the ∆(CsFR, CsUxuA) double KO on D-mannonate confirms that the 
CsUxuA deletion strain does not grow by conversion of D-mannonate to fructuronate/L-gulonate 
and then funneling into an undiscovered catabolic pathway. The unidentified pathway utilizes 
genes not included in the CsManD genome neighborhood.  
Other in vitro pathways implicated by low-efficiency ManDs: RspA.  An in vitro pathway 
for the catabolism of L-gulonate was derived from the genome neighborhood of a low-efficiency 
ManD discovered in Eschericia coli CFT073.  This pathway is encoded by four genes: RspA[59], 
a low-efficiency ManD (Uniprot ID Q8FHC7); RspB, annotated as an alcohol dehydrogenase 
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(Uniprot ID Q8FHC8); RspC, annotated as a hypothetical metabolite transporter (Uniprot ID 
Q8FHC9); and RspD, annotated as an oxidoreductase (Uniprot ID Q8FHD0) (Figure 4.5). 
 
 
 
Figure 4.5.  Genome neighborhood of the gene cluster in E. coli CFT073.  RspA, low-efficiency 
D-mannonate dehydratase (Uniprot ID Q8FHC7); RspB, L-gulonate dehydrogenase (Uniprot ID 
Q8FHC8); and RspD, fructuronate reductase (Uniprot ID Q8FHD0) are highlighted in green. 
The hypothetical metabolite transporter (RspC, Uniprot ID Q8FHC9) is highlighted in red.  
Hypothetical genes of unknown function are highlighted in orange. 
 
The genome neighborhood does not encode a UxuA, although one is encoded elsewhere in the 
genome. RspA (ManD), RspB (L-gulonate 5-dehydrogenase), and RspD (D-mannonate 
5-dehydrogenase) were found to catalyze the in vitro conversion of L-gulonate to 2-keto-
3-deoxy-D-gluconate (Table 4.2). Although RspA, RspB, and RspD convert L-gulonate to 2-
keto-3-deoxy-D-mannonate/2-keto-3-deoxy-D-gluconate in vitro, no upregulation or KO 
phenotype for growth on L-gulonate was observed in either E. coli K-12 or Salmonella enterica 
serovar Enteritidis str. P125109 where identical gene clusters are found: E. coli K-12 does not 
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grow on L-gulonate until spontaneous mutations occur[68]; and, while the RspABCD gene 
cluster in Salmonella enterica serovar Enteritidis str. P125109 is negligibly upregulated (Figure 
C.5), knockouts of RspA and RspB grow to turbidity overnight on L-gulonate.    
Other in vitro pathways implicated by low-efficiency ManDs: SeGlcD. Bausch and 
coworkers discovered a novel pathway for L-idonate metabolism in E. coli K-12 in which 
L-idonate is converted to D-gluconate via oxidation and subsequent reduction of the C5 hydroxyl 
group[69]. D-Gluconate is then phosphorylated and dehydrated to form 2-keto-3-deoxy-
D-gluconate-6-phosphate, which is cleaved by an aldolase to pyruvate and glyceraldehyde-
3-phosphate.  Interestingly, Salmonella enterica subsp. enterica serovar Enteritidis str. P125109 
encodes this L-idonate catabolic pathway as well as a similar pathway that is encoded by genes 
proximal to that encoding a low-efficiency GlcD (Uniprot ID B5R541; SeGlcD; kcat/KM = 80 M-1 
s-1 [59])(Figure 4.6 and 4.7). 
 
 
Figure 4.6.  The genome neighborhoods of the traditional L-idonate catabolic pathway and the 
low-efficiency ManD-containing L-idonate catabolic pathway present in Salmonella enterica 
subsp. enterica serovar Enteritidis str. P125109. 
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Figure 4.7.  The in vitro catabolic pathway for consumption of L-idonate present in Salmonella 
enterica subsp. enterica serovar Enteritidis str. P125109. 
 
In the latter pathway, L-idonate is converted to D-gluconate via two dehydrogenases as 
previously described (SeIdoDH and SeGlcDH; Uniprot IDs B5R538 and B5R540, respectively), 
but the subsequent steps of phosphorylation and dehydration apparently have shifted order:  
D-gluconate is dehydrated by SeGlcD to 2-keto-3-deoxy-D-gluconate which can be catabolized 
by either the non-phosphorylated or phosphorylated Entner-Doudoroff pathway (Table 3).  We 
have been unable to determine a physiological role for this pathway; it is a cryptic pathway, i.e., 
growth on L-idonate or D-gluconate at concentrations as large as 100 mM did not result in 
upregulation of the genes (Figures A4.6 and A4.7).  
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As for the pathways for catabolism of L-gulonate using 1) CsGulDH, CsFR, CsUxuA, 
and CsManD or 2) RspA, RspB, and RspD, the pathway for catabolism of L-idonate using 
SeIdoDH, SeGlcDH, and SeGlcD demonstrates the successive use of two dehydrogenases to 
epimerize the configuration of carbon-5.  Although all three pathways are found via genome 
neighorhoods involving the low-efficiency ManDs, the physiological purposes, if any, of these 
dehydratases has yet to be discovered.  
 
4.4 Conclusions 
Our investigations into the role of the low-efficiency CsManD discovered a novel 
pathway for the catabolism of L-gulonate in C. salexigens DSM3043 via oxidation/reduction of 
carbon-5 (Figure 4.2).  This pathway was proposed more than 30 years ago for E. coli K-12 
when it was observed that spontaneous mutations allowed growth on L-gulonate, although the 
enzyme/gene for L-gulonate oxidation was not identified[68].  Based on sequence homology to 
CsGulDH, HeGulDH, and RspB, we propose that the likely L-gulonate 5-dehydrogenase in E. 
coli K-12 for which Cooper described the activity is Uniprot ID P38105 (44% identical to 
CsGulDH, 46% identical to HeGulDH, and 98% identical to RspB).  
We have determined that low efficiency D-gluconate and D-mannonate dehydratases 
need not be required for growth, although the their genome neighborhoods encode enzymes 
sufficient to constitute catabolic pathways for L-idonate and L-gulonate, respectively.  Perhaps, 
Table 4.3. Kinetics for Enzymes Encoded by the SeGlucD Operon 
Protein Substrate kcat (s-1) kcat/KM (M-1s-1) 
SeIdoDH L-idonate 1.2 ± 0.09 4.8 x 102 
SeGlcDH 5-keto-D-gluconate 3.4 ± 0.5 3.8 x 103 
SeGlcD[59] D-gluconate 0.05 ± 0.003 8.0 x 101 
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these “cryptic” pathways have been silenced as the result of lack of selective pressure or, 
alternatively, are evolving to meet new metabolic needs. Enzyme promiscuity has long been 
hypothesized to be the starting point of evolution[70]. A similar view, which is supported by 
laboratory evolution, is that the emergence of new functions is a gradual process where the 
evolution of a low-efficiency, promiscuous activity is the most favored option rather than starting 
“from scratch”[71]. This ideology supports the proposal that low-efficiency GlcDs are in 
evolutionary flux toward a new function if one assume that the high-efficiency ManD activity is 
the progenitor function in the ManD subgroup.  These hypotheses imply that low-efficiency 
ManDs are such because they are under no selective pressure: they may be derived from 
high-efficiency ManDs and are becoming less efficient; or they are relics that have not yet 
evolved to high-efficiency because of a lack of selective pressure. Or, it is possible that we have 
not yet discovered the true physiological role of the low-efficiency ManDs/GlcDs.  Finally, 
assessing the physiological roles of these pathways also may be complicated because in Nature 
E. coli and S. enteriditis are members of bacterial communities, i.e., these pathways may be 
activated by unknown metabolites produced by other members of the community.   
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CHAPTER 5: ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF rTSγ 
PROVIDES INSIGHTS INTO THE FUNCTION OF rTSβ 
 
ABSTRACT:  In humans, the gene encoding a reverse thymidylate synthase (rTS) is transcribed 
in the reverse direction of the gene encoding the thymidylate synthase (TS) that involved in DNA 
biosynthesis.  Three isoforms are found: α, β, and γ, with the transcript of the α-isoform 
overlapping with that of TS.  rTSβ has been of interest since the discovery of its overexpression 
in methotrexate and 5-fluorouracil resistant cell lines.  Despite more than 20 years of study, none 
of the rTS isoforms have not been biochemically or structurally characterized.  In this study, we 
identified rTSγ as an L-fuconate dehydratase and determined its high-resolution crystal structure.  
Our data provide an explanation for the observed difference in enzymatic activities between 
rTSβ and rTSγ, enabling more informed proposals for the possible function of rTSβ in 
chemotherapeutic resistance.  
 
Reprinted (adapted) with permission from Wichelecki, D. J., Froese, D. S., Kopec, J., Muniz, J. 
R. C., Yue, W. W., and Gerlt, J. A. Biochemistry. 2014 Apr 29;53(16):2732-8. 
 
5.1. Introduction 
In establishing a quantitative PCR assay for human thymidylate synthase (TS), a partially 
overlapping gene at the chromosome location 18p11.32, designated reverse thymidylate synthase 
(rTS), was found to be transcribed in the reverse direction with marginal overlap between the 
3’-untranslated region of rTS and the last intron of TS [72]. Since then, two other isoforms have 
been identified from alternatively spliced mRNA, yielding a total of three isoforms: rTSα 
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(UniprotKB G2MQH2), rTSβ (G2MQH3), and rTSγ (Q7L5Y1) [73, 74].  All three proteins 
share the same 341 C-terminal amino acid sequence but differ in their N-terminal sequences and 
lengths.  rTSα appends an additional 20 residues to the N-terminal of the shared sequence 
making it a 361 residue polypeptide. rTSβ has a different N-terminal sequence of 75 residues, 
i.e., 416 residue polypeptide, while rTSγ appends an additional 27 amino acids to the N-terminus 
of rTSβ to form a 443 residue polypeptide (Figure D.1).  The rTS genes have been of clinical 
interest in the cancer research community for over 20 years, yet their functions remain largely 
unknown. The main interest lies in the correlation of cell lines resistant to the common 
chemotherapeutics methotrexate and 5-fluorouracil, with rTSβ overexpression [73-78]. 
Methotrexate is a competitive inhibitor of dihydrofolate reductase (DHFR), and 5-fluorouracil is 
an irreversible inhibitor of TS. Both DHFR and TS play central roles in the synthesis of dTMP, a 
precursor for DNA synthesis. In clinical studies, rTSβ was found to be expressed in breast cancer 
tissue but not the surrounding tissues [79]. Furthermore, a statistically significant correlation was 
found between the level of rTSβ expression and a decrease in the five year survival rate of colon 
cancer patients [76]. The 27 residue longer N-terminus of rTSγ, compared to rTSβ, is proposed 
to constitute a mitochondrial signaling sequence [80], suggesting that rTSβ and rTSγ serve 
similar enzymatic functions.  The function of rTSα, the shortest of the three proteins, remains to 
be postulated.  
 Based on sequence homology and inspection of key catalytic residues, the three rTS 
isozymes are members of the mandelate racemase (MR) subgroup of the enolase superfamily 
(ENS) that is known to catalyze the racemization of mandelate as well as dehydration of various 
acid sugar [81]. All ENS members catalyze the abstraction of a proton alpha to a carboxylate 
group of the substrate to form a Mg2+ stabilized enediolate anion, although the overall reaction is 
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not conserved [82]. Furthermore, members of the ENS share common structural motifs that form 
the catalytic machinery, including a capping domain for substrate specificity and a (β/α)7β-barrel 
domain for acid/base chemistry [24, 83].  
In order to provide functional insights into the medically relevant rTSβ and facilitate 
future studies, we isolated recombinant human rTSβ and rTSγ isoforms, identified rTSγ as an 
L-fuconate dehydratase using a medium throughput enzymatic screen, and determined the crystal 
structure of rTSγ at 1.74 Å resolution.  
 
5.2. Materials and methods 
Cloning, expression and purification of human rTSγ (HsrTSγ). A DNA fragment 
containing residues 1-440 of HsrTSγ (IMAGE clone: 3454185) was subcloned into the 
pNIC28-Bsa4 vector (GenBank accession EF198106) incorporating an N-terminal 
TEV-cleavable His6-tag.  The plasmid was transformed into E. coli BL21(DE3)-R3-pRARE2 
cells, grown overnight at 18 °C in 12 L of TB medium after induction by 0.1 mM IPTG.  Cells 
were harvested, lysed in buffer A (50 mM HEPES, pH 7.4, containing 500 mM NaCl, 5% 
glycerol, 10 mM imidazole, 0.5 mM TCEP, and an EDTA-free protease inhibitor), and 
centrifuged to remove insoluble debris.  
The initial stage of purification involved passing the clarified cell extract through 2.5 ml 
Ni-NTA resin pre-equilibrated with buffer A.Bound protein was eluted with buffer B (buffer A + 
250 mM imidazole). The fractions containing HsrTSγ were applied onto a HiLoad 16/60 
Superdex 200 column pre-equilibrated with GF buffer (10 mM HEPES, pH 7.4, containing 500 
mM NaCl, 5% glycerol, and 0.5 mM TCEP).  Fractions containing HsrTSγ were treated with 
TEV protease overnight at 4 °C, and passed over Ni-Sepharose resin pre-equilibrated with GF 
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buffer. The tagless protein was then diluted to 50 mM NaCl, and applied to a 1 mL Resource-S 
column pre-equilibrated with IEX buffer (50 mM Tris-HCl pH 8.5, containing 50 mM NaCl). 
Protein was eluted with a linear gradient of 0-500 mM NaCl and concentrated to 35 mg/mL for 
storage at -80 °C. Further purification details can be found on: 
http://www.thesgc.org/structures/4a35. 
Crystallization, data collection, and structure determination. Crystals of HsrTSγ were 
grown by vapor diffusion at 20 °C.  A sitting drop containing 100 nL protein (35 mg/mL) and 50 
nL well solution was equilibrated against well solution containing 25% (v/v) PEG3350 and 0.1 
M Bis-Tris, pH 5.5.  Crystals were mounted in the presence of 25% (v/v) ethylene glycol and 
flash-cooled in liquid nitrogen.  Diffraction data for the native HsrTSγ crystal were collected at 
the Diamond Light Source beamline I03 and processed with the XDS and SCALA.  HsrTSγ 
crystallized in the hexagonal space group P6522 with one polypeptide in the asymmetric unit.  
The structure was solved by single-wavelength anomalous dispersion (SAD) phasing.   
Crystals were derivatized by incubation with reservoir solution supplemented with 1 mM 
thiomersal for 60 min. Diffraction data were collected at the Diamond Light Source beamline 
I03, and processed and scaled with XDS [84] and Scala [85], respectively.  SHELXD [86] 
identified two heavy atom sites, and after phase refinement in SHARP [87] and subsequent 
density modification with SOLOMON, [88] an electron density map of excellent quality was 
obtained and substantial parts of the model were automatically built with ARP/wARP [89].  The 
resulting model was refined against the native data, where manual model rebuilding was carried 
out with Coot [90], and structure refinement with BUSTER (Global Phasing Ltd, Cambridge, 
UK). 
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Cloning, expression, and purification of human rTSβ (HsrTSβ). The gene encoding 
HsrTSβ was PCR amplified from the HsrTSγ:pNIC28-Bsa4 plasmid using platinum Pfx 
polymerase (Invitrogen). The PCR reaction (30 µL) contained 50 ng template, 1 mM MgCl2, 1X 
Pfx Amp Buffer, 0.33 mM dNTP, 0.33 µM of each primer (forward primer 
5’-TGGGTACCGAGAACCTGTACTTCCAACATATGCACACGGACCC-3’ and reverse 
primer  5’-CAGTGGTGGTGGTCGTGGTGCTCGAGT3’), and 1.25 units Pfx polymerase 
(Invitrogen Platinum Pfx DNA Polymerase kit).  Amplifications were performed according to 
the manufacturer’s guidelines.  The amplification product was digested by NdeI and EcoRI (New 
England Biolabs) and ligated into NdeI/EcoRI digested pET17b (Novagen). The rTSβ gene in 
pET17b was expressed in Escherichia coli BL21 (DE3).  Small-scale cultures were grown at 
37 ˚C for 18 hrs in 5 mL of LB containing 100 µg/mL ampicillin and used to inoculate 1 L LB 
containing 100 µg/mL ampicillin.  The 1 L cultures were grown for an additional 18 hrs at 37 ˚C 
without induction.  The cells were harvested by centrifugation at 5000 rpm for 10 minutes and 
resuspended in 70 mL of binding buffer (6 mM imidazole, 20 mM Tris-HCl, 5 mM MgCl2, and 
500 mM NaCl, pH 7.9).  The resuspended cells were lysed by sonication and centrifuged at 
17,000 rpm for 30 minutes.  The supernatant was loaded onto a 300 ml DEAE-Sepharose column 
(Amersham Biosciences) and eluted with a NaCl gradient (0 - 1 M over 1.6 L) in 10 mM 
Tris-HCl, pH 7.9, containing 5 mM MgCl2.  Fractions were analyzed using SDS-PAGE. 
Fractions that contained rTSβ were combined and dialyzed for 2 hrs at 4˚C against 4 L of 10 mM 
Tris-HCl, pH 7.9, containing 5 mM MgCl2.  The dialyzed protein was then loaded onto a 30 ml 
Q-Sepharose column (Amersham Biosciences) and eluted with a NaCl gradient (0 - 1 M over 
500 mL) in 10 mM Tris-HCl, pH 7.9, containing 5 mM MgCl2.  Fractions were analyzed using 
SDS-PAGE.  Fractions that contained HsrTSβ at high purity were combined and dialyzed for 2 
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hrs at 4˚C against 4 L of 10 mM Tris-HCl, pH 7.9, containing 5 mM MgCl2.  Ammonium sulfate 
was added to a final concentration of 1 M, and the protein was loaded onto a 30 mL 
phenylsepharose column (Amersham Biosciences). The protein was eluted with a gradient of 
ammonium sulfate (1 - 0 M over 500 mL) in 10 mM Tris-HCl, pH 7.9, containing 5 mM MgCl2.  
Fractions were analyzed using SDS-PAGE.  Fractions with pure HsrTSβ were combined and 
dialyzed for 2 hr at 4˚C against 4 L of 10 mM Tris-HCl pH 7.9, containing 5 mM MgCl2, 100 
mM NaCl, and 10% glycerol. Finally, the protein was concentrated to 7.6 mg/mL, flash frozen 
using liquid N2, and stored at -80 ˚C prior to use. 
Screen for dehydration.  Reactions to test for dehydration activity for HsrTSβ and 
HsrTSγ were performed in acrylic, UV transparent 96-well plates (Corning Incorporated) using a 
library of 72 acid sugars (Figure D.2).  Reactions (60 µL total volume) contained 50 mM 
HEPES, pH 7.9, 10 mM MgCl2, 1 µM enzyme, and 1 mM of acid sugar substrate (blanks with no 
enzyme).  The plates were incubated at 30 ˚C for 16 hr.  After incubation, 240 µL of a 
semicarbazide solution (1% semicarbazide w/v, 1% sodium acetate w/v) was added to each well 
and the plate was incubated for 1 hr at room temperature. The absorbance at 250 nm was 
measured (semicarbazone ε = 10,200 M-1 cm-1) using an Infinite M200 PRO microplate reader 
(Tecan Group Ltd.).  
Kinetic assays of HsrTSγ.  Kinetic constants for the dehydration of L-galactonate, 
D-arabinonate, L-arabarate, and D-ribonate were measured using a discontinuous assay 
containing the semicarbazide assay [35, 91].  Kinetic constants for the dehydration of L-fuconate 
were determined using a coupled enzyme assay as described by Yew and coworkers [92]. 
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Differential scanning fluorimetry.  HsrTSβ and HsrTSγ were assayed for shifts in melting 
temperature as previously described [93].  Each protein (5 µg) was assayed as purified and, also, 
in the presence of 5 mM MgCl2 or 5 mM MgCl2 and 5 mM D-erythronohydroxamate. 
Methotrexate and 5-fluorouracil Assays.  Methotrexate (Sigma-Aldrich) or 5-fluorouracil 
(Sigma-Aldrich) (10 mM) was incubated (800 µL) with 50 mM deuterated Tris-DCl,  pD 7.9, 5 
mM MgCl2  and 1 µM purified protein (rTSβ or rTSγ) in D2O for 48 hr at 37 °C. Immediately 
following incubation, samples were analyzed for deuterium incorporation into methotrexate or 
5-fluorouracil via 1H-NMR.  In the case of a reaction that occurs without deuterium 
incorporation (with methotrexate), the optical activity at 589 nm was measured for an 800 µL 
reaction containing 10 mM methotrexate, 50 mM HEPES, pH 7.9, 10 mM MgCl2, and 1 µM 
rTSβ in H2O.  Measurements were made at room temperature using a Jasco P-1010 polarimeter 
(Jasco Inc.) conFigured with a halogen lamp and 589 nm sodium d-line filter.  
 
5.3. Results and discussion 
Characterization of rTSγ.  A sequence similarity network of all proposed acid sugar 
dehydratases within the ENS is shown in Figure D.3.  Clusters in the network were assigned 
specific acid sugar dehydratase functions based on homology to known acid sugar dehydratases, 
including conservation of metal binding and catalytic residues. HsrTSγ, together with the 
canonical FucD from Xanthomonas campestris (XcFucD), is found within the fuconate 
dehydratase (FucD) clustered at an e-value threshold of 10-80 (~40% identity) (Figure D.3).  
HsrTSγ and XcFucD diverge as the e-value threshold is decreased to 10-180 (~70% identity) 
(Figure 5.1) [92]. The sequences of HsrTSγ and XcFucD are 52% identical and 71% similar.  In 
the mannonate dehydratase subgroup of the ENS, proteins that are 67% identical and 79% can 
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catalyze different enzymatic reactions [52]. Therefore, experimental characterization is necessary 
to assign an enzymatic function to HsrTSγ. HsrTSγ was screened for dehydration activity with a 
library of 72 acid sugars. Positive screening hits were verified via 1H-NMR, and steady-state 
kinetic constants were obtained the confirmed substrates. The following sugars were positive hits 
in the screen: L-fuconate, L-galactonate, D-arabinonate, L-arabarate, and D-ribonate (Figure 
5.2). All sugars with the exception of L-arabarate were similarly identified as substrates for  
XcFucD substrates [92].  L-Fuconate shows the greatest catalytic efficiency (kcat/KM = 2.5 x 103 
M-1 s-1), which is an order of magnitude greater than that for the second best substrate, L-
galactonate (kcat/KM = 1.0 x 102 M-1 s-1) (Table 1).  Together with conservation of active site 
catalytic and metal binding residues, the kinetic  
 
Table 5.1. Steady-State Kinetic Parameters for rTSγ 
Substrate kcat (s-1) KM (mM) kcat/KM (M-1 s-1) 
L-fuconate 0.5 ± 0.006 0.2 ± 0.01 2.5 x 103 
L-galactonate 0.3 ± 0.01 3.0 ± 0.2 1.0 x 102 
L-arabinarate 0.3 ± 0.004 4.0 ± 0.5 7.5 x 101 
D-arabinonate 0.04 ± 0.002 2.0 ± 0.1 2.0 x 101 
D-ribonate 0.002 ± 0.001 0.4 ± 0.2 5.0 
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Figure 5.1. Panel A, sequence similarity network for the L-fuconate dehydratase subgroup at an 
e-value threshold of 10-80 (~40% identity).  Panel B, network at an e-value threshold of 10-160 
(~65% identity).  Panel C, network at an e-value threshold of 10-180 (~70% identity). The nodes 
for XcFucD (PDB 2HXT) and rTSγ are colored red and blue, respectively.  
 
 
 
 
E-80 
E-160 
E-180 
A B 
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Figure 5.2. Structures of the top dehydration screening hits for rTSγ. The first order rate 
constants for dehydration are shown below the corresponding acid sugar. Carbons with 
conserved stereochemistry to L-fuconate have their hydroxyl groups highlighted in red.  
 
data establish rTSγ as an L-fuconate dehydratase. In humans, as well as bacteria, L-fuconate 
dehydratase is important for the metabolism of L-fucose, which is found on the cellular surface 
of mammalian, insect, and plant cells [92, 94, 95]. 
The kcat/KM value for L-fuconate in HsrTSγ is 10-fold lower than for XcFucD (4.5 x 104 
M-1 s-1) [92].  This difference in catalytic efficiency may not be surprising given the moderate 
percent identity shared between the two enzymes.  Additionally, the ten-fold reduction could also 
be explained by post-translational modifications in native HsrTSγ that may not be present in the 
recombinant protein expressed in bacteria.  
Crystal structure of HsrTSγ.   The crystal structure of HsrTSγ with Mg2+ was solved by 
Hg-SAD phasing to a resolution of 1.74 Å (Table 5.2, PDB 4A35). The structure confirms its 
membership within the MR subgroup of the ENS, with XcFucD being the closest structural 
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relative, as identified by the DALI server [92] (root-mean-square deviation of 1.03 Å for 430 Cα 
atoms, Z-score 62.0, PDB 2HXT) (Figure 5.3a).  As a member of the MR subgroup, HsrTSγ 
contains the following canonical signature sequences in the core (β/α)7β-barrel domain that are 
essential for catalysis (Figure D.1): 1) a KxK motif (Lys 220-Val 221-Lys 222; HsrTSγ residue 
numbering hereafter) at the end of the 2nd β-strand of the barrel domain for base-catalyzed proton 
abstraction, 2) acidic residues Asp 250, Glu 276, and Glu 305 at the ends of the 3rd , 4th , and 5th 
β-strands of the barrel domain, respectively, which provide the ligands for the essential Mg2+ 
(Figure 5.3b), and 3) a His-Asp dyad (His 355-Asp 328) at the ends of the 7th and 6th β-strands 
of the barrel domain, respectively, which is the general acid catalyst for dehydration of the 
enediolate intermediate [96]. The RMSD of these conserved residues between the HsrTSγ and 
XcFucD structures is 0.31 Å, supporting their catalytic roles in HsrTSγ. Based on the 
characterization of XcFucD, HsrTSγ is assumed to utilize Lys 222 as the general basic catalyst 
for proton abstraction and His 355 as the general acid catalyst for dehydration (Figure 5.3b).  
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Table 5.2.  Data collection and refinement statistics for rTSγ  
Data collection  
Space group P6522 
No. of molecules 1 
in asym. unit  
Cell dimensions  
    a (Å) 84.77 
    b (Å) 84.77 
    c (Å) 316.30 
    βº  γ=120 
Resolution (Å) 1.74 
No. of unique reflections                69165 
Rmerge 0.04 (0.79) 
Completeness (%) 99.0 (93.9) 
 
 
Refinement  
Resolution (Å) 20.00-1.74 (1.78-1.74) 
Rcryst 0.152 (0.240) 
Rfree 0.176 (0.288) 
No. atoms  
    Protein 3468 
    Waters 594 
Bound ligands   MG, EDO 
Ligand atoms 30 
R.m.s deviations  
    Bond lengths (Å) 0.015 
    Bond angles (°)                                                    1.11 
PDB accession code                                                         4A35
 
Bracketed values represent highest resolution shell. 
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Liang and coworkers previously postulated that HsrTSγ was simply an isoform of 
HsrTSβ appended with a mitochondrial signaling sequence at its N-terminus [80]. Structural 
analysis of HsrTSγ reveals that the extra 27 residues in the γ isoform comprise the first β-strand 
within the capping domain, a short alpha-helix, and a large portion of the “20s” loop.  This β-
strand is part of a three-stranded β-sheet in the capping domain and packs closely against the C-
terminus, while the “20s” loop, a conserved structural feature in MR subgroup members, is 
known to confer substrate specificity while occluding solvent from the active site [97-100] 
(Figure 5.4). Considering the structural integrity of this region and its close proximity to the 
active site, we propose that the extra 27 residues are not involved in mitochondrial targeting, but 
instead are necessary for the enzyme architecture and also possibly confer L-fuconate 
dehydratase activity to HsrTSγ. This is supported by the lack of definitive mitochondrial 
targeting signals identified from various bioinformatics servers (data not shown).  
 Pursuit of rTSβ Function.  The importance of the N-terminal 27 residues for HsrTSγ 
reactivity and integrity implies that HsrTSβ, lacking this region, may have a deformed active site 
(e.g. highly solvent exposed, Figure D.4) and be devoid of L-fuconate dehydratase activity. 
Accordingly, we pursued enzymatic characterization of recombinantly produced HsrTSβ.  Our 
initial attempt to subclone the gene encoding HsrTSβ, as described for HsrTSγ (i.e. N-terminal 
His-tagged fusion protein), resulted in insoluble protein. This suggests the importance of the 
N-terminal 27 residues for protein stability, in addition to its role in enzyme activity, and is also 
consistent with our observations that truncation constructs of HsrTSγ lacking the N-terminal 5, 8, 
or 12 residues rendered the γ isoform to be highly insoluble in E. coli (Figure D.5). We managed 
to subclone HsrTSβ as a tag-less construct which resulted in a low level of expression in E. coli.  
The purified protein was screened for dehydration activity on the library of 72 acid sugars as 
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described above.  Based on the expectation that the complete 20s loop is necessary for catalysis, 
no dehydration activity was detected for HsrTSβ.  We also characterized HsrTSβ and HsrTSγ by 
differential scanning fluorimetry (Table D.1) and showed that HsrTSβ is more thermolabile than 
HsrTSγ (∆Tm = 5 oC) and, unlike HsrTSγ, is not thermally stabilized by the addition of D-
erythronohydroxamate, an enediolate intermediate analog, thereby suggesting that HsrTSβ does 
not bind the ligand.  Taken together, our data substantiate the hypothesis that the N-terminal 27 
amino acid residues in rTSγ are necessary for catalytic activity and confer stability to the protein. 
Several studies have observed uncharacteristically high levels of HsrTSβ expression in 
tumor cell lines that also exhibit resistance to either methotrexate or 5-fluorouracil [73-78]. This 
correlation suggests the possibility that HsrTSβ, which does not exhibit the L-fuconate 
dehydratase activity of HsrTSγ, could instead harbor an alternative metabolic activity on these 
small molecules in a manner that inactivates them. The observation that HsrTSβ expression was 
found to be induced by TS inhibitors indicates the protein may indeed be acting on these drug 
molecules [73][75, 101]. To explore this possibility, methotrexate and 5-fluorouracil were 
analyzed for their ability to act as substrates for HsrTSγ.  Methotrexate has a proton alpha to the 
carboxylate group of its glutamate side chain, which could be racemized by an ENS member. 
Because methotrexate has more than twice the molecular weight of L-fuconate, a truncation of 
the “20s” loop, such as that seen in the β isoform, could expose a larger binding surface to 
accommodate methotrexate in the active site.  Reactions were performed in D2O to determine if 
exchange of the alpha proton (racemization) were occurring. Also, 5-fluorouracil was tested for 
defluorination. No incorporation of deuterium was observed via 1H NMR in the presence of 
either HsrTSγ or HsrTSβ. Furthermore, to test a racemization mechanism in which deuterium  
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Figure 5.3. Panel A, an overlay of the structure of rTSγ (PDB 4A35, tan) and XcFucD bound to 
the substrate analog L-erythronohydroxamate (PDB 2HXT, blue). The Cα RMSD is 1.03 Å. 
Panel B shows an overlay of the active site residues of the structures. The Cα RMSD for these 
metal binding and catalytic residues is 0.31 Å. Residue number is from the structure of rTSγ. 
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Figure 5.4. The structure of rTSγ (PDB 4A35) from side and top views. Each structure has the 
first 27 amino acids, which would be missing in rTSβ, highlighted in red. The metal binding 
residues are highlighted in green and catalytic residues in cyan. 
 
 
 
Top View 
Side View 
 
90° 
“20s” Loop  
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exchange does not occur, methotrexate was incubated with HsrTSβ or HsrTSγ in a polarimeter, 
but no change in optical rotation was observed. These negative results, in conjunction with the 
lack of identification of an acid sugar substrate, allow us to conclude that rTSβ is not involved in 
chemical modification of methotrexate or 5-fluorouracil. 
Dolnick proposed that HsrTSβ could function by transferring a carboxylate group from S-
adenosylmethionine to a lipophilic acceptor [101-103]. We find this unlikely, considering that 
MR subgroup members catalyze the abstraction of a proton alpha to a carboxylate group, which 
is not a partial reaction known to result in decarboxylation.  Based on the in vitro function of 
HsrTSγ and sequence homology to members of the MR subgroup, HsrTSβ likely lacks an 
enzymatic activity. This, however, does not prohibit HsrTSβ from participating in protein-protein 
interactions that may produce the observed resistance phenotype. In fact, TS can physically 
associate with proteins of the same molecular weight as rTSα and rTSβ, and conversely, rTSα 
and rTSβ could coimmunoprecipitate with TS [75].  Furthermore, preliminary data suggesting 
that rTS proteins interact with dihydrofolate reductase (DHFR) could explain the correlation 
between rTSβ overexpression and methotrexate resistance [103].  The characterization of HsrTSγ 
as an L-fuconate dehydratase, coupled with the inability of HsrTSβ to catalyze this reaction, 
points to a mechanism of resistance that does not involve catalysis, but rather interactions with 
one of the above proposed partners.  Future in vitro studies are needed to confirm the rTS/TS or 
rTS/DHFR protein-protein interactions and characterize their effect on TS or DHFR function. 
 
5.4. Conclusions 
Human rTSγ has been characterized in vitro as an L-fuconate dehydratase that belongs to 
the mandelate racemase subgroup of the enolase superfamily. The additional N-terminal amino 
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acids in rTSγ compared to rTSβ are important for catalysis and stability, refuting previous 
proposals that rTSγ is merely a variant of rTSβ with an N-terminal mitochondrial signaling 
domain.  rTSβ has been implicated in the resistance of tumor cell lines to methotrexate and 5-
fluorouracil. Unfortunately, rTSβ does not catalyze any chemical modification of these 
chemotherapeutics.  Therefore, we believe attempts to sensitize resistant cells lines via inhibitors 
to rTSβ will not be successful.  Based on the crystal structure of rTSγ and the enzymatic 
screening performed in this study, we do not believe rTSβ is catalytically active. Therefore, 
hypotheses that involve protein-protein interactions are more likely the source of the observed 
phenotypes and should be investigated further.   
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CHAPTER 6: CONCLUSIONS 
 
6.1. Mannonate dehydratases in the enolase superfamily  
 
6.1.1. Sequential versus functional divergence in the ManDs  
 In this study it was found that the D-mannonate dehydratase subgroup of the enolase 
superfamily (ManD) was not only multifunctional [with the discovery of the D-gluconate 
dehydratase activity (GlcD)], but also displayed a variance in catalytic efficiency: 1) high 
efficiency (kcat/KM = 103 to 104 M-1 s-1) and specific for D-mannonate; 2) low efficiency (kcat/KM 
= 101 to 102 M-1 s-1) and specific for either D-mannonate, D-gluconate,  or promiscuous for both; 
and 3) no-activity with either D-mannonate or D-gluconate (or any acid sugar in the library). 
When these activities are mapped onto a sequence similarity network (SSN), one can visualize 
how function diverges as sequence diverges in the subgroup [52]. Surprisingly, these distinct 
functions do not separate until a fairly stringent cut-off is applied: >70% sequence identity. The 
deconvolution of function in this subgroup exemplifies how razor thin the line is between 
structure and function, or rather how sensitive the balance is between enzyme sequence and 
catalysis. 
 
6.1.2. ManD/GlcD impact on synthetic biology/metabolic engineering 
The information gathered on the ManD/GlcD disparity in the ManD subgroup makes an 
impact in the field of metabolic engineering, where researchers work to optimize cellular 
processes with the end goal of increasing production of a certain substance. Generically, this is 
done by one of two methods: improving flux through the metabolic process or removing flux 
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through pathways which deplete from the pathway of interest [104]. Additionally, synthetic 
biology can be coupled with metabolic engineering to devise new pathways [105]. In the area of 
advanced biofuel production, one sees a combination of these strategies since advanced biofuels 
[longer chain alcohols (≥ C4) and fatty-acid based fuels] are generally produced in such low 
abundance naturally [106]. Researchers are utilizing synthetic biology to design metabolically 
engineered biosynthetic pathways or redesign naturally occurring pathways to increase yields of 
advanced biofuels [107-110]. The subtle differences observed in ManD/GlcD activity can help 
synthetic biologists discern how novel chemistry can arise in similar protein scaffolds; 
knowledge which can then be applied to the development or optimization of novel biosynthetic 
pathways. 
 
6.1.3. Physiological role of high efficiency ManDs 
 Prior to this dissertation, there was no verified physiological role for ManDs. It was 
discovered that a ManD in Caulobacter crescentus NA1000 (D-mannonate dehydration to 2-
keto-3-deoxy-D-mannonate with a kcat/KM of 1.2 x 104 M-1 s-1 [52]) was responsible for D-
mannonate dehydration in D-glucuronate metabolism via RT-PCR, phenotypic knockout studies, 
and complementation [111]. The protein UxuA (utilization of hexuronate A) was originally 
characterized as the mannonate dehydratase in this pathway [29]. It was discovered that every 
organism with a high efficiency ManD lacks UxuA in its genome [52]. Alternate pathways exist 
to metabolize D-glucuronate (www.metacyc.org); therefore, this incidence of convergent 
evolution was not obvious and needed experimental verification. Now validated, this 
physiological function can be confidently applied to all high efficiency ManDs discovered, thus 
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far resulting in the simultaneous annotation of 55 enzymes that were largely misannotated 
previously [52]. 
 
6.1.4. Physiological activity of low efficiency ManDs 
 The discovery of low-efficiency GlcDs and ManDs calls into question what value of 
kcat/KM is physiologically relevant: Can a low efficiency enzyme be physiologically relevant if 
enough substrate is present in the cell/enough enzyme is produced to overcome a low kcat? Or is 
low efficiency an indication that other factors are needed for full activity (i.e. cofactors, protein-
protein interactions, different substrate, etc.)? Organisms with low efficiency ManDs generally 
also contain the UxuA gene within their genomes and, therefore, are thought to be involved in 
pathways other than D-glucuronate metabolism. In Chromohalobacter salexigens DSM3043, a 
low efficiency ManD (dehydration of D-mannonate with a kcat/KM of 5 M-1 s-1 and dehydration of 
D-gluconate with a kcat/KM of 5 M-1 s-1: CsManD) was investigated with the aim of finding a 
physiological role. The genome neighborhood surrounding CsManD was indicative of L-
gulonate or D-mannonate metabolism. Additionally, a UxuA protein is present in this genome 
neighborhood. Through extensive in vivo experiments (RT-PCR and phenotypic knockout 
studies), it was proven that the UxuA is physiologically relevant to the metabolism of L-gulonate 
and D-mannonate (preferred pathway). CsManD was not found to be physiologically relevant for 
either pathway. While this result does not answer the question put forth, it does reveal a novel 
physiological role for a previously characterized enzyme – representing a unique form of 
functional discovery. 
Similar studies have been performed in Salmonella enterica enterica serovar Enteritidis 
P125109 with a redundant L-idonate metabolizing pathway involving a low efficiency GlcD 
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(unpublished data). This ManD also failed to display a physiological role in our phenotypic 
knockout studies. Given these two test cases and the findings of Huisman and Kolter [112], it is 
postulated that low efficiency ManDs are not directly involved in metabolism, but may have a, 
heretofore undiscovered, regulatory role within the cell related to starvation sensing.  
 
6.1.5. No-activity ManDs 
 Many no-activity ManDs are located in genome neighborhoods containing genes 
encoding components of downstream metabolism of the ManD product, 2-keto-3-deoxy-D-
mannonate: 2-keto-3-deoxy-D-mannonate kinase and 2-keto-3-deoxy-D-mannonate-6-phosphate 
aldolase. Despite this fact, any attempt to elicit enzyme activity in vitro failed. Variations in pH, 
temperature, salt concentration, osmolarity (glycerol/betaine), and metal cations, as well as the 
presence of the reducing agent dithiothreitol and nucleotide mono-, di-, and triphosphates were 
tested to see if these enzymes were activated by any of these conditions/molecules [52]. 
Furthermore, C6 phosphorylated D-mannonate, D-gluconate, D-allonate, and D-altronate were 
tested for activity with Uniprot ID A5KUH4 (no-activity protein from Vibrionales bacterium 
SWAT-3 with downstream metabolism genes nearby) since they are all susceptible to 
dehydration to 2-keto-3-deoxy-D-mannonate-6-phosphate (unpublished data). Still, no activity 
was observed. Many of these organisms have UxuAs in their genomes so it is unclear which 
carbon source would require ManD for metabolism; therefore, no knockout studies have been 
attempted. Furthermore, none of the no-activity proteins characterized herein are from organisms 
which are considered genetically tractable. The leading hypothesis is that these enzymes function 
in multienzyme complexes (channeling) or utilize a substrate our lab does not yet have access to 
(presumabley an acid sugar or carbohydrate due to genome contexts). 
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6.1.6. Reflections on annotation 
 In this dissertation, the previously described in vitro characterization of the ManDs 
covered the majority of the sequence space within the ManD subgroup. As such, a clear picture 
of the boundaries between function and sequence identity was observed. A log(BLAST E-value) 
of -190 was needed to fully separate the diverse functions of the ManD subgroup. This 
corresponds to ~75% identity (Figure 6.1). In 2002, Rost examined the current state of 
automated annotations and found that most group’s calculations had found that between 50 and 
70% sequence identity should be used to transfer function with confidence [113]. Furthermore, 
in 2003 it was concluded that over 60% sequence identity was needed to transfer all four EC 
numbers with 90% accuracy [32]. Both of these conclusions fall short of the ~75% identity 
required by the ManD subgroup to accurately transfer function. Therefore, the ManD subgroup is 
a strong example of how difficult it is to annotate proteins via strictly homology-based methods. 
Some experimental characterization is still required, but it is necessary to couple that with 
intelligent interpretation of SSNs to transfer the functions accurately to a large number of 
homologous proteins.  
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Figure 6.1. A quartile plot for the ManD subgroup. This displays the relationship between 
-log(BLAST E-value) and sequence identity. The “functional cut-off”, which determines 
isofunctional clusters for this subgroup, has a –log10(E) value of 190 or ~75% identity. 
 
6.1.7. Hypotheses on enzyme evolution in the ManD subgroup 
 When one visualizes the experimentally characterized members of the ManD subgroup 
with a phylogenetic tree (http://www.phylogeny.fr/), a clear dichotomy is seen (Figure 6.2). 
Standouts like EFI Target IDs 501675 and 501645 can be explained by their highly divergent 
nature: singletons in the ManD SSN at a log(BLAST E-value) of -190. More interestingly, this 
phylogenetic tree illustrates that the no activity proteins and low activity GlcDs diverge from the 
D-mannonate dehydrating  ManDs immediately in the phylogenetic tree. The next branch on the 
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ManD side separates the high activity and low activity ManDs with the exception of the 
promiscuous ManD/GlcDs which branch with the high activity ManDs. The ManD subgroup 
phylogenetic tree taken as a whole can be seen as a snapshot of the subgroup’s evolution, where 
some organisms have no need for a ManD in D-glucuronate metabolism and have thusly 
“repurposed” it. The logical evolutionary flow would be from high activity ManD to GlcD or no-
activity protein; evidence for this comes in the form of the gene duplications present in some 
organisms with high-efficiency ManDs [52]. Specifically in Caulobacter crescentus NA1000, 
two high-efficiency ManDs exist (Uniprot IDs B8GZZ7 and B8H1R9), but only one was found 
to be physiologically relevant (B8GZZ7) [111]. These genes are highly similar (~80% identical), 
which indicates gene duplication may have taken place and B8H1R9 is in the process of 
evolving a new function.  
The His residue at the end of the 7th β-strand is a prime example of how evolution has 
occurred in this subgroup. It shows how evolution has taken advantage of a conserved residue 
that could serve multiple purposes and derived a new function from those possibilities (i.e. 
hydrogen bonding partner vs catalytic residue). Granted, GlcDs have low catalytic efficiency, but 
perhaps their transformation is not yet complete. Rather than explaining the lack of activity seen 
in no-activity proteins with the limitations of our modest acid sugar library, it is possible they are 
in the midst of their own “repurposing” and have yet to fully evolve their next function. 
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Figure 6.2. A phylogenetic tree for the characterized members of the ManD subgroup. High 
activity ManDs are in green. Low activity ManDs in blue. No activity proteins in red. It should 
be noted that 501676 to 502246 are specific to D-gluconate. Highly divergent ManDs [singletons 
on the ManD SSN at a –log(BLAST E-value) of 190] are marked with an asterisks.  
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6.2. L-Fuconate dehydratases in the mandelate racemase subgroup of the enolase 
superfamily 
 
6.2.1. rTSγ characterization and insights into rTSβ overexpression phenotypes 
 It was discovered that human reverse thymidylate synthase γ (rTSγ) acts as an L-fuconate 
dehydratase, which catalyses the in vitro dehydration of L-fuconate to 2-keto-3-deoxy-L-
fuconate: kcat of 0.5 ± 0.006 s-1 and kcat/KM of 2.5 x 103 M-1 s-1 [114]. This is the only human 
enolase superfamily member to have been enzymatically characterized to date, other than the 
namesake enolase. rTSβ, an isoform of rTS γ, has been linked to cancer via implications of 
involvement in the resistance of tumor cell lines to methotrexate and 5-fluorouracil [73-78]. 
Unfortunately, we were unable to find any reactivity with rTSβ on either chemotherapeutic 
compound or our acid sugar library. The 27 N-terminal amino acids of rTSγ, which are missing 
in rTSβ, were found here to be essential for catalysis and ,therefore, are unlikely a mitochondrial 
signaling sequence for rTSβ as was previously hypothesized [80]. Based on the crystal structure 
of rTSγ and the truncated “blank” region observed in the rTSβ sequence, we do not believe rTSβ 
is catalytically active. Therefore, rTSβ likely contributes to the observed resistance phenotypes 
via mechanisms independent of dehydratase activity, such as protein-protein interactions. 
Evidence for the association of rTSβ with thymidylate synthase and dihydrofolate reductase has 
been observed elsewhere, and is a promising hypothesis for the rTSβ phenotypes seen [75, 103].  
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6.3 The Enzyme Function Initiative 
 
6.3.1. ManD-related advances in the EFI  
 Since the work described in this dissertation was completed, many advances in the EFI 
have been validated by the successes of the work in the ManD subgroup. First and foremost, the 
generation of SSNs has become trivial with the EFI-Enzyme Similarity Tool (EFI-EST; 
http://efi.igb.illinois.edu/efi-est/). The initial SSN generated for functional discovery in the 
ManD subgroup (Chapter 2) was quite labor intensive (constructed by Dr. Shoshana Brown, 
Babbitt lab, UCSF). Through the characterization of the ManD subgroup, along with other EFI 
projects, it was found that SSNs were essential for visualizing protein similarity in large datasets, 
which in turn is used to select targets in large-scale functional discovery projects and aide in the 
accurate transfer of function between homologous proteins. EFI-EST uses a web interface for 
automated creation of SSNs for any protein family (Pfam or InterPro) or for individual protein 
sequence BLASTs (2000 returned sequences). In a matter of hours a quartile plot and SSN are 
generated with minimal input from the user. This tool has made the generation of SSNs 
accessible to all researchers, not just those proficient in bioinformatics. 
 Additionally, the manual analysis of the genome neighborhoods of every ManD proved 
useful in determining targets as well as for predicting functions/pathways. Naturally, manually 
determining the genome neighborhoods of a large group of proteins can be a bottleneck in the 
functional discovery process. Genome neighbors are extremely useful in functional discovery 
and a more efficient method was needed. The EFI has since developed the EFI-Genome 
Neighborhood Tool (EFI-GNT) tool (http://efi.igb.illinois.edu/efi-gnt/). Similar to EFI-EST, 
EFI-GNT is an automated, web-based tool that requires little input from the user (a SSN is all 
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that is required). The program generates a wheel-and-spoke genome neighborhood network 
(GNN) that connects SSn clusters with commonly occurring Pfam protein families, in an effort 
to summarize the enzymatic capacity of the genome neighbors and shed light on the function of 
the SSN query sequences. A colored-coded version of the user-submitted SSN allows the user to 
visually recognize which clusters are present in each wheel-and-spoke in the GNN. EFI-GNT is 
another researcher-friendly tool developed by the EFI to aid in the quick and accurate 
characterization of proteins of unknown function. 
 Furthermore, the work done in Chromohalobacter salexigens DSM3043 (Chapter 4) 
verified that ThermoFluor of transcriptional regulators could be a useful strategy in determining 
the substrate for a particular genome neighborhood. The initial idea for ThermoFluor was to 
screen the solute-binding domains of ATP-binding cassette (ABC) and Tripartite ATP-
independent periplasmic (TRAP) transporters. This was done on a large scale and many ligands 
were found (used in Chapter 3 for a TRAP DctP, but no hits were seen in that case). The 
information is being formatted for publication at the time of this dissertation’s preparation. The 
“Chromohalobacter story” verified that this strategy could also be applied to GntR 
transcriptional regulators (generally inhibitors). GntRs contain an N-terminal DNA-binding 
domain and a C-terminal solute-binding domain. It was unknown how the DNA-binding domain 
effects the screening hits. The results indicate that useful information can be gleaned from 
screening the entire protein without having to engineer truncations, and that this is a useful 
strategy for gaining insights into the potential substrate of a particular genome neighborhood.      
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6.3.2. Future of the EFI  
 The EFI has taken great strides during the work described in this dissertation, and will 
continue to do so in the future. The current future goals of the EFI are to correlate physiological 
data to ThermoFluor screening of solute binding proteins. This will likely result in the 
deorphanization of many proteins of unknown function, and hopefully elucidate novel metabolic 
pathways. A recent collaboration with Dr. Andrei Osterman from the Sanford-Burnham Institute 
has given the EFI a new lens to visualize potential metabolic pathways. The Osterman group 
takes advantage of the fact that many genes organize into genetic motifs that share common 
regulators (determined by proximal conserved transcription factor binding sites) and have co-
occurrence across many related organisms to identify novel metabolic pathways. This approach 
is being combined with ThermoFluor data of solute binding proteins to fill in the “blanks” of 
incomplete metabolic networks. 
The EFI is also moving into the realm of the human microbiome. Preparations are 
underway to accommodate the large-scale purification of proteins in an anaerobic environment, 
and also to facilitate anaerobic cultivation/genetic manipulation of these source bacteria. In this 
manner, the EFI hopes to apply its functional discovery prowess to the human microbiota and 
discover new metabolic/syntrohic pathways, enzymatic reactions, and drug targets which could 
be important for human health. 
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APPENDIX: A 
 
Crystallization conditions 
The crystals of high-activity ManD/EFI target 502214 from Caulobacter sp. K31 
liganded with Mg2+, Cl-, and glycerol (4FI4) were grown by the sitting drop vapor diffusion 
method at room temperature. The protein solution contained the protein (17.4 mg/mL) in 10 mM 
HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 5 mM DTT, 5 mM MgCl2; the precipitant 
contained 0.16 M MgCl2, 0.08 M Tris-HCl, pH 8.5, 24% PEG4K, 20% glycerol. 
The crystals of high-activity ManD/Uniprot ID Q9AAR4 from Caulobacter crescentus 
CB15 liganded with Mg2+, Cl-, D-mannonic acid, CO32-, and glycerol (4GME) were grown by 
the sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (17 mg/mL) in 10 mM HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 5 mM DTT, 5 mM 
MgCl2; the precipitant contained 0.1 M ammonium sulfate, 0.1 M Tris-HCl, pH 8.5, 25% 
PEG3350, and 10% glycerol. 
The crystals of high-activity ManD/Uniprot ID Q9AAR4 from Caulobacter crescentus 
CB15 liganded with Mg2+, Cl-, CO32-, and glycerol (3VCN) were grown by the sitting drop vapor 
diffusion method at room temperature. The protein solution contained the protein (17 mg/mL) in 
10 mM HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 mM MgCl2; the precipitant 
contained 0.1M bicine, pH 9.0, and 20% PEG6000. 
The crystals of low-activity ManD/Uniprot ID B3PDB1from Cellvibrio japonicus 
Ueda107 liganded with Mg2+, Cl-, 2-[N-cyclohexylamino]ethane sulfonic acid, and glycerol 
(3V3W) were grown by the sitting drop vapor diffusion method at room temperature. The 
protein solution contained the protein (10.1 mg/mL) in 10 mM HEPES pH 7.8, 150 mM NaCl, 
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10% glycerol, 5 mM DTT, 5 mM MgCl2; the precipitant contained 0.1 M CHES/NAOH pH 9.5, 
30% PEG3000, and 15% glycerol. 
The crystals of D-mannonate dehydratase from Cellvibrio japonicus Ueda107 liganded 
with Mg2+, Cl-, and L-tartaric acid (3V4B) were grown by the sitting drop vapor diffusion 
method at room temperature. The protein solution contained the protein (10.1 mg/mL) in 10 mM 
HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 5 mM DTT, 5 mM MgCl2; the precipitant 
contained 0.2M KNaTartrate, 20% Peg3350, and 20% glycerol. 
The crystals of the mutant P317A of promiscuous ManD/GlcD/Uniprot ID Q1QT89 from 
Chromohalobacter salexigens liganded with Mg2+ and D-gluconate (3QKF) were grown by the 
sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (12 mg/mL) in 10 mM Tris (pH 8.0), 100 mM NaCl, 5 mM MgCl2, and 40 mM D-
gluconate; the precipitant contained 15% PEG 3350, 0.1 M succinic acid (pH 7.0), and 5 mM 
MgCl2.  
The crystals of promiscuous ManD/GlcD/ Uniprot ID Q1QT89 from Chromohalobacter 
salexigens DSM 3043 liganded with Na+, Cl-, and glycerol (4F4R) were grown by the sitting 
drop vapor diffusion method at room temperature. The protein solution contained the protein 
(13.3 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 mM 
MgCl2; the precipitant contained 0.2 M sodium acetate, 0.1 M Tris-HCl pH 8.5, 30% Peg4000, 
and 20% glycerol. 
The crystals of promiscuous ManD/GlcD/ Uniprot ID Q1QT89 from Chromohalobacter 
salexigens DSM 3043 liganded with Mg2+, SO42-, and glycerol (3OW1) were grown by the 
sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (26 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 mM 
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MgCl2; the precipitant contained 1.5 M ammonium sulfate, 0.1 M Bis-Tris, 0.1 M sodium 
chloride, pH 6.5. 
The crystals of promiscuous ManD/GlcD/ Uniprot ID Q1QT89 from Chromohalobacter 
salexigens DSM 3043 liganded with Mg2+ and glycerol (3PK7) were grown by the sitting drop 
vapor diffusion method at room temperature. The protein solution contained the protein (26 
mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 mM MgCl2; the 
precipitant contained 15% PEG3350, 0.1 M succinic acid, pH 7.0. 
The crystals of promiscuous ManD/GlcD/ Uniprot ID Q1QT89 from Chromohalobacter 
salexigens DSM 3043 liganded with Mg2+, D-mannonic acid, and 2-keto-3-deoxygluconate 
(3P93) were grown by the sitting drop vapor diffusion method at room temperature. The protein 
solution contained the protein (26 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% 
glycerol, 1 mM DTT, 5 mM MgCl2; the precipitant contained 0.3 M magnesium formate, 0.1M 
bis-tris, pH 5.5. 
The crystals of promiscuous ManD/GlcD/ Uniprot ID Q1QT89 from Chromohalobacter 
salexigens liganded with Mg2+, and D-gluconate (3QKE) were grown by sitting drop vapor 
diffusion method at room temperature. The protein solution contained the protein (26 mg/mL) in 
10 mM Tris (pH 8.0), 5 mM MgCl2; and 40 mM D-gluconate; the precipitant contained 20% 
PEG3350, 0.2 M sodium malonate (pH 7.0), and 5 mM MgCl2.  
The crystals of promiscuous ManD/GlcD/ Uniprot ID Q1QT89 from Chromohalobacter 
salexigens liganded with Co2+ and D-arabinohydroxamate (3RGT) were grown by the sitting 
drop vapor diffusion method at room temperature. The protein solution contained the protein (26 
mg/mL) in 10 mM Tris (pH 8.0), and 40 mM D-arabinohydroxamate; the precipitant contained 
20% polyvinylpyrrolidone K15, 0.1 M Tris (pH 8.5), and 10 mM CoCl2.  
105 
 
The crystals of no-activity protein/Uniprot ID A6M2W4 from Clostridium beijerinckii 
liganded with Mg2+ (3S47) were grown by the sitting drop vapor diffusion method at room 
temperature. The protein solution contained the protein (37 mg/mL) 10 mM Tris (pH 8.0), 100 
mM NaCl, and 5 mM MgCl2; the precipitant contained 45% 2-methyl-2,4-pentanediol, 0.1 M 
Bis-Tris (pH 5.5), 0.2 M ammonium acetate, and 5 mM MgCl2.  
The crystals of no-activity protein/Uniprot ID A4W7D6 from Dickeya dadantii Ech703 
liganded with Mg2+, formic acid, I-, Cl-, and glycerol (4IHC) were grown by the sitting drop 
vapor diffusion method at room temperature. The protein solution contained the protein (16.4 
mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 mM MgCl2; the 
precipitant contained 0.2 M ammonium iodide, pH 7.5, 20% PEG3350. 
The crystals of low-activity ManD/Uniprot ID Q8FHC7 from Enterobacter sp. 638 
liganded with Mg2+, Cl-, and glycerol (3TJI) were grown by the sitting drop vapor diffusion 
method at room temperature. The protein solution contained the protein (16.2 mg/mL) in 10 mM 
HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 5 mM DTT, 5 mM MgCl2; the precipitant 
contained 2.5 M NaCl, 100 mM Tris pH 7.5, 200 mM MgCl2, 20% glycerol. 
The crystals of no-activity protein/Uniprot ID C8ZZN2 from Enterococcus gallinarum 
EG2 liganded with Mg2+, Cl-, and glycerol (4HNL) were grown by the sitting drop vapor 
diffusion method at room temperature. The protein solution contained the protein (19.7 mg/mL) 
in 10 mM HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 5 mM DTT, 5 mM MgCl2; the 
precipitant contained 0.2 M MgCl2, pH 8.5, 0.1 M Tris-HCl, and 16% PEG MME4000. 
The crystals of low-activity ManD/Uniprot ID Q8FHC7 from Escherichia coli CFT073 
complexed with Mg2+ (4IL2) were grown by the sitting drop vapor diffusion method at 9⁰ C. The 
crystallization drop contained protein solution (10 mg/ml) in 20 mM Tris (pH 7.5), 100 mM 
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NaCl, 50 mM imidazole, and 10 mM D-mannonate; precipitant contained 25% PEG 1,500 and 
20% v/v glycerol.  
The crystals of the loop mutant (V161A, R163A, K165G, L166A, Y167G, Y168A, 
E169G) of high-activity D-mannonate dehydratase (ManD) from Novosphingobium 
aromaticivorans liganded with Mg2+ and glycerol (4K8G) were grown by the sitting drop vapor 
diffusion method at 4⁰ C. The crystallization drop contained protein solution (20 mg/ml) in 50 
mM Tris (pH 7.5), 100 mM NaCl, 5 mM MgCl2, and 10 mM D-mannonate; the precipitant 
contained 28% PEG 400, 100 mM HEPES-Na+, and 200 mM CaCl2. 
The crystals of the mutant A314P of high-activity D-mannonate dehydratase from 
Novosphingoium aromaticivorans liganded with Mg 2+ and D-mannonate (3R4E) were grown by 
the sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (12 mg/mL) in 100 mM imidazole, 20 mM Tris (pH 8.0), 150 mM NaCl, 5 mM MgCl2, 
and 40 mM D-mannonate; the precipitant contained 30% PEG 400, 0.1 M HEPES (pH 7.5), and 
5 mM MgCl2.  
The crystals of low-activity GlcD/Uniprot ID D4GJ14 from Pantoea ananatis LMG 
20103  liganded with Mg2+, Cl-, 1,2-ethanediol, and gluconic acid (3T6C) were grown by the 
sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (13.1 mg/mL) in 10 mM HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 5 mM DTT, 5 
mM MgCl2; the precipitant contained 1 M K/Na tartrate and 100 mM MES pH 6.0; the soak 
contained 1 M K/Na tartrate, 100 mM MES pH 6.0, 20% ethylene glycol, and 70 mM sodium 
gluconate. 
The crystals of D-mannonate dehydratase from Pectobacterium carotovorum subsp. 
carotovorum PC1 liganded with Mg2+, formic acid, Cl-, and glycerol (4E4F) were grown by the 
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sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (17.9 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 
mM MgCl2; the precipitant contained 0.17 M sodium acetate, pH 8.5, 0.085 M Tris-HCl, 25.5% 
PEG4000, 15% glycerol. 
The crystals of low-activity GlcD/Uniprot ID B5R541 from  Salmonella enterica subsp. 
enterica serovar Enteritidis str. P125109 liganded with Cl- and glycerol (3TW9) were grown by 
the sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (15.2 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 
mM MgCl2; the precipitant contained 0.2 M sodium chloride, 100 mM sodium acetate, pH 4.6, 
and 30% MPD. 
The crystals of low-activity GlcD/Uniprot ID B5R541 from Salmonella enterica subsp. 
enterica serovar Enteritidis str. P125109 liganded with Mg2+, Cl-, and glycerol (3TWA) were 
grown by the sitting drop vapor diffusion method at room temperature. The protein solution 
contained the protein (15.2 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 
mM DTT, 5 mM MgCl2; the precipitant contained 0.2 M ammonium acetate, 100 mM Tris-HCl 
pH 8.5, and 25% PEG3350. 
The crystals of low-activity GlcD/Uniprot ID B5R541 from Salmonella enterica subsp. 
enterica serovar Enteritidis str. P125109 liganded with Cl- and glycerol (3TWB) were grown by 
the sitting drop vapor diffusion method at room temperature. The protein solution contained the 
protein (15.2 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 
mM MgCl2; the precipitant contained 0.2 M sodium chloride, 100 mM sodium acetate, pH 4.6, 
and 30% MPD. 
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The crystals of high-activity ManD/Uniprot ID Q1NAJ2 from Sphingomonas sp. SKA58 
liganded with Mg2+, Cl-, and glycerol (3THU) were grown by the sitting drop vapor diffusion 
method at room temperature. The protein solution contained the protein (9.0 mg/mL) in 10 mM 
HEPES pH 7.8, 150 mM NaCl, 10% glycerol, 5 mM DTT, 5 mM MgCl2; the precipitant 
contained 25% PEG3350, 100 mM TRIS pH 8.5, 200 mM MgCl2, and 20% glycerol.  
The crystals of no-activity protein/Uniprot ID A5KUH4 from Vibrionales bacterium 
liganded with Mg2+, and glycerol (3R25) were grown by sitting drop vapor diffusion method at 
room temperature. The protein solution contained the protein (44 mg/mL) in 10 mM Tris (pH 
8.0), and 5 mM MgCl2; the precipitant contained 0.5 M magnesium formate, and 0.1 M Bis-Tris 
(pH 6.5). 
The crystals of the no-activity protein/ Uniprot ID A5KUH4 from Vibrionales bacterium 
liganded with Mg2+ and D-arabinonate (3SBF) were grown by the sitting drop vapor diffusion 
method at room temperature. The protein solution contained the protein (116 mg/mL) in 10 mM 
Tris (pH 7.8), 5 mM MgCl2, and 40 mM D-arabinonate; the precipitant contained 10% 
PEG3350, 0.1 M HEPES (pH 7.5), 0.2 M L-proline, and 5 mM MgCl2.  
The crystals of no-activity protein/Uniprot ID D0X4R4 from Vibrio harveyi liganded 
with Mg2+, Cl-, glycerol, maleic acid, and malonic acid (4GIS) were grown by the sitting drop 
vapor diffusion method at room temperature. The protein solution contained the protein (13.56 
mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 mM MgCl2; the 
precipitant contained 35% Tascimate pH 7.0, 20% glycerol and 50 mM MgCl2.  
The crystals of no-activity protein/Uniprot ID D0X4R4 from Vibrio harveyi liganded 
with Mg2+, Cl-, 1,2-ethanediol, Na+, and SO42- (4GIR) were grown by the sitting drop vapor 
diffusion method at room temperature. The protein solution contained the protein (13.56 mg/mL) 
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in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 5 mM MgCl2; the 
precipitant contained 2 M ammonium sulfate, 20% ethylene glycol, and 50 mM MgCl2.  
The crystals of no-activity protein/Uniprot ID D0X4R4 from Vibrio harveyi liganded 
with Mg2+, Cl-, 1,2-ethanediol, glycerol, 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid 
(4GGH) were grown by the sitting drop vapor diffusion method at room temperature. The 
protein solution contained the protein (13.56 mg/mL) in 10 mM HEPES pH 7.5, 150 mM NaCl, 
10% glycerol, 1 mM DTT, 5 mM MgCl2; the precipitant contained 200 mM NaCl, 0.1 M 
HEPES, 25% PEG3350, 20% ethylene glycol, 50 mM MgCl2, and pH 7.5. 
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L-glycerate L-xylonate D-glucarate/L-
gularate 
L-galactonate L-alturonate 
D-glycerate D-xylonate L-glucarate/D-
gularate 
D-galactonate D-alturonate 
D-glycerate 3-P L-ribonate L-talonate L-fuconate L-alluronate 
meso-tartrate D-ribonate D-talonate D-fuconate D-alluronate 
L-tartrate L-lyxonate L-mannonate 6-deoxy-L-talonate L-taluronate 
D-tartrate D-lyxonate D-mannonate L-rhamnonate D-taluronate 
L-malate L-arabinonate L-idonate L-galacturonate L-glucuronate 
D-malate D-arabinonate D-idonate D-galacturonate D-glucuronate 
L-threonate D/L allarate L-gluconate L-galactonate 6-P  
D-threonate D/L galactarate D-gluconate D-gluconate 6-P  
D-erythronate L-altrarate/D-
talarate    
L-allonate L-mannuronate  
L-erythronate D-altrarate/L-
talarate 
D-allonate D-mannuronate  
D/L xylarate L-mannarate L-gulonate L-iduronate  
D/L ribarate D-mannarate D-gulonate D-iduronate  
L-arabinarate/D-
lyxarate 
L-idarate L-altronate L-guluronate  
D-arabinarate/L-
lyxarate 
D-idarate D-altronate D-guluronate  
Figure A.1. The 72 acid sugars in the acid sugar library which was used for detection of 
dehydration activity. 
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Figure A.2. The sequence alignment of one ManD from each catalytically active cluster in the 
ManD log(BLAST E-value) of -190 SSN (cluster 2, 3, 4, 5, 7, and 8) shows that His315 of 
CsManD is conserved. This alignment was generated using ESPript (www. espript.ibcp.fr). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
* 
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Figure A.3. The sequence alignment of one ManD from each cluster of screened ManDs, 
highlighting the “150-180s” loop region, shows a high degree of divergence. Most notably we 
can see a variance in loop length given by the gaps in alignment present. This alignment was 
generated using clustalW (http://embnet.vital-it.ch/software/ClustalW.html). 
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Figure A.4. Circular dichroism data shows that the secondary structure of 3BSM WT (blue 
squares) matches the secondary structure of 3BSM loop mutant (red diamonds. The low UV 
range is disrupted due to buffer conditions. 
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Figure A.5. The high degree of superposition seen in these structural overlays show that the GA 
loop mutants (tan) have the same secondary structure as wild type CsManD (3PK9, blue) or 
NaManD (2QJM, blue). The “150-180s” loop is not ordered in any structure. 
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Figure A.6. The above genome neighborhood is an example of the genomic context in which no 
activity ManDs can be found. In this case, the downstream genes of ManD in glucuronate 
metabolism are present (KdgK and KdgpA). The annotations are as follows: (1) ManD, (2) 
phosphotransferase system protein, (3) KdgK, and (4) KdgpA. 
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Table A.1. SDM primers used in this study 
Primer name Sequence 
NaManD_GA_Loop_FOR 
5'-
CATCAAGGACGCCTATGGCGCGGGTGCCGGCGGGGCCGGCGGCGGA
CCGGCCGATGCCAGCCTCC -3' 
NaManD_GA_Loop_REV 
5'- 
GGAGGCTGGCATCGGCCGGTCCGCCGCCGGCCCCGCCGGCACCCGC
GCCATAGGCGTCCTTGATG -3' 
CsManD_GA_Loop_FOR 
5'- 
CGGGCATCGAGACAACGTATGGTGTGGCAGGAGCCGGAGGGGCAG
GAGGTGGACCTGCGGACTCATC -3' 
CsManD_GA_Loop_REV 
5'- 
GATGAGTCCGCAGGTCCACCTCCTGCCCCTCCGGCTCCTGCCACACC
ATACGTTGTCTCGATGCCCG -3' 
NaManD_A314P_FOR 5'-GCTGCCACGGCCCGACCGACCTT -3’ 
NaManD_A314P_REV 5’- AAGGTCGGTCGGGCCGTGGCAGC -3’ 
CsManD_P317A_FOR 5'-GGGATTCCATGGCGCGACCGATCTGTC -3’ 
CsManD_P317A_REV 5’- GACAGATCGGTCGCGCCATGGAATCCC -3’ 
CsManD_H315N_FOR 5'-CCGTACGGGATTCAATGGCCCGACCGA -3' 
CsManD_H315N_REV 5'- GCATGCCCAAGTTACCGGGCTGGCT -3' 
CsManD_H315Q_FOR 5'-GTCCGTACGGGATTCCAGGGCCCGACC -3' 
CsManD_H315Q_REV 5'-CAGGCATGCCCTAAGGTCC CGGGCTGG -3'  
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Table A.2. Data collection and refinement statistics for D-mannonate dehydratases 
 Caulobacter sp. K31 
 
 
WT 
Caulobacter crescentus 
CB15 
 
WT 
Caulobacter 
crescentus CB15  
 
WT 
Cellvibrio japonicus      
 
 
WT 
Cellvibrio japonicus     
 
 
WT     
Chromohalobacter 
salexigens 
 
WT 
Data collection       
Space group I422 I4 I4 I422 I422 P21 
No. of molecules 3 2 2 1 1 8 
in asym. unit       
Cell dimensions       
    a (Å) 137.62 115.80 116.3 124.3 124.71 86.58 
    b (Å) 137.62 115.80 116.3 124.3 124.71 177.79 
    c (Å) 264.70 118.13 
 118.08  111.3 
110.87 109.99 
βº        102.62 
       
Resolution (Å) 2.00 2.00 1.37 1.4 1.4 1.8 
No. of unique                  85719 53061 163715 85189 85453 295193 
reflections       
Rmerge 0.091 0.082 0.090 0.076 0.071 0.081 
Completeness (%) 100.0 91.0 92.60 98.60 100.0 98.5 
       
 
      
Refinement       
Resolution (Å) 47.7-2.0 50.0-2.0 50.0-1.45 32.1-1.4 32.14-1.4 25.0-1.8 
Rcryst 0.151 0.157 0.130 0.137 0.148 0.161 
Rfree 0.204 0.196 0.188 0.152 0.161 0.194 
No. atoms       
    Protein 9479 6312 6312 3172 3076 24501 
    Waters 878 507 848 427 475 2195 
Bound ligands   GOL, CL, MG, UNL GOL, CL, MG, CO3, 
D-mannonate 
MG, GOL, CL, 
CO3 
MG, GOL, CL, 
NHE 
TARTRATE, 
MG, CL 
MG,GOL, SO4 
 
Ligand atoms 84 27 32 40 12 149 
R.m.s deviations       
    Bond lengths (Å) 0.007 0.008 0.012 0.017 0.017 0.007 
    Bond angles (°)                                                    1.222 1.223 1.454 1.732 1.628 1.1 
PDB entry                                                                 4FI4 4GME          3VCN        3V3W          3V4B 3OW1 
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 Chromohalobacter 
salexigens 
 
WT 
Chromohalobacter 
salexigens 
 
WT 
Chromohalobacter 
salexigens 
 
WT   
Chromohalobacter 
salexigens 
 
WT 
Chromohalobacter 
salexigens 
 
WT 
Chromohalobacter    
salexigens 
  
Mutant  P317A 
Data collection       
Space group C2 P21212 P422 C2 P212121 C2 
No. of molecules 8 4 1 8 8 8 
in asym. unit       
Cell dimensions       
    a (Å) 195.54 110.71 111.39 195.27 110.24 196.33 
    b (Å) 85.78 179.66 111.39 85.76 167.26 85.79 
    c (Å) 195.14 85.42 84.58 195.10 168.86 195.64 
βº   110.33   110.31  110.47 
       
Resolution (Å) 1.55 1.9 1.8 1.64 1.8 1.7 
No. of unique                  398136 133334 49800 366762 286929 332505 
reflections       
Rmerge 0.093 0.106 0.120 0.078 0.109 0.095 
Completeness (%) 91.0 99.2 100.0 99.8 99.8 99.4 
       
       
Refinement       
Resolution (Å) 25.0-1.55 25.0-1.9 30.9-1.4 25.0-1.64 25.0-1.8 25.0-1.7 
Rcryst 0.179 0.178 0.146 0.158 0.199 0.168 
Rfree 0.211 0.222 0.171 0.184 0.241 0.202 
No. atoms       
    Protein 25315 12349 3236 24894 24392 25043 
    Waters 2513 857 343 2889 1871 3144 
Bound ligands   Mg, D-Gluconate 
 
Co,  
D-arabinohydroxamate 
MG, CL, NA MG, GOL D-mannonate 
MG, KDG 
D-gluconate, 
MG, GOL, CL 
Ligand atoms 128 52 14 57 108 124 
R.m.s deviations       
    Bond lengths (Å) 0.006 0.007 0.008 0.006 0.007 0.007 
    Bond angles (°)                                                    1.06 1.06 1.052 1.0 1.1 1.0 
PDB entry                                                                 3QKE 3RGT 4F4R 3PK7 3P93 3QKF                         
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Clostridium 
beijerincki 
 
WT 
Dickeya dadantii 
Ech703 
 
WT 
Enterobacter SP. 
638 
 
WT 
Enterococcus 
gallinarum EG2 
 
WT 
Escherichia coli 
CFT073 
 
WT 
Novosphingobium  
aromaticivorans 
 
Mutant A314P   
Data collection       
Space group P4212 C2 P42212 I422 P4                                                       C2221
No. of molecules 2 8 4 1 4                                                                   4
in asym. unit       
Cell dimensions       
    a (Å) 111.26 224.33 182.15 115.94 123.78 116.22 
    b (Å) 111.26 224.35 182.15 115.94 123.78 165.36 
    c (Å) 139.80 87.08 104.80 119.97 112.21 167.20 
βº        90.0, 90.0, 90.0  
       
Resolution (Å) 1.7 1.94 1.8 1.48 1.95 (1.95-2.0)                      1.65
No. of unique                  85180 277432 113519 67893   122958                    191348 
reflections       
Rmerge 0.096 0.19 0.129 0.056 0.116 (0.663)                     0.088 
Completeness (%) 88.1 88.2 99.2 99.9 99.9 (100.0)                     98.9 
       
       
Refinement       
Resolution (Å) 25.0-1.7 40.0-2.0 128.8-1.8 47.6-1.48 29.83-1.95                     25.0-1.65 
Rcryst 0.243 0.175 0.252 0.124 0.166 0.158 
Rfree 0.285 0.228 0.282 0.162 0.198                    0.183 
No. atoms       
    Protein 6183 24589 12620 3174 12364                                                   12435
    Waters 326 1978 1329 405 472                           1003 
Bound ligands   Mg GOL, CL, MG, IOD, 
FMT 
CL, MG, GOL GOL, CL, MG MG 
                      
D-mannonate 
MG, PGE, PDO 
Ligand atoms 2 147 46 9 4                        116 
R.m.s deviations       
    Bond lengths (Å) 0.007 0.01 0.011 0.008 0.01                         0.006 
    Bond angles (°)                                                    1.07 1.437 1.274 1.248 1.5                      1.1 
PDB entry                                                                 3S47 4IHC 3TJI 4HNL 4IL2                                           3R4E 
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  Novosphingobium  
aromaticivorans 
 
Loop mutant 
Pantoea ananatis 
 
 
WT 
Pectobacterium 
carotovorum PC1 
 
WT 
Salmonella 
enterica P125109 
 
WT 
Salmonella 
enterica P125109 
 
WT 
Salmonella 
enterica P125109 
 
WT 
Data collection       
Space group I422 P4212 C2 P42212 I422 I422 
No. of molecules 1 2 4 4 5 5 
in asym. unit       
Cell dimensions       
    a (Å) 125.77 130.79 204.28 177.53 144.68 144.73 
    b (Å) 124.77 130.79 86.34 177.53 144.68 144.73 
    c (Å) 119.74 104.68 114.46 110.15 446.80 447.00 
βº   90.0, 90.0, 90.0  123.07    
       
Resolution (Å) 1.25 (1.25-1.28) 1.6 2.0 1.65 1.76 1.76 
No. of unique                  131204 110754 113519 209416 233074 232167 
reflections       
Rmerge 0.093 (0.766) 0.1 0.077 0.129 0.177 0.18 
Completeness (%) 100.0 (100.0) 99.0 99.2 100.0 100.0 99.8 
       
       
Refinement       
Resolution (Å) 29.9-1.25 21.2-1.6 50.0-2.0 50.0-1.7 50.0-1.8 40.0-1.76 
Rcryst 0.141 0.139 0.190 0.212 0.169 0.171 
Rfree 0.148 0.168 0.245 0.252 0.206 0.206 
No. atoms       
    Protein 3072 6454 12295 12522 16120 16139 
    Waters 534 954 730 1171 2002 2016 
Bound ligands   GLYCEROL, MG D-GLUCONATE 
MG, CL, EDO 
FORMATE, CL, 
MG, GOL 
GLYCEROL, CL GLYCEROL, CL, 
MG 
GLUCONATE, 
CL, MG, GOL 
Ligand atoms 7 67 90 35 61 115 
R.m.s deviations       
    Bond lengths (Å) 0.006 0.016 0.007 0.013 0.009 0.013 
    Bond angles (°)                                                    1.1 1.771 1.034 1.448 1.274 1.497 
PDB entry                                        4K8G    3T6C 4E4F  3TW9                    3TWA 3TWB 
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 Sphingomonas SP. 
SKA58 
 
WT 
Vibrionales bacterium 
 
 
WT 
Vibrionales bacterium 
 
 
P311A 
Vibrio harveyi 
 
 
WT 
Vibrio harveyi 
 
 
WT 
Vibrio harveyi 
 
 
WT 
Data collection       
Space group I422 I222 P42212 I4122 P41212 C2221 
No. of molecules 3 8 4 2 4 4 
in asym. unit       
Cell dimensions       
    a (Å) 124.8 167.99 163.37 181.20 146.84 92.95 
    b (Å) 124.8 211.52 163.37 181.20 146.84 209.55 
    c (Å) 343.09 211.67 110.41 115.83 169.52 208.47 
βº         
       
Resolution (Å) 1.8 1.6 1.5 1.8 2.0 1.9 
No. of unique                  123065 419783 232178 88533 113621 158060 
reflections       
Rmerge 0.077 0.089 0.083 0.133 0.133 0.113 
Completeness (%) 98.60 86.2 98.3 100.0 91.7 99.2 
       
       
Refinement       
Resolution (Å) 171.55-1.8 25.0-1.6 25.0-1.5 29.0-1.8 38.2-1.8 93.6-1.8 
Rcryst 0.138 0.161 0.180 0.152 0.149 0.169 
Rfree 0.165 0.186 0.206 0.183 0.193 0.203 
No. atoms       
    Protein 9540 25388 12660 6489 12973 12760 
    Waters 1142 1827 1397 788 1357 1694 
Bound ligands   MG, GOL, CL, UNX Mg, GOL Mg, D-Arabinonate CL, MG, GOL, 
MAE, MLA 
CL, MG, GOL, 
EDO, SO4,NA 
CL, MG, GOL, 
EDO, EPE 
Ligand atoms 59 58 79 39 54 141 
R.m.s deviations       
    Bond lengths (Å) 0.007 0.006 0.006 0.007 0.009 0.008 
    Bond angles (°)                                                    1.057 0.98 1.06 1.118 1.088 1.096 
PDB entry                                                                 3THU             3R25 3SBF                         4GIS 4GIR 4GGH 
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Table A.3. List of all structures solved in the ManD subgroup. 
PDB Bound Uniprot ID Activity 
4FI4 Glycerol, Mg2+ B0T0B1 D-Mannonate (12000 M-1s-1)  
3THU Glycerol, Mg2+ Q1NAJ2 D-Mannonate (4200 M-1s-1)  
4GME D-Mannonate, Mg2+ Q9AAR4 D-Mannonate (12300 M-1s-1)  
3VCN Glycerol, Mg2+ Q9AAR4 D-Mannonate (12000 M-1s-1)  
2QJJ* Mg2+ A4XF23 D-Mannonate (3200 M-1s-1)  
2QJM*,** D-Mannonate, Mg2+ A4XF23 D-Mannonate (3200 M-1s-1)  
2QJN* 2-keto-3-deoxy-D-Gluconate, Mg2+ A4XF23 D-Mannonate (3200 M-1s-1)  
3R4E** D-Mannonate, Mg2+ A4XF23 D-Mannonate (3200 M-1s-1)  
4K8G** Glycerol, Mg2+ A4XF23 D-Mannonate (3200 M-1s-1)  
3V3W Glycerol, Mg2+ B3PDB1 D-Mannonate (100 M-1s-1)  
3V4B Tartrate, Mg2+ B3PDB1 D-Mannonate (100 M-1s-1)  
3BSM* Apo CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
3OW1 Sulfate, Mg2+ CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
3PK7 Glycerol, Mg2+ CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
4F4R Glycerol, Mg2+ CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
3P93 2-keto-3-deoxy-D-Gluconate, Mg2+ CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
3QKE D-Gluconate, Mg2+ CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
3QKF** D-Gluconate, Mg2+ CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
3RGT D-Arabinohydroxamate, Co2+ CsManD/Q1QT89 D-Mannonate (5 M-1s-1) D-Gluconate (40 M-1s-1)  
3T6C D-Gluconate, Mg2+ D4GJ14 D-Gluconate (120 M-1s-1)  
3TW9 Glycerol B5R541 D-Gluconate (80 M-1s-1)  
3TWA Glycerol, Mg2+ B5R541 D-Gluconate (80 M-1s-1)  
3TWB D-Gluconate, Mg2+ B5R541 D-Gluconate (80 M-1s-1)  
4IHC Glycerol, Mg2+ C6CBG9 D-Mannonate (60 M-1s-1) D-Gluconate (50 M-1s-1)  
4E4F Glycerol, Mg2+ C6D9S0 D-Mannonate (N/A M-1s-1)  
4IL2 Mg2+ Q8FHC7 D-Mannonate (10 M-1s-1)  
3DFH* Apo A5KUH4 None 
3R25 Glycerol, Mg2+ A5KUH4 None 
3SBF** D-Arabinonate, Mg2+ A5KUH4 None 
3TJI Glycerol, Mg2+ A4W7D6 None 
3GY1* Mg2+ A6M2W4 None 
3S47 Mg2+ A6M2W4 None 
4GIS Glycerol, Mg2+, maleic acid, malonic acid D0X4R4 None 
4GIR Mg2+, HEPES, ethylene glycol D0X4R4 None 
4GGH Mg2+, HEPES, ethylene glycol D0X4R4 None 
4HNL Glycerol, Mg2+ C8ZZN2 None 
*denote structures solved in previous studies 
**mutant proteins 
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APPENDIX: B 
 
Figure B.1. Growth of Caulobacter crescentus NA1000 wild type and the indicated strains 
grown on M2 minimal salts media with D-glucuronate as the sole source of carbon. WT (purple 
circles), WT complemented with B8GZZ7 in pSRK-Kan (red squares), ∆B8GZZ7 
complemented with B8GZZ7 in pSRK-Kan (blue diamonds), and ∆B8GZZ7 (orange triangles).  
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Figure B.2. A SSN of the ManDs that cluster with B8GZZ7 (highlighted in red) at a log(BLAST 
E_value) of -185 (~70% identity). 
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Table B.1. Compounds screened via ThermoFluor 
D-altrarate/L-talarate  D-threose  D-altrose   trans-ferulate D-tryptophan suberate 
L-altrarate/D-talarate     L-threose  L-altrose   trans-cinnamate L-tyrosine tetradecandiate 
L-mannarate  D-erythrose  D-allose   hydrocinnamate D-tyrosine N-caproate 
D-mannarate  L-erythrose  L-allose   gallate L-asparagine malonate 
L-idarate  D-arabinose  L-fucose   syringic D-asparagine meleate 
D-idarate  L-arabinose  D-fucose   sinapate L-glutamine D/L-malate 
D-glucarate/L-gularate  D-lyxose  D-arabitol L-alanine D-glutamine fumarate 
L-glucarate/D-gularate  L-lyxose  D-mannitol D-alanine L-histidine succinate 
L-galacturonate  D-xylose  ribitol L-serine D-histidine pyruvate 
D-galacturonate  L-xylose  galacitol D-serine L-aspartate 2-oxobutyrate 
L-glucuronate  D-ribose  D-sorbitol L-threonine D-aspartate 2-oxovalerate 
D-glucuronate  L-ribose  xylitol D-threonine L-glutamate D/L-lactate 
L-mannuronate  D-galactose  myo-inositol L-valine D-glutamate mandelate 
D-mannuronate  L-galactose  benzoate D-valine L-arginine fructose/lactose 
L-iduronate  D-glucose  3-hydroxybenzoate L-leucine D-arginine maltose/sucrose 
D-iduronate  L-glucose  4-hydroxybenzoate D-leucine L-lysine trehalose/D-(+)raffinose 
L-guluronate  D-mannose  3,4-dihydroxybenzoate L-isoleucine L-ALA-D-GLU glucosamine/N-AcGlucosamine 
D-guluronate  L-mannose  3,4-dihydroxyhydrocinnamate L-phenylalanine D-ALA-D-ALA 
N-acetylneuraminate/ 
N-acetylmuramate 
L-alluronate  D-idose  phenylacetate D-phenylalanine 3OH-proline ectoine/5-hydroxyectoine 
D-alluronate  L-idose  3,4-dihydroxylphenylacetate L-proline 4OH-proline 
glycinebetaine/prolinebetaine/ 
4OH-prolinebetaine 
L-taluronate  D-gulose   benzoylformate D-proline 2,6-diaminopimelate 
D-taluronate  L-gulose   vanillate L-methionine 5-aminolevulinate 
L-alturonate  D-talose   caffeate D-methionine pyroglutamate 
D-alturonate  L-talose   p-coumarate L-tryptophan adipate 
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Table B.2. Uniprot IDs of ManDs that cluster with B8GZZ7 at a log(BLAST E-value) of -185 
Uniprot ID Organism 
H0FAQ8 Achromobacter arsenitoxydans SY8. 
D4X6T3 Achromobacter piechaudii ATCC 43553. 
J4Y6C9 Achromobacter piechaudii HLE. 
E3HXJ3 Achromobacter xylosoxidans (strain A8). 
F7T116 Achromobacter xylosoxidans AXX-A. 
E5U881 Achromobacter xylosoxidans C54. 
R4XUN6 Achromobacter xylosoxidans NH44784-1996. 
F4QU87 Asticcacaulis biprosthecum C19. 
F4QMQ4 Asticcacaulis biprosthecum C19. 
E8RU01 Asticcacaulis excentricus (strain ATCC 15261 / DSM 4724 / VKM B-1370 /CB 48). 
G1XZX5 Azospirillum amazonense Y2. 
G1Y3L2 Azospirillum amazonense Y2. 
A9I6B4 Bordetella petrii (strain ATCC BAA-461 / DSM 12804 / CCUG 43448). 
U2Z8M6 Brevundimonas abyssalis TAR-001. 
H5WQ02 Burkholderiales bacterium JOSHI_001. 
B8GZZ7 Caulobacter crescentus (strain ATCC 19089 / CB15). 
Q9A4L8 Caulobacter crescentus (strain ATCC 19089 / CB15). 
B8GZZ7 Caulobacter crescentus (strain NA1000 / CB15N). 
B8H1R9 Caulobacter crescentus (strain NA1000 / CB15N). 
R0EHE5 Caulobacter crescentus OR37. 
D5VMM7 Caulobacter segnis (strain ATCC 21756 / DSM 7131 / JCM 7823 / NBRC15250 / LMG 17158 / TK0059) 
D5VIA4 Caulobacter segnis (strain ATCC 21756 / DSM 7131 / JCM 7823 / NBRC15250 / LMG 17158 / TK0059) 
B0T4L2 Caulobacter sp. (strain K31). 
B0T0B1 Caulobacter sp. (strain K31). 
J2GJ67 Caulobacter sp. AP07. 
J2GPJ8 Caulobacter sp. AP07. 
C9YAX2 Curvibacter putative symbiont of Hydra magnipapillata. 
C6XQG0 Hirschia baltica (strain ATCC 49814 / DSM 5838 / IFAM 1418). 
A4XF23 Novosphingobium aromaticivorans (strain DSM 12444). 
T0H4U1 Novosphingobium lindaniclasticum LE124. 
F6IDM5 Novosphingobium sp. PP1Y. 
I9C4A3 Novosphingobium sp. Rr 2-17. 
B4RGH9 Phenylobacterium zucineum (strain HLK1). 
Q125C0 Polaromonas sp. (strain JS666 / ATCC BAA-500). 
J3DGV2 Polaromonas sp. CF318. 
I5BD85 Sphingobium indicum B90A. 
D4Z888 Sphingobium japonicum (strain NBRC 101211 / UT26S). 
N1MUR2 Sphingobium japonicum BiD32. 
T0HEJ9 Sphingobium lactosutens DS20. 
T0HV29 Sphingobium lactosutens DS20. 
J2CPU4 Sphingobium sp. AP49. 
T0GGY0 Sphingobium sp. HDIP04. 
T0JBK1 Sphingobium ummariense RL-3. 
K9D2S0 Sphingobium yanoikuyae ATCC 51230. 
J8VM37 Sphingomonas sp. LH128. 
M4S302 Sphingomonas sp. MM-1. 
M4S4D7 Sphingomonas sp. MM-1. 
Q1NAJ2 Sphingomonas sp. SKA58. 
A5V6Z0 Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273). 
A5V7I3 Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273). 
C5CMZ1 Variovorax paradoxus (strain S110). 
T1XA18 Variovorax paradoxus B4. 
J3CQN2 Variovorax sp. CF313. 
A1WNS2 Verminephrobacter eiseniae (strain EF01-2). 
T1WB97 uncultured organism. 
T1WB73 uncultured organism. 
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APPENDIX: C 
 
 
L-glycerate L-xylonate D-glucarate/L-
gularate 
L-galactonate L-alturonate 
D-glycerate D-xylonate L-glucarate/D-
gularate 
D-galactonate D-alturonate 
D-glycerate 3-P L-ribonate L-talonate L-fuconate L-alluronate 
meso-tartrate D-ribonate D-talonate D-fuconate D-alluronate 
L-tartrate L-lyxonate L-mannonate 6-deoxy-L-talonate L-taluronate 
D-tartrate D-lyxonate D-mannonate L-rhamnonate D-taluronate 
L-malate L-arabinonate L-idonate L-galacturonate L-glucuronate 
D-malate D-arabinonate D-idonate D-galacturonate D-glucuronate 
L-threonate D/L allarate L-gluconate L-galactonate 6-P  
D-threonate D/L galactarate D-gluconate D-gluconate 6-P  
D-erythronate L-altrarate/D-
talarate    
L-allonate L-mannuronate  
L-erythronate D-altrarate/L-
talarate 
D-allonate D-mannuronate  
D/L xylarate L-mannarate L-gulonate L-iduronate  
D/L ribarate D-mannarate D-gulonate D-iduronate  
L-arabinarate/D-
lyxarate 
L-idarate L-altronate L-guluronate  
D-arabinarate/L-
lyxarate 
D-idarate D-altronate D-guluronate  
 
Figure C.1. The 72 acid sugars in the acid sugar library used for screening CsGulDH and CsFR 
homologues for oxidation. 
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Figure C.2. Compounds screened via ThermoFluor 
 
 
D-altrarate/L-talarate  D-threose  D-altrose   trans-ferulate D-tryptophan suberate 
L-altrarate/D-talarate     L-threose  L-altrose   trans-cinnamate L-tyrosine tetradecandiate 
L-mannarate  D-erythrose  D-allose   hydrocinnamate D-tyrosine N-caproate 
D-mannarate  L-erythrose  L-allose   gallate L-asparagine malonate 
L-idarate  D-arabinose  L-fucose   syringic D-asparagine meleate 
D-idarate  L-arabinose  D-fucose   sinapate L-glutamine D/L-malate 
D-glucarate/L-gularate  D-lyxose  D-arabitol L-alanine D-glutamine fumarate 
L-glucarate/D-gularate  L-lyxose  D-mannitol D-alanine L-histidine succinate 
L-galacturonate  D-xylose  ribitol L-serine D-histidine pyruvate 
D-galacturonate  L-xylose  galacitol D-serine L-aspartate 2-oxobutyrate 
L-glucuronate  D-ribose  D-sorbitol L-threonine D-aspartate 2-oxovalerate 
D-glucuronate  L-ribose  xylitol D-threonine L-glutamate D/L-lactate 
L-mannuronate  D-galactose  myo-inositol L-valine D-glutamate mandelate 
D-mannuronate  L-galactose  benzoate D-valine L-arginine fructose/lactose 
L-iduronate  D-glucose  3-hydroxybenzoate L-leucine D-arginine maltose/sucrose 
D-iduronate  L-glucose  4-hydroxybenzoate D-leucine L-lysine trehalose/D-(+)raffinose 
L-guluronate  D-mannose  3,4-dihydroxybenzoate L-isoleucine L-ALA-D-GLU glucosamine/N-AcGlucosamine 
D-guluronate  L-mannose  3,4-dihydroxyhydrocinnamate L-phenylalanine D-ALA-D-ALA 
N-acetylneuraminate/ 
N-acetylmuramate 
L-alluronate  D-idose  phenylacetate D-phenylalanine 3OH-proline ectoine/5-hydroxyectoine 
D-alluronate  L-idose  3,4-dihydroxylphenylacetate L-proline 4OH-proline 
glycinebetaine/prolinebetaine/ 
4OH-prolinebetaine 
L-taluronate  D-gulose   benzoylformate D-proline 2,6-diaminopimelate 
D-taluronate  L-gulose   vanillate L-methionine 5-aminolevulinate 
L-alturonate  D-talose   caffeate D-methionine pyroglutamate 
D-alturonate  L-talose   p-coumarate L-tryptophan adipate 
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Figure C.3.  Genome neighborhood of the genes encoding the D-glucuronate pathway in 
Chromohalobacter salexigens DSM3043.  Enzymes are highlighted in green: uronate 
dehydrogenase (Uniprot ID Q1QUN7), D-galactarolactone cycloisomerase (Uniprot ID 
Q1QUN5; Gci), amidohydrolase (Uniprot ID Q1QUN6), glucarate dehydratase (Uniprot ID 
Q1QUM5: GlucD), and 5-dehydro-4-deoxy-D-glucarate dehydratase (Uniprot ID Q1QUM4).  
The TRAP transport system is highlight in red.  A GntR regulator is highlighted in orange. 
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Figure C.4.  qRT-PCR data for D-glucuronate metabolism in C. salexigens DSM3043 
(D-glucuronate vs. D-glucose).  
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Figure C.5.   qRT-PCR data of the RspABCD genes in Salmonella enterica serovar Enteritidis 
str. P125109, comparing growth on L-gulonate to D-glucose.  Cells were grown as described in 
the Material and Methods section to an optical density of 0.4 - 0.5 at 600 nm (early log phase).   
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Figure C.6.  qRT-PCR data of the SeGlcD genome neighborhood in Salmonella enterica serovar 
Enteritidis str. P125109, comparing growth on L-Idonate to D-glucose at varying concentrations.  
Cells were grown as described in the Material and Methods section to an optical density of 0.4 - 
0.5 at 600 nm (early log phase).   
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Figure C.7.  qRT-PCR data of the SeGlcD genome neighborhood in Salmonella enterica serovar 
Enteritidis str. P125109, comparing growth on D-gluconate to D-glucose at varying 
concentrations.  Cells were grown as described in the Material and Methods section to an optical 
density of 0.4 - 0.5 at 600 nm (early log phase). 
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Table C.1. PCR primers used in this study 
Purpose Primer name Sequence 
Cloning RspB_FOR 
5’- 
AATGGTTATCTCTAAAAAAGAGGTAGGATCCGTACTACTT
ACTCG -3’ 
Cloning RspB_REV 
5’- CGGCGAAATATCCATATGAACCTGCTTATCTGCCAGT -
3’ 
Cloning RspD_FOR 5’- GATCAACCACATGTTGTAAGAGCTCCGCAACCGTCC -3’ 
Cloning RspD_REV 5’- GTCTGACCGCTGAGCGGATCCGCCGC -3’ 
Cloning CsGntR_FOR 5’- GCAGGGTTTTCATATGACGCCATCGC -3’ 
Cloning CsGntR_REV 5’- GTCGCGAATCCTCATGCACTGACTC -3’ 
RT-PCR CsGntR_RTPCR_FOR 5’- GCGAAGCCTTCATTCGTCTC -3’ 
RT-PCR CsGntR_RTPCR_REV 5’- GAGTTCATGCAGCTCGTCGT -3’ 
RT-PCR CsManD_RTPCR_FOR 5’- CGACTATCGCTTCGAGGATG -3’ 
RT-PCR CsManD_RTPCR_REV 5’- TACTTGGCAGCGAGTTCCTC -3’ 
RT-PCR CsAD_RTPCR_FOR 5'- ACCGTCTGCGACGTCATC -3' 
RT-PCR CsAD_RTPCR_REV 5’- AGGTCCTGTCGTTGTCCATT-3’ 
RT-PCR CsDctP_RTPCR_FOR 5'- ATGGCCTTCAGCGAGGTATTC -3' 
RT-PCR CsDctP_RTPCR_REV 5’- GGCATCGATTCGAGCTTCTG -3’ 
RT-PCR CsDctQ_RTPCR_FOR 5'- CTGATCTGTCTCGCGGTAGG -3' 
RT-PCR CsDctQ_RTPCR_REV 5'- GCGGTCAAGCCAAAGAGAAC -3' 
RT-PCR CsDctM_RTPCR_FOR 5’- CATCGACACCGTCCTGACC -3’ 
RT-PCR CsDctM_RTPCR_REV 5’- TCCATGAAGGTACCCACCAC -3’ 
RT-PCR CsFR_RTPCR_FOR 5’- GAGCGAACCCGATGTACG -3’ 
RT-PCR CsFR_RTPCR_REV 5’- GCATCGAGCCGTAGTCGT -3’ 
RT-PCR CsUxuA_RTPCR_FOR 5'- TACCATCATCGCCGGACT -3' 
RT-PCR CsUxuA_RTPCR_REV 5’- GCATCGATCTCGGCATACTC-3’ 
RT-PCR CsRpoD_RTPCR_FOR 5'- GTCTCGCACATCAAGGAAGTC -3' 
RT-PCR CsRpoD_RTPCR_REV 5’- AGGTTGGCCTCGACCATT-3’ 
RT-PCR CsUdh_RTPCR_FOR 5'- GTTCGCCAGTTCCAATCACAC -3' 
RT-PCR CsUdh_RTPCR_REV 5'- GAACCGATGCGTATGTTGAGG -3' 
RT-PCR CsGci_RTPCR_FOR 5’- GCGGCAATCACTTTCACGTC -3’ 
RT-PCR CsGci_RTPCR_REV 5’- ATATCAAGGGCAAGCATTACGG -3’ 
RT-PCR CsAH_RTPCR_FOR 5’- GGGACTGGCATGACAAAGG -3’ 
RT-PCR CsAH_RTPCR_REV 5’- GATCCGCGAGGTAATCGTTC -3’ 
RT-PCR CsGlucD_RTPCR_FOR 5'- CCTTCGAGGTTGCCTTTCTC -3' 
RT-PCR CsGlucD_RTPCR_REV 5’- ATCGACTGGAAGCCGTATTGG -3’ 
RT-PCR CsKdgD_RTPCR_FOR 5'- GTATTGACGCCAATGGAGAGG -3' 
RT-PCR CsKdgD_RTPCR_REV 5’- CAACCGTGGCAATGGTGTTCT -3’ 
RT-PCR SeRspA_RTPCR_FOR 5’- TACCCATGCCGGTGGTATTAC -3’ 
RT-PCR SeRspA_RTPCR_REV 5’-CCCTCGAACGTCCAGTTATG-3’ 
RT-PCR SeRspB_RTPCR_FOR 5’- ATCGCATACCGGACAACATCG-3’ 
RT-PCR SeRspB_RTPCR_REV 5’- GCCATCGCTAAACGCTCTTCA -3’ 
RT-PCR SeRspC_RTPCR_FOR 5’- CGTTAACGCCTGCGTCAGAAA -3’ 
RT-PCR SeRspC_RTPCR_REV 5’- ATTAACGCATCGGTTGGGATAG-3’ 
RT-PCR SeRspD_RTPCR_FOR 5’- TCTATACCGTGGCGGAGATG -3’ 
RT-PCR SeRspD_RTPCR_REV 5’- CATGGGATGTTCCAGCAGAAG-3’ 
RT-PCR SeGlcD_RTPCR_FOR 5’- TTTCTGGTTGGCAAAGATCC-3’ 
RT-PCR SeGlcD_RTPCR_REV 5’- CAACTTCATCACCACCATCG-3’ 
RT-PCR SeIdoDH_RTPCR_FOR 5’- GCAATGCATTCCTTACGACA-3’ 
RT-PCR SeIdoDH_RTPCR_REV 5’- AATGGGCAACCTGTTCTTCA-3’ 
RT-PCR SeGlucDH_RTPCR_FOR 5’- GTGCACGGGTTATCCTGAAT-3’ 
RT-PCR SeGlucDH_RTPCR_REV 5’- AATGCGCTGGTCAGGTTAGT-3’ 
Knockout SeRspA_KO_FOR 
5’- 
TTTCCTGCATCCCATAATGCGATGTAAGGAATAAAAATGT
GTAGGCTGGAGCTGCTTCG -3’ 
Knockout SeRspA_KO_REV 
5’- 
GTTTTTCGATTACGATGCTTTTCATTTTTCGCTCCTTACATA
TGAATATCCTCCTTAG -3’ 
Knockout SeRspB_KO_FOR 5’- 
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AAGACGGCACACTGTGGAACTGGTAAGGAGCGAAAAATG
TGTAGGCTGGAGCTGCTTCG -3’ 
Knockout SeRspB_KO_REV 
5’- 
GGTAAGATGCGTACCACTTACTCGCAATTATTTATATTATT
TCGCCATATGAATATCCTCCTTAG-3’ 
Knockout KO_CsAD_EcoRI_OE_FOR 
5'-
CGACCTGCACGTCCTGCACGAATTCCACCATCGCCTGACG
CC -3' 
Knockout KO_CsAD_EcoRI_OExt_REV 5’- GGCGCATCGCGCGATGCGGACGGACTCCGCTCTGG -3’ 
Knockout KO_CsAD_HindIII_OExt_FOR 5'- CCAGAGCGGAGTCCGTCCGCATCGCGCGATGCGCC -3' 
Knockout KO_CsAD_HindIII_OE_REV 
5’- 
CGCCTGCCAGGTATCGACGAAAAGCTTCACGTTGGGTACG
CGCAGC -3’ 
Knockout KO_CsFR_EcoRI_OE_FOR 
5'- 
GACCTTCATCATTCTCTACGGAATTCTCGGCGGCGTTTTCA
CCCCCACCG -3' 
Knockout KO_CsFR_EcoRI_OExt_REV 
5'- 
CCAGGTGTGTTCCATGGTCGTCTCGAACGATCACTCCCCGA
GCAGC -3' 
Knockout KO_CsFR_HindIII_OExt_FOR 
5’- 
GCTGCTCGGGGAGTGATCGTTCGAGACGACCATGGAACAC
ACCTGG -3’ 
Knockout KO_CsFR_HindIII_OE_REV 
5’- 
GTGGCCGAGGTTGTCGCGCAAGCTTTCGGCATCGATCTCG
GCATAC -3’ 
Knockout KO_CsFRUxuA_EcoRI_OE_FOR 
5’- 
GATGACCTTCATCATTCTCTACGGAATTCTCGGCGGCGTTT
TCACCCCCACCG -3’ 
Knockout KO_CsFRUxuA_EcoRI_OExt_REV 
5’- 
CCTGGGAGCGGGTCGTCTCGAACGATCACTCCCCGAGCAG 
-3’ 
Knockout KO_CsFRUxuA_HindIII_OExt_FOR 
5'- 
CTGCTCGGGGAGTGATCGTTCGAGACGACCCGCTCCCAGG 
-3' 
Knockout KO_CsFRUxuA_HindIII_OE_REV 
5’- GACCGGTGCCTCCGCAAGCTTGGCGAGCAGCGCCTCC -
3’ 
Knockout KO_CsUxuA_EcoRI_OE_FOR 
5'- 
CGGCATCGAAACGGTGGCAGAAGCCGTCGAGCGCCCTGAA
TTCG -3' 
Knockout KO_CsUxuA_EcoRI_OExt_REV 
5’- CGTCCCCCTCCTGGGAGCGGGTCGTCTCCTATCGTGTGC 
-3’ 
Knockout KO_CsUxuA_HindIII_OExt_FOR 
5'- 
GCACACGATAGGAGACGACCCGCTCCCAGGAGGGGGACG 
-3' 
Knockout KO_CsUxuA_HindIII_OE_REV 
5’- GACCGGTGCCTCCGCAAGCTTGGCGAGCAGCGCCTCC -
3’ 
Knockout KO_CsManD_BamHI_OE_FOR 
5'- 
CGCCAGCCGGTCCGCGGATCCTTCATTCGTCTCTCGGAGG -
3' 
Knockout KO_CsManD_BamHI_OExt_REV 
5’- 
GCTCTGGATAAGGGAAGACGGGACTTCATGCACTGACTCC
AGAGGGCAGC -3’ 
Knockout KO_CsManD_HindIII_OExt_FOR 
5'- 
GCTGCCCTCTGGAGTCAGTGCATGAAGTCCCGTCTTCCCTT
ATCCAGAGC -3' 
Knockout KO_CsManD_HindIII_OE_REV 
5’- 
GTCCATTGACGGTGAAGCTTGCGCCCAGCGAGCGGGCGG -
3’ 
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Table C.2. CsGntR ThermoFluor hits 
Substrate ∆Tm 
Mandelate  9.4 
D-Mannonate  7.1 
D/L-Lactate  6.2 
L-Arabinarate/D-Lyxarate  4.9 
D-Lyxonate  3.6 
D-Tryptophan  2.7 
Pyruvate  2.5 
D-Arabinarate/L-Lyxarate  2.4 
Gallate  2.2 
L-Gulonate  2.1 
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APPENDIX: D 
 
Figure D.1. Sequence alignment of human rTS isoforms and the structural homologue XcFucD. 
Secondary structure elements from the HsrTSγ structure are shown on top of the aligned 
sequences of HsrTSα/β/γ isoforms and XcFucD (PDB code 2HXT). Putative catalytic residues 
inferred from the XcFucD structure are indicated as black dots. 
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Figure D.2. The list of 72 acid sugars in the acid sugar library, which were used for detection of 
dehydration activity. 
 
 
 
L-glycerate L-xylonate D-glucarate/L-
gularate 
L-galactonate L-alturonate 
D-glycerate D-xylonate L-glucarate/D-
gularate 
D-galactonate D-alturonate 
D-glycerate 3-P L-ribonate L-talonate L-fuconate L-alluronate 
meso-tartrate D-ribonate D-talonate D-fuconate D-alluronate 
L-tartrate L-lyxonate L-mannonate 6-deoxy-L-talonate L-taluronate 
D-tartrate D-lyxonate D-mannonate L-rhamnonate D-taluronate 
L-malate L-arabinonate L-idonate L-galacturonate L-glucuronate 
D-malate D-arabinonate D-idonate D-galacturonate D-glucuronate 
L-threonate D/L allarate L-gluconate L-galactonate 6-P  
D-threonate D/L galactarate D-gluconate D-gluconate 6-P  
D-erythronate L-altrarate/D-
talarate    
L-allonate L-mannuronate  
L-erythronate D-altrarate/L-
talarate 
D-allonate D-mannuronate  
D/L xylarate L-mannarate L-gulonate L-iduronate  
D/L ribarate D-mannarate D-gulonate D-iduronate  
L-arabinarate/D-
lyxarate 
L-idarate L-altronate L-guluronate  
D-arabinarate/L-
lyxarate 
D-idarate D-altronate D-guluronate  
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Figure D.3. A sequence similarity network for all acid sugar dehydratases and mandelate 
racemases in the enolase superfamily at an e-value threshold of 10-80 (~40% identity). rTSγ clusters 
with the L-fuconate dehydratases (olive green). All other nodes with known activities are colored 
and labeled in the legend.  Grey denotes unknown activity.  
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Figure D.4. Surface representation of HsrTSγ structure in orthogonal views. Top, structure of 
HsrTSγ highlighting the N-terminal 27 residues (cyan) and the juxtaposed C-terminal helix 
(orange). Bottom, structure of HsrTSγ with the N-terminal 27 residues deleted from the model. 
In all views, the active site is indicated by the modeled ligand L-erythronohydroxamate (sticks) 
from the homologous XcFucD structure (PDB 2HXT). 
 Figure D.5. Small scale expression and affinity purification of various 
as HsrTSβ.  TP, total cell pellet; E, elution from nickel column p
position of rTS protein in SDS-PAGE.
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HsrTSγ constructs as well 
urification. Arrow indicates 
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Table D.1. Melting temperatures (Tm) of HsrTSβ and HsrTSγ as measured by differential scanning fluorimetry (n=4) 
Tm (oC) HsrTSβ HsrTSγ 
as purified 52.77 ± 0.1 57.17 ± 0.3 
+MgCl2 53.15 ± 0.1 57.51 ± 0.4 
+MgCl2, D-ertythronohydroxamate 53.38 ± 0.1 59.48 ± 0.2 
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